Original Article
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
N Engl J Med 1996; 334:693-700March 14, 1996
- Abstract
Background
The role of orthotopic liver transplantation in the treatment of patients with cirrhosis and hepatocellular carcinoma is controversial, and determining which patients are likely to have a good outcome after liver transplantation is difficult.
Methods
We studied 48 patients with cirrhosis who had small, unresectable hepatocellular carcinomas and who underwent liver transplantation. In 94 percent of the patients, the cirrhosis was related to infection with hepatitis B virus, hepatitis C virus, or both. The presence of tumor was confirmed by biopsy or serum alpha-fetoprotein assay. The criteria for eligibility for transplantation were the presence of a tumor 5 cm or less in diameter in patients with single hepatocellular carcinomas and no more than three tumor nodules, each 3 cm or less in diameter, in patients with multiple tumors. Twenty-eight patients with sufficient hepatic function underwent treatment for the tumor, mainly chemoembolization, before transplantation. After liver transplantation, the patients were followed prospectively for a median of 26 months (range, 9 to 54). No anticancer treatment was given after transplantation.
Results
The overall mortality rate was 17 percent. After four years, the actuarial survival rate was 75 percent and the rate of recurrence-free survival was 83 percent. Hepatocellular carcinoma recurred in four patients (8 percent). The overall and recurrence-free survival rates at four years among the 35 patients (73 percent of the total) who met the predetermined criteria for the selection of small hepatocellular carcinomas at pathological review of the explanted liver were 85 percent and 92 percent, respectively, whereas the rates in the 13 patients (27 percent) whose tumors exceeded these limits were 50 percent and 59 percent, respectively (P = 0.01 for overall survival; P = 0.002 for recurrence-free survival). In this group of 48 patients with early-stage tumors, tumor–node–metastasis status, the number of tumors, the serum alpha-fetoprotein concentration, treatment received before transplantation, and 10 other variables were not significantly correlated with survival.
Conclusions
Liver transplantation is an effective treatment for small, unresectable hepatocellular carcinomas in patients with cirrhosis.
Media in This Article
Figure 1
Overall Survival (Panel A) and Recurrence-free Survival (Panel B) after Liver Transplantation in 48 Patients with Small Hepatocellular Carcinomas and Cirrhosis.Figure 2
Effect of Anticancer Treatment before Transplantation on Overall Survival (Panel A) and Recurrence-free Survival (Panel B) in 48 Patients with Cirrhosis and Hepatocellular Carcinomas.Article Activity
- Article
The value of orthotopic liver transplantation in the treatment of hepatocellular carcinoma has often been debated. Although liver replacement could be curative for patients with tumors confined to the liver, the long-term results of liver transplantation in patients with hepatocellular carcinoma have been disappointing, with an overall five-year survival rate ranging from 30 to 40 percent.1-9
In recent years, revisions of the tumor–node–metastasis (TNM) classification system9 and other systems for determining the stage of hepatocellular carcinoma10 have made possible a more detailed, retrospective analysis of treatment in these patients. In several studies, tumor stage before transplantation was directly related to the rate of recurrence of cancer after liver transplantation. Moreover, in patients with early-stage hepatocellular carcinoma, liver transplantation was more effective than resection of the liver.11-15 To examine further the efficacy of transplantation, we undertook a prospective cohort study of patients with cirrhosis who had unresectable hepatocellular carcinomas and who received liver transplants; in this study we also assessed the influence of characteristics used to select patients for transplantation on the recurrence of cancer and on survival.
Methods
Study Design
Between January 1991 and December 1994, 295 patients with hepatocellular carcinoma who were seen at the Division of Gastrointestinal Surgery of the National Cancer Institute in Milan, Italy, were judged to have cancer that was unresectable because of the location of the tumor in the liver, because the tumor was multifocal, or because the patient had advanced hepatic insufficiency related to cirrhosis. Among those 295 patients, 60 who had histologically proved cirrhosis (20 percent) were eligible for the present study because their tumors were at an early stage. The diagnosis of hepatocellular carcinoma was confirmed in all patients either by biopsy of the tumor or by a serum alpha-fetoprotein measurement above 300 ng per milliliter.
For patients with a single hepatocellular carcinoma to be eligible for the study, the tumor could not exceed 5 cm in diameter. In patients with multiple tumors, there could be no more than three tumors, none exceeding 3 cm in diameter. Patients in whom tumor invasion of blood vessels or lymph nodes was evident or suspected preoperatively were excluded.
Forty-eight patients received transplants during the study period, 1 patient died while awaiting transplantation, and 11 others were still awaiting transplantation on September 30, 1995. Once patients were accepted as candidates for transplantation, preoperative treatment of their tumor was scheduled, depending on their Child–Pugh class (indicating the adequacy of liver function) at that time (Table 1Table 1
Child–Pugh System for Grading the Severity of Liver Disease.). Patients in Child–Pugh class A (12 patients) or class B (21 patients) received anticancer treatment before transplantation (hepatic-artery chemoembolization in 26 patients, percutaneous injection of alcohol in 1 patient, and hepatic resection three years before liver transplantation in the single patient with the fibrolamellar variant of hepatocellular carcinoma). The five remaining patients who were otherwise eligible for chemoembolization were not treated for technical or anatomical reasons. The 15 patients with Child–Pugh class C hepatic insufficiency received no treatment before surgery.Because liver transplantation was considered the keystone of treatment, it was performed whenever a compatible liver became available, regardless of any scheduled anticancer therapy. So that the influence of the tumor stage before transplantation on patients' survival could be assessed, neither medical therapy nor radiation treatment was given after transplantation unless recurrence of the cancer was detected. In addition to regular post-transplantation follow-up, the tumor stage was determined every three months (by ultrasonography, chest radiography, and measurement of serum alpha-fetoprotein) in all patients; abdominal and thoracic computed tomographic (CT) scans were obtained every six months, and radionuclide bone scans were obtained every eight months. The study protocol was approved by the ethics committee of the institute, and all the patients gave informed consent for the procedures.
Characteristics of Patients and Staging Procedures
Of the 48 patients, 38 were men and 10 were women, with a median age of 52 years (range, 39 to 60). Forty-five patients had cirrhosis caused by chronic viral hepatitis (hepatitis B virus [HBV] in 11 patients, hepatitis C virus [HCV] in 32, and both HBV and HCV in 2). In all patients, viral status was assessed before and after transplantation with the latest-generation antibody-detection techniques and was confirmed by the identification of HBV DNA, HCV RNA, or both in serum. Only three patients had no evidence of hepatitis at the time of transplantation; one had a multifocal fibrolamellar hepatocellular carcinoma, and the other two had alcoholic or cryptogenic cirrhosis. All the patients were judged to have unresectable cancer because the tumor was centrally located in the liver (5 patients) or multifocal (7 patients) or because the patient had advanced cirrhosis (36 patients).
Assessment of the tumor before transplantation consisted of hepatic angiography and liver CT scanning performed during the period of portal venous flow after the arterial injection of contrast material (CT arterial portography).17 Iodized oil (Lipiodol) was then injected into the hepatic artery, and transarterial chemoembolization was performed in 26 patients.18 Four weeks later, the intrahepatic retention and distribution of iodized oil were measured, and a map of the apparent distribution of tumor within the liver was prepared. For chemoembolization, 14 patients received iodized oil plus doxorubicin (35 mg per square meter of body-surface area), and 12 patients received iodized oil plus mitoxantrone (14 mg per square meter). The treatments were repeated every six to eight weeks, with a median of two cycles per patient (range, one to four). There were no deaths related to chemoembolization; nevertheless, seven of these patients had deterioration in liver function.
Tumor staging was completed a median of 143 days (range, 2 to 294) before liver transplantation. During that period, only one patient who was originally considered eligible for liver transplantation was removed from the waiting list because of disease progression (she died six months later).
Liver transplantation was performed with an average of 8 units of packed red cells (range, 0 to 98). Venovenous bypass was used in 22 patients; in the remaining 26 patients, the recipient's inferior vena cava was preserved.19 The livers removed at the time of total hepatectomy were fixed in formalin and were cut into slices 1 cm thick (the same thickness as the “slices” of a CT scan). The number, diameter, anatomical location, and microscopical appearance of each tumor were recorded (T stage), as well as the possible presence of tumor-capsule or microvascular invasion. The lymph nodes of the hepatic hilum were removed and studied separately for possible tumor spread (N stage). An autopsy was always performed in patients who died after transplantation, and the possible recurrence of cancer was investigated.
The immunosuppressive regimen after liver transplantation consisted of cyclosporine, azathioprine, and corticosteroids. Azathioprine was stopped after one month. The dose of corticosteroids was progressively tapered, and administration was stopped altogether after six months. Cyclosporine monotherapy was maintained successfully thereafter in 40 of the 45 long-term survivors. Three patients received tacrolimus at various times after liver transplantation because of rejection resistant to treatment with corticosteroids and cyclosporine.
Statistical Analysis
The cumulative overall and recurrence-free survival rates were calculated by the Kaplan–Meier method.20 Data on three patients who died within one month after transplantation were included in the calculations of recurrence-free survival on the assumption that the patients did not survive long enough for recurrent tumors to develop. The survival curves were compared by means of the log-rank test.21 All statistical tests were two-tailed. Analyses were performed with the SAS statistical package, with the inclusion of 15 variables related to the patients, their cirrhosis, and their tumors, including treatment before transplantation and the criteria used for the selection of patients.
Results
As of September 30, 1995, the median follow-up for the 48 patients with cirrhosis and unresectable hepatocellular carcinomas who underwent liver transplantation was 26 months (range, 9 to 54). Among these patients, two required retransplantation because of recurrent viral hepatitis (one with HBV and one with HCV). Three patients died perioperatively (6 percent). Altogether, eight patients died after transplantation (17 percent), with recurrent cancer accounting for only two of the deaths (Table 2Table 2
Causes of Death after Liver Transplantation among Eight Patients with Small Hepatocellular Carcinomas and Cirrhosis.). Four patients had recurrent cancer a median of 3 months after transplantation; two of them died, and a third patient with metastases to the lung was still alive 26 months after transplantation. The fourth patient had a single subcutaneous mass of hepatocellular carcinoma detected along the needle track of the percutaneous liver biopsy performed before transplantation; that tumor was surgically removed, and the patient was free of disease 14 months later. In three of the four patients with recurrent cancer, the tumor stage assigned preoperatively was lower than that of the resected tumor (two patients had more than three tumors, and one patient's tumor was more than 5 cm in diameter). The fourth patient (who had the subcutaneous recurrence) had a single tumor 2.8 cm in diameter. The overall actuarial four-year survival was 75 percent, and the recurrence-free survival at four years was 83 percent, with three-year standard errors of 5.8 percent and 5.9 percent, respectively (Figure 1AFigure 1Overall Survival (Panel A) and Recurrence-free Survival (Panel B) after Liver Transplantation in 48 Patients with Small Hepatocellular Carcinomas and Cirrhosis. and Figure 1B). After three years, recurrence-free survival became higher than overall survival, because recurrence of cancer was excluded at autopsy in some patients who died or because data were censored earlier in the calculation of recurrence-free survival.The influence of several variables on overall and recurrence-free survival is shown in Table 3Table 3
Prognostic Variables Related to Survival and Recurrence of Cancer after Liver Transplantation in 48 Patients with Small Hepatocellular Carcinomas and Cirrhosis.. Survival was not affected by the patient's age or sex or by common markers of chronic liver disease, such as the type of hepatitis virus and the Child–Pugh stage at the time of transplantation. Of particular importance was the fact that, as long as all liver cancers were removed at an early stage, even classic prognostic factors such as the T stage, number of tumors, serum alpha-fetoprotein concentration, and presence or absence of a capsule were not statistically significant predictors of survival (with so few recurrences, however, these analyses had very low power).In this selected group of patients with small tumors, preoperative chemoembolization proved ineffective (Figure 2AFigure 2
Effect of Anticancer Treatment before Transplantation on Overall Survival (Panel A) and Recurrence-free Survival (Panel B) in 48 Patients with Cirrhosis and Hepatocellular Carcinomas. and Figure 2B), even though this treatment was not randomly assigned but, rather, was used only if liver function was not seriously impaired. In the 28 pretreated patients (58 percent of the total) four-year survival was 79 percent and recurrence-free survival was 87 percent. Similarly, 69 percent of the 20 patients who received no treatment before transplantation were alive and 78 percent were free of recurrence after the same period of follow-up.The selection of patients (and tumors) was the main factor affecting survival after transplantation, as was confirmed by the small number of recurrences (in four patients) and by pathological examination of the explanted livers, which revealed a median of 2 tumor masses per liver (range, 1 to 11) and a median diameter of 1.5 cm per tumor (range, 0.2 to 6). With respect to TNM stage, neither vascular invasion nor lymph-node metastases were detected, and the number and size of the tumors in each liver were not significantly different at various T stages. Fifteen patients had single tumors of 2 cm or less in diameter (stage T1); 18 patients had a median of 1 tumor 2 cm or less in diameter (stage T2); and 13 patients had multiple tumors (range, 2 to 10) 2.2 cm in diameter (stage T3). Finally, only two patients had multiple tumors (range, 2 to 10) that were 2.5 cm or more in diameter diffused to both lobes of the liver (stage T4). The size, number, and location of tumors were the only variables that affected the TNM stage; there was no macroscopic or microscopic vascular invasion and no lymph-node or distant metastasis.
Since an early tumor stage at the time of transplantation was the critical factor associated with greater rates of recurrence-free survival, we attempted to define more exactly the small cancers (either single or multiple) that could be cured by liver transplantation. Although there were no differences in overall or recurrence-free survival after transplantation between patients who had single tumors and those with multiple tumors (Table 3), the particular criteria for tumor stage that we used in recruiting patients proved effective in predicting outcome after transplantation (Figure 3AFigure 3
Correlation of Post-Transplantation Pathological Confirmation of Early-Stage Hepatocellular Carcinoma with Overall Survival (Panel A) and Recurrence-free Survival (Panel B) among 48 Patients with Cirrhosis. and Figure 3B). On pathological examination of the explanted livers, 35 patients (73 percent) were found to have tumors that met the predetermined selection criteria (i.e., single tumors <5 cm in diameter or no more than three tumors <3 cm in diameter), whereas 13 patients (27 percent) had tumors that exceeded those limits and were in fact assigned too low a stage before surgery.The actuarial four-year survival rate among the 35 patients in whom preoperative staging was correct, as determined by post-transplantation pathological examination, was 85 percent, and the rate of recurrence-free survival was 92 percent. In contrast, the four-year rates of survival and recurrence-free survival among the 13 patients whose tumors were not correctly identified as to stage before transplantation were 50 and 59 percent, respectively. Comparisons between the two groups showed a significant advantage for the patients who had tumors at earlier stages (P = 0.01 for overall survival and P = 0.002 for recurrence-free survival) (Figure 3A and Figure 3B).
Using the same statistical analysis, we tested seven other variables: duration of the waiting period before transplantation, variation in the Child–Pugh class over time, extent of donor–recipient HLA cross-matching, incidence of graft rejection, type of immunosuppressive regimen, perioperative use of blood products, and surgical technique used in graft implantation. None of these variables were significantly related to recurrence of the tumor or survival of patients.
Discussion
Patients with cirrhosis are at substantial risk for hepatocellular carcinoma; the yearly incidence in such patients is 3 percent.22 The prognosis for patients with the disease is poor, because the number of new cases roughly equals the number of deaths per year, and cirrhosis itself may be a preneoplastic condition,23 even though the incidence of hepatocellular carcinoma is not related to the severity of liver disease.13,22,23 In fact, about one third of our patients with hepatocellular carcinoma underwent liver transplantation although they had good hepatic function (Child–Pugh class A); those patients could not be treated without transplantation because their cancer was multiple or centrally located in the organ.
The length of follow-up in this study (median, 26 months) is notable, because most recurrences of cancer occur within 2 years after transplantation.11-13,24 The overall results (four-year actuarial survival, 75 percent; recurrence-free survival, 83 percent) are encouraging when compared with the natural history of small, untreated hepatocellular carcinomas in patients with cirrhosis, in whom the three-year survival rate is only 25 percent.25 The survival of our patients after transplantation is quite similar to the 70 percent reported after four years in patients with cirrhosis alone who underwent transplantation.26
Such good results were first predicted 10 years ago, when an excellent survival rate after liver transplantation was reported in patients with incidentally detected hepatocellular carcinomas (tumors <5 cm in diameter discovered by pathological examination in resected livers not originally thought to contain tumors27). Today, because of the high rate of diagnosis of liver carcinoma, incidentally detected tumors in patients with cirrhosis are mainly less than 2 cm in diameter.
With very few exceptions,15 a diameter of 5 cm is still the generally accepted upper limit for small intrahepatic tumors. That cutoff was used in selecting patients for the present study; moreover, patients with multiple tumors (up to three tumors, none exceeding 3 cm in diameter) were considered eligible for transplantation. These criteria for the selection of patients were significant predictors of good survival rates after liver transplantation (Figure 1A, Figure 1B, Figure 3A, and Figure 3B).
At this early stage of tumor development, there were no other factors (such as the TNM stage, serum alpha-fetoprotein concentration, or the presence or absence of capsule) that had prognostic value. Recognized indicators of poor prognosis, such as lymph-node spread, vascular invasion, or metastases, were not detected in this study, confirming that in Western patients the clinical and pathological progression of hepatocellular carcinoma is usually slow and is related to tumor size.28
At the time of diagnosis, 20 to 60 percent of small hepatocellular carcinomas are multifocal.23,25,29 We found that 27 percent of small tumors in patients with cirrhosis were assigned too low a stage before transplantation, despite extensive preoperative evaluation. Nevertheless, survival after transplantation was similar in patients with a single tumor and those with multiple tumors.14 (The TNM classification does not distinguish among patients with multiple hepatocellular carcinomas on the basis of the number of tumors, although a limit of three tumors is probably important with respect to better patient survival after liver replacement.14) In fact, since patients with multifocal hepatocellular carcinomas (48 percent of our patients) are currently not considered for transplantation, the procedure should be proposed only if the patient has no more than three small tumors.
If our results are confirmed by others, the optimal treatment for patients with cirrhosis who have single hepatocellular carcinomas no more than 5 cm in diameter — resection or transplantation — may become a subject of debate. Retrospective analysis has shown that patients with cirrhosis who have stage T1 or T2 tumors do better after transplantation (five-year survival, 67 to 75 percent) than after hepatic resection (0 to 56 percent).11,12 Furthermore, the five-year rate of recurrence-free survival after the resection of single, small (<5 cm) hepatocellular carcinomas is practically zero.30 Our study does not address the issue of liver transplantation for patients with small, resectable hepatocellular carcinomas. None of the tumors in the patients we studied were considered resectable; indeed, this was a requirement for entering the trial. Consequently, as long as the number of donors remains limited and until the results of randomized studies become available, liver transplantation should be proposed only for patients with cirrhosis who have small hepatocellular carcinomas that cannot be resected.
There have been reports of detrimental effects of immunosuppression in patients with cancer who undergo solid-organ transplantation.31 Most of our patients were treated with a cyclosporine-based immunosuppressive regimen, with corticosteroids discontinued after six months in most cases. The risk of recurrence among patients who continue to receive corticosteroids may be as much as four times higher than the risk in patients in whom the corticosteroid is discontinued soon after transplantation.32 Our results confirm previous experience2 and may lead to further studies of the influence of different immunosuppressive regimens on the development of cancer after transplantation, with particular reference to the corticosteroid-sparing properties of tacrolimus and the possible reduction in the dosage of immunosuppressive agents under favorable conditions.33
In the past, it was tempting to conclude that liver transplantation for hepatocellular carcinoma was futile.5,24 However, as documented in this study, long-term survival can be achieved with liver transplantation in carefully selected patients.
Supported by the Italian Association for Cancer Research.
We are indebted to the following people and institutions for their help and support at various stages of our work: D. Baratti, G. Cozzi, M. Dal Fante, B. Damascelli, G. Facchetti, L. Gangeri, E. Majno, A. Marchianò, E. Meroni, M. Milella, P. Notti, C. Orlandini, M. Pasquali, G. Pellegris, A. Prada, F. Ravagnani, F. Rilke, F. Romano, R. Rossi, A. Rubino, M. Salvetti, P. Serafin, A. Severini, C. Spreafico, P. Tabeni, the transplant coordinators, and the staffs of the Nutrition Support Unit, the intensive care unit, and the operating room at the National Cancer Institute, Milan; M. Scalamogna, G. Sirchia, C. Pizzi, and the staff of the North Italian Transplant Procurement Agency, Milan; M. Camisasca, M. Podda, and M. Zuin at the Department of Medicine, San Paolo Hospital, Milan; F. Bonino and M.R. Brunetto at the Liver Pathology Laboratory, Molinette Hospital, Turin, Italy; M. Barbi, M.L. Ribero, and A. Tagger at the Institute of Virology, University of Milan, Milan; A. Alberti, L.S. Belli, and G. Ideo at Niguarda Hospital, Milan; L. Caccamo, M. Colledan, L.R. Fassati, D. Galmarini, and M. Langer at the Liver Transplant Unit, Maggiore Hospital, Milan; M. Colombo at the Department of Internal Medicine, University of Milan; R. Gesu, A. Lazzarin, L. Luzi, and C. Socci at the Departments of Infectious Diseases, Internal Medicine, and Surgery, San Raffaele Hospital, Milan; L. Pagliaro and U. Palazzo at Cervello Hospital, Palermo, Italy; G. Corbetta and E. Grossi at Sandoz, Milan; A. Consonni at Fujisawa, Milan; and M.A. Cerri, A. Di Padova, and P. Giulidori at Knoll, Milan. We are also indebted to B. Ringe of Georg-August University, Göttingen, Germany, and to D.H. Van Thiel, Oklahoma City, for helpful discussion of the results of our study.
Source Information
From the Liver Transplantation Unit, Department of Surgery (V.M., E.R., R.D., A.P., F.B., F.M., L.G.), and the Departments of Pathology (S.A.) and Anesthesia (M.A.), National Cancer Institute, and the Institute of Medical Statistics and Biometry, University of Milan (A.M.) — all in Milan, Italy.
Address reprint requests to Dr. Gennari at the Liver Transplantation Unit, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.
- References
References
1
Iwatsuki S ,Gordon RD ,Shaw BW Jr ,Starzl TE . Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401-407
CrossRef | Web of Science | Medline2
O'Grady JG ,Polson RJ ,Rolles K ,Calne RY ,Williams R . Liver transplantation for malignant disease: results in 93 consecutive patients. Ann Surg 1988;207:373-379
CrossRef | Web of Science | Medline3
Ringe B ,Wittekind C ,Bechstein WO ,Bunzendahl H ,Pichlmayr R . The role of liver transplantation in hepatobiliary malignancy: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989;209:88-98
CrossRef | Web of Science | Medline4
Ismail T ,Angrisani L ,Gunson BK , et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg 1990;77:983-987
CrossRef | Web of Science | Medline5
Olthoff KM ,Millis JM ,Rosove MH ,Goldstein LI ,Ramming KP ,Busuttil RW . Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:1261-1268
Web of Science | Medline6
Haug CE ,Jenkins RL ,Rohrer RJ , et al. Liver transplantation for primary hepatic cancer. Transplantation 1992;53:376-382
CrossRef | Web of Science | Medline7
Moreno-Gonzalez E ,Gomez R ,Garcia I , et al. Liver transplantation in malignant primary hepatic neoplasms. Am J Surg 1992;163:395-400
CrossRef | Web of Science | Medline8
Penn I . Hepatic transplantation for primary and metastatic cancer of the liver. Surgery 1991;110:726-735
Web of Science | Medline9
Hermanek P, Sobin LH, eds. TNM classification of malignant tumours. 4th ed. Berlin, Germany: Springer-Verlag, 1987:53-5.
10
Okuda K ,Ohtsuki T ,Obata H , et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985;56:918-928
CrossRef | Web of Science | Medline11
Ringe B ,Pichlmayr R ,Wittekind C ,Tusch G . Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285
CrossRef | Web of Science | Medline12
Iwatsuki S ,Starzl TE ,Sheahan DG , et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-228
CrossRef | Web of Science | Medline13
Selby R ,Zakiyah K ,Carr B ,Tzakis A ,Madariaga JR ,Iwatsuki S . Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:53-58
CrossRef | Web of Science | Medline14
Bismuth H ,Chiche L ,Adam R ,Castaing D ,Diamond T ,Dennison A . Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151
CrossRef | Web of Science | Medline15
Tan KC ,Rela M ,Ryder SD , et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995;82:253-256
CrossRef | Web of Science | Medline16
Trey C ,Burns DG ,Saunders SJ . Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966;274:473-481
Full Text | Web of Science | Medline17
Steves MA ,Vidal-Jove J ,Sugarbaker PH , et al. Preoperative radiological evaluation of the liver by computerized tomographic portography in patients with hepatic tumors. Am Surg 1992;58:608-612
Web of Science | Medline18
Spreafico C ,Marchiano A ,Regalia E , et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994;192:687-690
Web of Science | Medline19
Tzakis A ,Todo S ,Starzl TE . Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989;210:649-652
CrossRef | Web of Science | Medline20
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science21
Mantel H ,Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748
Web of Science | Medline22
Colombo M ,de Franchis R ,Del Ninno E , et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680
Full Text | Web of Science | Medline23
Okuda K, Okuda H. Primary liver cell carcinoma. In: McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Vol. 2. Oxford, England: Oxford University Press, 1991:1019-52.
24
Yokoyama I ,Todo S ,Iwatsuki S ,Starzl TE . Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990;37:188-193
Web of Science | Medline25
Barbara L ,Benzi G ,Gaiani S , et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-137
CrossRef | Web of Science | Medline26
Report of the European Liver Transplant Registry. Villejuif, France: Hôpital Paul Brousse, June 1994.
27
Starzl TE ,Zitelli BJ ,Shaw BW Jr , et al. Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr 1985;106:604-606
CrossRef | Web of Science | Medline28
Colombo M . Hepatocellular carcinoma in cirrhotics. Semin Liver Dis 1993;13:374-383
CrossRef | Web of Science | Medline29
Utsunomiya T ,Matsumata T ,Adachi E ,Honda H ,Sugimachi K . Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology 1992;16:694-701
CrossRef | Web of Science | Medline30
Belghiti J ,Panis Y ,Farges O ,Benhamou JP ,Fekete F . Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117
CrossRef | Web of Science | Medline31
Yokoyama I ,Carr B ,Saitsu H ,Iwatsuki S ,Starzl TE . Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095-2100
CrossRef | Web of Science | Medline32
Mazzaferro V ,Rondinara GF ,Rossi G , et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994;26:3557-3560
Web of Science | Medline33
Starzl TE ,Demetris AJ ,Trucco M , et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152
CrossRef | Web of Science | Medline
- Citing Articles (1443)
Citing Articles
1
Masashi Mizumoto, Toshiyuki Okumura, Takayuki Hashimoto, Kuniaki Fukuda, Yoshiko Oshiro, Nobuyoshi Fukumitsu, Masato Abei, Atsushi Kawaguchi, Yasutaka Hayashi, Ayako Ohkawa, Haruko Hashii, Ayae Kanemoto, Takashi Moritake, Eriko Tohno, Koji Tsuboi, Takeji Sakae, Hideyuki Sakurai. (2012) Evaluation of Liver Function After Proton Beam Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 82:3, e529-e535
CrossRef2
Naglaa Allam. (2012) Liver transplantation for hepatocellular carcinoma: how far can the selection criteria be expanded?. Hepatology International
CrossRef3
Masayuki Sakae, Shoji Kubo, Shigekazu Takemura, Chikaharu Sakata, Takahiro Uenishi, Shintaro Kodai, Hiroji Shinkawa, Yorihisa Urata, Kazunori Ohata, Kazuhisa Kaneda, Takayoshi Nishioka, Akinori Nozawa, Shigefumi Suehiro. (2012) Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. Hepatology Researchno-no
CrossRef4
Michael A. Nalesnik, George Tseng, Ying Ding, Guo-Sheng Xiang, Zhong-liang Zheng, YanPing Yu, James Wallis Marsh, George K. Michalopoulos, Jian-Hua Luo. (2012) Gene Deletions and Amplifications in Human Hepatocellular Carcinomas. The American Journal of Pathology
CrossRef5
F. Cauchy, D. Fuks, J. Belghiti. (2012) HCC: current surgical treatment concepts. Langenbeck's Archives of Surgery
CrossRef6
Caroline Rochon, Patricia Sheiner, Basant Mahadevappa, Ganesh Gunasekaran, Joyti Sharma, David C. Wolf, Marcelo Facciuto. (2012) Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?. Langenbeck's Archives of Surgery
CrossRef7
Chia-Yang Hsu, Yun-Hsuan Lee, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Yi-You Chiou, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee. (2012) Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy. Hepatology International
CrossRef8
Luciano De Carlis, Stefano Di Sandro, Alessandro Giacomoni, Abdallah Slim, Andrea Lauterio, Iacopo Mangoni, Plamen Mihaylov, Vincenzo Pirotta, Paolo Aseni, Antonio Rampoldi. (2012) Beyond the Milan Criteria. Journal of Clinical Gastroenterology 46:1, 78-86
CrossRef9
Gisèle N’Kontchou, Mounir Aout, Alexis Laurent, Pierre Nahon, Nathalie Ganne-Carrié, Véronique Grando, Iman Baghad, Dominique Roulot, Jean Claude Trinchet, Nicolas Sellier, Daniel Cherqui, Eric Vicaut, Michel Beaugrand, Olivier Seror. (2012) Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. Journal of Hepatology 56:1, 160-166
CrossRef10
Ju Dong Yang, Bohyun Kim, Schuyler O. Sanderson, Jennifer L. St. Sauver, Barbara P. Yawn, Rachel A. Pedersen, Joseph J. Larson, Terry M. Therneau, Lewis R. Roberts, W. Ray Kim. (2012) Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008. Mayo Clinic Proceedings 87:1, 9-16
CrossRef11
Alessandro Furlan, Daniele Marin, Francesco Agnello, Michele Di Martino, Vito Di Marco, Roberto Lagalla, Carlo Catalano, Giuseppe Brancatelli. (2012) Hepatocellular Carcinoma Presenting at Contrast-Enhanced Multi–Detector-Row Computed Tomography or Gadolinium-Enhanced Magnetic Resonance Imaging as a Small (≤2 cm), Indeterminate Nodule. Journal of Computer Assisted Tomography 36:1, 20-25
CrossRef12
Pierre-Alain Clavien, Mickael Lesurtel, Patrick MM Bossuyt, Gregory J Gores, Bernard Langer, Arnaud Perrier. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. The Lancet Oncology 13:1, e11-e22
CrossRef13
Arndt Weinmann, Ina Maria Niederle, Sandra Koch, Maria Hoppe-Lotichius, Michael Heise, Christoph Düber, Marcus Schuchmann, Gerd Otto, Peter Robert Galle, Marcus-Alexander Wörns. (2012) Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Digestive and Liver Disease
CrossRef14
Ioannis Papaconstantinou, Andreas Karakatsanis, Maria Gazouli, George Polymeneas, Dionissios Voros. (2012) The role of microRNAs in liver cancer. European Journal of Gastroenterology & Hepatology1
CrossRef15
Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig, Jordi Bruix. (2012) Management of HCC. Journal of Hepatology 56, S75-S87
CrossRef16
Kenneth Siu Ho Chok, See Ching Chan, Ronnie Tung Ping Poon, Sheung Tat Fan, Chung Mau Lo. (2012) Re-resection for metachronous primary hepatocellular carcinoma: is it justified?. ANZ Journal of Surgeryno-no
CrossRef17
Stefan G. Hübscher, Andrew D. Clouston. 2012. Transplantation pathology. , 853-933.
CrossRef18
Jorge A. Marrero. 2012. Hepatocellular Carcinoma. , 1005-1031.
CrossRef19
Scott W. Biggins. 2012. Pretransplant Evaluation and Care. , 837-852.
CrossRef20
Parsia A. Vagefi, Sandy Feng. 2012. Transplantation of the Liver. , 853-868.
CrossRef21
Stevan A. Gonzalez, Emmet B. Keeffe. 2012. Liver transplantation. , 420-433.
CrossRef22
Gustavo Pereira, Mónica Guevara, Claudia Fagundes, Elsa Solá, Ezequiel Rodríguez, Javier Fernández, Marco Pavesi, Vicente Arroyo, Pere Ginès. (2012) Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. Journal of Hepatology
CrossRef23
Khairuddin Memon, Laura Kulik, Robert J. Lewandowski, Edward Wang, Robert K. Ryu, Ahsun Riaz, Paul Nikolaidis, Frank H. Miller, Vahid Yaghmai, Talia Baker, Michael Abecassis, Al B. Benson, Mary F. Mulcahy, Reed A. Omary, Riad Salem. (2012) Alpha-fetoprotein Response Correlates with EASL Response and Survival in Solitary Hepatocellular Carcinoma Treated with Trans-arterial Therapies: A Subgroup Analysis. Journal of Hepatology
CrossRef24
Karim M. Eltawil, Robert Berry, Mohamed Abdolell, Michele Molinari. (2012) Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre. HPBno-no
CrossRef25
Rahul Kakodkar, A. S. Soin. (2011) Liver Transplantation for HCC: A Review. Indian Journal of Surgery
CrossRef26
Feng Xie, Jiajie Zang, Xiaojing Guo, Feng Xu, Rongxi Shen, Long Yan, Jiamei Yang, Jia He. (2011) Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology
CrossRef27
T. Piardi, F. Gheza, B. Ellero, M. L. Woehl-Jaegle, D. Ntourakis, M. Cantu, E. Marzano, M. Audet, P. Wolf, Patrick Pessaux. (2011) Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology
CrossRef28
Federico Collettini, Dirk Schnapauff, Alexander Poellinger, Timm Denecke, Eckart Schott, Thomas Berg, Peter Wust, Bernd Hamm, Bernhard Gebauer. (2011) Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (>7 cm) tumours. European Radiology
CrossRef29
Angelo Sangiovanni, Massimo Colombo. 2011. Rival Scoring Systems: Do they Offer more?. , 81-90.
CrossRef30
Myron Schwartz. 2011. Transplant Considerations. , 168-175.
CrossRef31
Riccardo Lencioni. (2011) Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Critical Reviews in Oncology/Hematology
CrossRef32
Meng-Hsing Ho, Chih-Yung Yu, Kuo-Piao Chung, Teng-Wei Chen, Heng-Cheng Chu, Chih-Kung Lin, Chung-Bao Hsieh. (2011) Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology 18:13, 3632-3639
CrossRef33
B. Kocman, D. Mikulić, S. Jadrijevic, M. Poljak, I. Kocman, S. Gašparov, T. Filipec Kanižaj, V. Čolić Cvrlje. (2011) Long-Term Survival After Living-Donor Liver Transplantation for Unresectable Colorectal Metastases to the Liver: Case Report. Transplantation Proceedings 43:10, 4013-4015
CrossRef34
Alan W. Katz, Sheema Chawla, Zhenhong Qu, Randeep Kashyap, Michael T. Milano, Aram F. Hezel. (2011) Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation. International Journal of Radiation Oncology*Biology*Physics
CrossRef35
S. Aktas, H. Karakayali, G. Moray, H. Ozdemir, M. Haberal. (2011) Effects of Risk Factors and Ki-67 on Rates of Recurrence on Patients Who Have Undergone Liver Transplant for Hepatocellular Carcinoma. Transplantation Proceedings 43:10, 3807-3812
CrossRef36
Beatriz Mínguez, Yujin Hoshida, Augusto Villanueva, Sara Toffanin, Laia Cabellos, Swan Thung, John Mandeli, Daniela Sia, Craig April, Jian-Bing Fan, Anja Lachenmayer, Radoslav Savic, Sasan Roayaie, Vincenzo Mazzaferro, Jordi Bruix, Myron Schwartz, Scott L. Friedman, Josep M. Llovet. (2011) Gene-expression signature of vascular invasion in hepatocellular carcinoma. Journal of Hepatology 55:6, 1325-1331
CrossRef37
Dhanwant Gomez, Dileep N. Lobo. (2011) Malignant liver tumours. Surgery (Oxford) 29:12, 632-639
CrossRef38
Bieke Lambert, Emiel Sturm, Jeroen Mertens, Ruth Oltenfreiter, Peter Smeets, Roberto Troisi, Hans Vlierberghe, Luc Defreyne. (2011) Intra-arterial treatment with 90Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. European Journal of Nuclear Medicine and Molecular Imaging 38:12, 2117-2124
CrossRef39
Qing Zhang, Hong Chen, Qin Li, Yunjin Zang, Xinguo Chen, Weilong Zou, Letian Wang, Zhong-yang Shen. (2011) Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study. Investigational New Drugs 29:6, 1360-1369
CrossRef40
I.A. Hanouneh, C. Macaron, R. Lopez, F. Aucejo, N.N. Zein. (2011) Rate of Tumor Growth Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation in Patients Beyond Milan or UCSF Criteria. Transplantation Proceedings 43:10, 3813-3818
CrossRef41
Lorenzo Andreana, Graziella Isgrò, Laura Marelli, Neil Davies, Dominic Yu, Shaunak Navalkissoor, Andrew K. Burroughs. (2011) Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: Trans-arterial radio-embolisation of HCC. Cancer Treatment Reviews
CrossRef42
Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Roberto Sorge, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, Massimo Rossi. (2011) Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. Clinical Transplantationno-no
CrossRef43
Manuel L. Rodríguez-Perálvarez, Jose Luis Montero, Manuel De la Mata García. (2011) Current challenges and future trends in liver transplantation. Digestive and Liver Disease Supplements 5:1, 2-5
CrossRef44
Paul Douglas Renfrew, Michele Molinari. (2011) Rural residency and the risk of mortality while waiting for liver transplantation. Clinical Transplantationno-no
CrossRef45
Kenichi Takayasu, Shigeki Arii, Masatoshi Kudo, Takafumi Ichida, Osamu Matsui, Namiki Izumi, Yutaka Matsuyama, Michiie Sakamoto, Osamu Nakashima, Yonson Ku, Norihiro Kokudo, Masatoshi Makuuchi. (2011) Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. Journal of Hepatology
CrossRef46
Alastair L. Young, Robert Adair, K. Rajendra Prasad, Giles J. Toogood, J. Peter A. Lodge. (2011) Hepatocellular Carcinoma Within a Noncirrhotic, Nonfibrotic, Seronegative Liver: Surgical Approaches and Outcomes. Journal of the American College of Surgeons
CrossRef47
Clara Alsinet, Augusto Villanueva. (2011) Pronóstico genómico en el carcinoma hepatocelular. Gastroenterología y Hepatología
CrossRef48
Zhong-Bo Han, Hong-Yuan Chen, Jun-Wei Fan, Jun-Yi Wu, Hua-Mei Tang, Zhi-Hai Peng. (2011) Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. Journal of Cancer Research and Clinical Oncology
CrossRef49
C. K. Argo, G. J. Stukenborg, T. M. Schmitt, S. C. Kumer, C. L. Berg, P. G. Northup. (2011) Regional Variability in Symptom-Based MELD Exceptions: A Response to Organ Shortage?. American Journal of Transplantation 11:11, 2353-2361
CrossRef50
David M. Levi, Seigo Nishida. (2011) Liver Transplantation for Hepatocellular Carcinoma: Lessons Learned and Future Directions. Clinics in Liver Disease 15:4, 717-725
CrossRef51
Sameer H. Patel, Peter J. Kneuertz, Maria Delgado, David A. Kooby, Charles A. Staley, Bassel F. El-Rayes, John S. Kauh, Juan M. Sarmiento, Steven Hanish, Cynthia Cohen, Alton B. Farris, Shishir K. Maithel. (2011) Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 18:12, 3384-3390
CrossRef52
Mauricio F. Silva, Morris Sherman. (2011) Criteria for liver transplantation for HCC: What should the limits be?. Journal of Hepatology 55:5, 1137-1147
CrossRef53
Laura Tariciotti, Chiara Rocha, M. Thamara PR Perera, Bridget K. Gunson, Simon R. Bramhall, John Isaac, John A. C. Buckels, A. David Mayer, Paolo Muiesan, Darius F. Mirza. (2011) Is It Time to Extend Liver Acceptance Criteria for Controlled Donors After Cardiac Death?. Transplantation 92:10, 1140-1146
CrossRef54
Annagiulia Gramenzi, Stefano Gitto, Fabio Caputo, Maurizio Biselli, Stefania Lorenzini, Mauro Bernardi, Pietro Andreone. (2011) Liver transplantation for patients with alcoholic liver disease: An open question. Digestive and Liver Disease 43:11, 843-849
CrossRef55
Richard S. Finn. (2011) Sorafenib use while waiting for liver transplant: we still need to wait. Journal of Hepatology
CrossRef56
Fabio Farinati, Anna Giacomin, Veronica Vanin, Adriana Sergio, Patrizia Burra, Umberto Cillo, Annamaria Di Nolfo, Paolo Del Poggio, Luisa Benvegnu, Marco Zoli, Franco Borzio, Edoardo G. Giannini, Eugenio Caturelli, Nora Cazzagon, Gian Ludovico Rapaccini, Franco Trevisani. (2011) Liver transplantation for hepatocellular carcinoma in clinical practice. European Journal of Gastroenterology & Hepatology1
CrossRef57
Alton B. Farris, Nevra Dursun, Renumathy Dhanasekaran, Ipek Coban, Emily B. McIntosh, N. Volkan Adsay, Hyun S. Kim. (2011) Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy. Pathology - Research and Practice
CrossRef58
Jennifer Guy, Robin K. Kelley, John Roberts, Robert Kerlan, Francis Yao, Norah Terrault. (2011) Multidisciplinary Management of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology
CrossRef59
K. Berry, G. N. Ioannou. (2011) Are Patients with Child's A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?. American Journal of Transplantationno-no
CrossRef60
Yoshiyuki Narahara, Hidenori Kanazawa, Choitsu Sakamoto, Hitoshi Maruyama, Osamu Yokosuka, Satoshi Mochida, Masahito Uemura, Hiroshi Fukui, Yasukiyo Sumino, Yasushi Matsuzaki, Naohiko Masaki, Shigehiro Kokubu, Kiwamu Okita. (2011) The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study. Journal of Gastroenterology
CrossRef61
See Ching Chan, Sheung Tat Fan, Kenneth S. H. Chok, Tan To Cheung, Albert C. Y. Chan, James Y. Y. Fung, Ronnie T. P. Poon, Chung Mau Lo. (2011) Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatology International
CrossRef62
Yukinori Imai, Taku Chikayama, Manabu Nakazawa, Kazuhiro Watanabe, Satsuki Ando, Yoshie Mizuno, Kiyoko Yoshino, Kayoko Sugawara, Kazuhiro Hamaoka, Kenji Fujimori, Mie Inao, Nobuaki Nakayama, Masashi Oka, Sumiko Nagoshi, Satoshi Mochida. (2011) Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Journal of Gastroenterology
CrossRef63
Peter J. Kneuertz, David P. Cosgrove, Andrew M. Cameron, Ihab R. Kamel, Jean-Francois H. Geschwind, Joseph M. Herman, Timothy M. Pawlik. (2011) Multidisciplinary Management of Recurrent Hepatocellular Carcinoma Following Liver Transplantation. Journal of Gastrointestinal Surgery
CrossRef64
Luigi Bolondi, Laura Gramantieri. (2011) From liver cirrhosis to HCC. Internal and Emergency Medicine 6:S1, 93-98
CrossRef65
Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Junichi Kaneko, Haruhiko Yoshida, Taku Aoki, Kiyoshi Hasegawa, Masaaki Akahane, Kuni Ohtomo, Masashi Fukayama, Kazuhiko Koike, Norihiro Kokudo. (2011) Diagnostic accuracy of α-fetoprotein and des-γ-carboxy prothrombin in screening for hepatocellular carcinoma in liver transplant candidates. Hepatology Researchno-no
CrossRef66
Khairuddin Memon, Robert J. Lewandowski, Laura Kulik, Ahsun Riaz, Mary F. Mulcahy, Riad Salem. (2011) Radioembolization for Primary and Metastatic Liver Cancer. Seminars in Radiation Oncology 21:4, 294-302
CrossRef67
Shinji Tanaka, Kaoru Mogushi, Mahmut Yasen, Daisuke Ban, Norio Noguchi, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Hiroshi Tanaka, Masakazu Yamamoto, Norihiro Kokudo, Tadatoshi Takayama, Seiji Kawasaki, Michiie Sakamoto, Shigeki Arii. (2011) Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study. Hepatology 54:4, 1273-1281
CrossRef68
Stephanie A. Reid, Leslie M. Scoutt, Ulrike M. Hamper. (2011) Vascular Complications of Liver Transplants: Evaluation with Duplex Doppler Ultrasound. Ultrasound Clinics 6:4, 513-530
CrossRef69
Josep M. Llovet, Valerie Paradis, Masatoshi Kudo, Jessica Zucman-Rossi. (2011) Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma. Liver Transplantation 17:S2, S67-S71
CrossRef70
Jian-Wen Cheng, Ying-Hong Shi, Jia Fan, Xiao-Wu Huang, Shuang-Jian Qiu, Yong-Sheng Xiao, Zheng Wang, Zhi Dai, Zhao-You Tang, Jian Zhou. (2011) An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 137:10, 1445-1453
CrossRef71
Elizabeth A. Pomfret, J. Peter A. Lodge, Federico G. Villamil, Mark Siegler. (2011) Should we use living donor grafts for patients with hepatocellular carcinoma? ethical considerations. Liver Transplantation 17:S2, S128-S132
CrossRef72
Robert M. Merion, Pratima Sharma, Amit K. Mathur, Douglas E. Schaubel. (2011) Evidence-based development of liver allocation: a review. Transplant International 24:10, 965-972
CrossRef73
Mary Feng, Edgar Ben-Josef. (2011) Radiation Therapy for Hepatocellular Carcinoma. Seminars in Radiation Oncology 21:4, 271-277
CrossRef74
Christophe Duvoux, Tetsuya Kiuchi, Bernhard Pestalozzi, Ronald Busuttil, Rebecca Miksad. (2011) What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?. Liver Transplantation 17:S2, S147-S158
CrossRef75
Didier Samuel, Massimo Colombo, Hachem El-Serag, Rodolphe Sobesky, Nigel Heaton. (2011) Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transplantation 17:S2, S6-S13
CrossRef76
John O’Grady. (2011) Liver transplantation. Medicine 39:10, 621-623
CrossRef77
Wan Yee Lau, Eric C.H. Lai, Thomas W.T. Leung. (2011) Current Role of Selective Internal Irradiation With Yttrium-90 Microspheres in the Management of Hepatocellular Carcinoma: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics 81:2, 460-467
CrossRef78
Philip J. Johnson. (2011) Hepatobiliary tumours. Medicine 39:10, 630-633
CrossRef79
Giacomo Germani, Kurinchi Gurusamy, Matteo Garcovich, Christian Toso, Giuseppe Fede, Alan Hemming, Kyung-Suk Suh, Achim Weber, Andrew Kenneth Burroughs. (2011) Which matters most: Number of tumors, size of the largest tumor, or total tumor volume?. Liver Transplantation 17:S2, S58-S66
CrossRef80
Maria Pipa-Muniz, Maria Varela, Luisa Gonzalez-Dieguez, Manuel Rodríguez. (2011) Personalized medicine in hepatocellular carcinoma: rationale and clinical data. Clinical Investigation 1:10, 1403-1411
CrossRef81
Kun-Ming Chan, Hong-Shiue Chou, Ting-Jung Wu, Chen-Fang Lee, Ming-Chin Yu, Wei-Chen Lee. (2011) Characterization of hepatocellular carcinoma recurrence after liver transplantation: Perioperative prognostic factors, patterns, and outcome. Asian Journal of Surgery
CrossRef82
Wei-Chen Lee, Ting-Jung Wu, Hong-Shiue Chou, Ming-Chin Yu, Pao-Yueh Hsu, Hsiu-Ying Hsu, Chao-Ching Wang. (2011) The impact of CD4+CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery
CrossRef83
C. T. Barry, M. D'Souza, M. McCall, S. Safadjou, C. Ryan, R. Kashyap, C. Marroquin, M. Orloff, A. Almudevar, T. E. Godfrey. (2011) Micro RNA Expression Profiles as Adjunctive Data to Assess the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation. American Journal of Transplantationno-no
CrossRef84
Pratima Sharma, Kathy Welch, Hero Hussain, Shawn J. Pelletier, Robert J. Fontana, Jorge Marrero, Robert M. Merion. (2011) Incidence and Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation in the MELD Era. Digestive Diseases and Sciences
CrossRef85
, , , , Markus Peck-Radosavljevic, Wolfgang Sieghart, Claus Kölblinger, Markus Reiter, Martin Schindl, Gregor Ulbrich, Rudolf Steininger, Christian Müller, Rudolf Stauber, Maximilian Schöniger-Hekele, Manfred Gschwendtner, Christina Plank, Martin Funovics, Ivo Graziadei, Johannes Lammer, Thomas Gruenberger, Günther Gastl, Franz Karnel. (2011) Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma. Wiener klinische Wochenschrift
CrossRef86
El-Serag, Hashem B., . (2011) Hepatocellular Carcinoma. New England Journal of Medicine 365:12, 1118-1127
Full Text87
Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Jih-Tung Pai, Che-Chuan Loong, Yi-You Chiou, Rheun-Chuan Lee, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee. (2011) Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis. Annals of Surgical Oncology
CrossRef88
Yoji Kishi, Akio Saiura, Junji Yamamoto, Rintaro Koga, Makoto Seki, Ryo Morimura, Ryuji Yoshioka, Norihiro Kokudo, Toshiharu Yamaguchi. (2011) Significance of anatomic resection for early and advanced hepatocellular carcinoma. Langenbeck's Archives of Surgery
CrossRef89
Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. (2011) Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation. Pathology & Oncology Research
CrossRef90
D. Xia, H.-Q. Zuo, Y. Quan, H.-L. Dong, L. Xu. (2011) Ethical Selection on Liver Transplantation and Abandoning Treatment for Hepatocellular Carcinoma in China. Transplantation Proceedings 43:7, 2656-2659
CrossRef91
Hye Ryun KIM, Seong Ha CHEON, Sun Young RHA, Soohyeon LEE, Kwang-Hyub HAN, Chae Yoon CHON, Jong Doo LEE, Jin Sil SUNG, Hyun Cheol CHUNG. (2011) Treatment of recurrent hepatocellular carcinoma after liver transplantation. Asia-Pacific Journal of Clinical Oncology 7:3, 258-269
CrossRef92
A. N. Gordon-Weeks, A. Snaith, T. Petrinic, P. J. Friend, A. Burls, M. A. Silva. (2011) Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. British Journal of Surgery 98:9, 1201-1208
CrossRef93
Kenneth S. H. Chok, See Ching Chan, Tan To Cheung, Albert C. Y. Chan, Sheung Tat Fan, Chung Mau Lo. (2011) Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation. World Journal of Surgery 35:9, 2058-2062
CrossRef94
Krit Kitisin, Vignesh Packiam, Jennifer Steel, Abhinav Humar, T. Clark Gamblin, David A. Geller, J. Wallis Marsh, Allan Tsung. (2011) Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPBno-no
CrossRef95
T. Takahara, H. Nitta, Y. Hasegawa, N. Itou, M. Takahashi, G. Wakabayashi. (2011) Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation—Interactions Between Calcineurin Inhibitor: Two Case Reports. Transplantation Proceedings 43:7, 2800-2805
CrossRef96
Junichi Togashi, Yasuhiko Sugawara, Taku Aoki, Sumihito Tamura, Junichi Kaneko, Jun Nakajima, Atsushi Sano, Norihiro Kokudo. (2011) Resection of lung metastases from hepatocellular carcinoma after living donor liver transplantation: Report of two cases. Surgery Today 41:9, 1294-1297
CrossRef97
Kun-Ming Chan, Ming-Chin Yu, Hong-Shiue Chou, Ting-Jung Wu, Chen-Fang Lee, Wei-Chen Lee. (2011) Significance of Tumor Necrosis for Outcome of Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy Prior to Liver Transplantation. Annals of Surgical Oncology 18:9, 2638-2646
CrossRef98
David H. Oustecky, Andres R. Riera, Kenneth D. Rothstein. (2011) Long-Term Management of the Liver Transplant Recipient: Pearls for the Practicing Gastroenterologist. Gastroenterology Clinics of North America 40:3, 659-681
CrossRef99
J. A. Wertheim, H. Petrowsky, S. Saab, J. W. Kupiec-Weglinski, R. W. Busuttil. (2011) Major Challenges Limiting Liver Transplantation in the United States. American Journal of Transplantation 11:9, 1773-1784
CrossRef100
Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, Markus Peck-Radosavljevic, Christian Müller. (2011) Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?. Wiener klinische Wochenschrift 123:17-18, 542-551
CrossRef101
Yiing Lin, William C. Chapman. (2011) Towards More Effective Liver Allocation Criteria for Hepatocellular Carcinoma: Tumor Response to Locoregional Therapy. Annals of Surgical Oncology 18:9, 2416-2418
CrossRef102
Robert Wong, Catherine Frenette, Robert Gish. (2011) Hepatocellular Carcinoma: Locoregional and Targeted Therapies. Gastroenterology Clinics of North America 40:3, 599-610
CrossRef103
Leonidas G. Koniaris, David M. Levi, Felipe E. Pedroso, Dido Franceschi, Andreas G. Tzakis, Juan A. Santamaria-Barria, Jennifer Tang, Marissa Anderson, Subhasis Misra, Naveenraj L. Solomon, Xiaoling Jin, Peter J. DiPasco, Margaret M. Byrne, Teresa A. Zimmers. (2011) Is Surgical Resection Superior to Transplantation in the Treatment of Hepatocellular Carcinoma?. Annals of Surgery 254:3, 527-538
CrossRef104
Masato Fujiki, Federico Aucejo, Richard Kim. (2011) General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?. Liver International 31:8, 1081-1089
CrossRef105
Nicholas N. Nissen, Vijay Menon, Catherine Bresee, Tram T. Tran, Alagappan Annamalai, Fred Poordad, Jeffrey H. Fair, Andrew S. Klein, Brendan Boland, Steven D. Colquhoun. (2011) Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient. HPB 13:9, 626-632
CrossRef106
L. Prompers, J. Bucerius, B. Brans, Y. Temur, L. Berger, F.M. Mottaghy. (2011) Selective internal radiation therapy (SIRT) in primary or secondary liver cancer. Methods
CrossRef107
Matthew P. Landman, Irene D. Feurer, C. Wright Pinson, Derek E. Moore. (2011) Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?. HPBno-no
CrossRef108
Mauricio Stanzione Galizia, Hüseyin Gürkan Töre, Hamid Chalian, Vahid Yaghmai. (2011) Evaluation of Hepatocellular Carcinoma Size Using Two-dimensional and Volumetric Analysis. Academic Radiology
CrossRef109
Cheng-Maw Ho, Po-Huang Lee, Chi-Ling Chen, Ming-Chih Ho, Yao-Ming Wu, Rey-Heng Hu. (2011) Long-Term Outcomes After Resection Versus Transplantation for Hepatocellular Carcinoma Within UCSF Criteria. Annals of Surgical Oncology
CrossRef110
F P Costa, A C de Oliveira, R Meirelles, M C C Machado, T Zanesco, R Surjan, M C Chammas, M de Souza Rocha, D Morgan, A Cantor, J Zimmerman, I Brezovich, N Kuster, A Barbault, B Pasche. (2011) Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. British Journal of Cancer 105:5, 640-648
CrossRef111
Koji Kitamura, Etsuro Hatano, Tatsuya Higashi, Satoru Seo, Yuji Nakamoto, Kenya Yamanaka, Taku Iida, Kojiro Taura, Kentaro Yasuchika, Shinji Uemoto. (2011) Preoperative FDG-PET Predicts Recurrence Patterns in Hepatocellular Carcinoma. Annals of Surgical Oncology
CrossRef112
Daisuke Yamasaki, Natsuko Kawabe, Hitomi Nakamura, Keisuke Tachibana, Kenji Ishimoto, Toshiya Tanaka, Hiroyuki Aburatani, Juro Sakai, Takao Hamakubo, Tatsuhiko Kodama, Takefumi Doi. (2011) Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms. European Journal of Cell Biology 90:8, 657-664
CrossRef113
Deniz Balci, Murat Dayangac, Onur Yaprak, Baris Akin, Cihan Duran, Refik Killi, Yildiray Yuzer, Yaman Tokat. (2011) Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria. Transplant Internationalno-no
CrossRef114
Gonzalo Sapisochin, Nicholas Fidelman, John P. Roberts, Francis Y. Yao. (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transplantation 17:8, 934-942
CrossRef115
Theresa R. Harring, Jacfranz J. Guiteau, N. Thao T. Nguyen, Ron T. Cotton, Marie-Claude Gingras, David A. Wheeler, Christine A. O’Mahony, Richard A. Gibbs, F. Charles Brunicardi, John A. Goss. (2011) Building a Comprehensive Genomic Program for Hepatocellular Carcinoma. World Journal of Surgery 35:8, 1746-1750
CrossRef116
Yoon Hee Chun, Seung Up Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Chae Yoon Chon, Beom Kyung Kim, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Sang Hoon Ahn. (2011) Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. European Journal of Cancer
CrossRef117
Alessandro Cucchetti, Matteo Cescon, Giorgio Ercolani, Maria Cristina Morelli, Massimo Del Gaudio, Matteo Zanello, Antonio Daniele Pinna. (2011) Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. Transplant International 24:8, 787-796
CrossRef118
Sonia Radunz, Andreas Paul, Knut Nowak, Jürgen W. Treckmann, Fuat H. Saner, Zoltan Mathé. (2011) Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go?. Liver International 31:7, 1021-1027
CrossRef119
Gonzalo Sapisochin, Francis Y. Yao, John P. Roberts. (2011) Do Preoperative Inflammatory Markers Impact on Outcome After Liver Transplantation for Hepatocellular Carcinoma?. Annals of Surgery 254:2, 383
CrossRef120
Manli Jiang, F. Scott Nowakowski, Jason Wang, Sherif Heiba, Zhuangyu Zhang, Joshua Weintraub, Edward Kim, Josef Machac. (2011) Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy. Cancer Biotherapy & Radiopharmaceuticals 26:4, 511-518
CrossRef121
Khairuddin Memon, Laura Kulik, Robert J. Lewandowski, Edward Wang, Ahsun Riaz, Robert K. Ryu, Kent T. Sato, Karen Marshall, Ramona Gupta, Paul Nikolaidis, Frank H. Miller, Vahid Yaghmai, Seanthan Senthilnathan, Talia Baker, Vanessa L. Gates, Michael Abecassis, Al B. Benson, Mary F. Mulcahy, Reed A. Omary, Riad Salem. (2011) Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times. Gastroenterology 141:2, 526-535.e2
CrossRef122
Francesco Vasuri, Rita Golfieri, Michelangelo Fiorentino, Elisa Capizzi, Matteo Renzulli, Antonio D. Pinna, Walter F. Grigioni, Antonia D’Errico-Grigioni. (2011) OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Virchows Archiv 459:2, 141-146
CrossRef123
Marcelo E. Facciuto, Manoj K. Singh, Umadevi Katta, Susana Samaniego, Jyoti Sharma, Manuel Rodriguez-Davalos, Patricia Sheiner, Leona Kim-Schluger, David C. Wolf. (2011) Liver Transplantation for Hepatocellular Carcinoma: Defining the Impact of Using Extended Criteria Liver Allografts. Transplantation 92:4, 446-452
CrossRef124
Robin K. Kelley, Francis Yao. (2011) Salvage liver transplantation for recurrent hepatocellular carcinoma after radiofrequency ablation: A new strategy?. Journal of Hepatology
CrossRef125
Hong-Yuan Chen, Zhong-Bo Han, Jun-Wei Fan, Jun Xia, Jun-Yi Wu, Guo-Qiang Qiu, Hua-Mei Tang, Zhi-Hai Peng. (2011) miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver. Medical Oncology
CrossRef126
Qian Zhan, Bai-Yong Shen, Xia-Xing Deng, Zhe-Cheng Zhu, Hao Chen, Chen-Hong Peng, Hong-Wei Li. (2011) Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center. Journal of Hepato-Biliary-Pancreatic Sciences
CrossRef127
Jeong Han Kim, Hyung Joon Yim, Kwang Gyun Lee, Seung Young Kim, Eun Suk Jung, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun, Ho Sang Ryu. (2011) Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study. Hepatology International
CrossRef128
Abha A. Gupta, J. Ted Gerstle, Vicky Ng, Ansely Wong, Annie Fecteau, Marcio H. Malogolowkin, Rebecka L. Meyers, David Grant, Ronald M. Grant. (2011) Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatric Blood & Cancer 56:7, 1013-1018
CrossRef129
Fabrizio Romano, Paola Stroppa, Michela Bravi, Valeria Casotti, Alessandro Lucianetti, Michela Guizzetti, Aurelio Sonzogni, Michele Colledan, Lorenzo D’Antiga. (2011) Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma. Pediatric Transplantationno-no
CrossRef130
W. Ouedraogo, J. Tran-Van Nhieu, L. Baranes, S.-J. Lin, T. Decaens, A. Laurent, M. Djabbari, F. Pigneur, C. Duvoux, H. Kobeiter, J.-F. Deux, A. Rahmouni, A. Luciani. (2011) Évaluation des critères diagnostiques non invasifs du carcinome hépatocellulaire sur IRM pré-greffe hépatique (2010) : corrélations IRM – anatomopathologiques sur explants hépatiques. Journal de Radiologie 92:7-8, 688-700
CrossRef131
Thomas Decaens, Françoise Roudot-Thoraval, Hanaa Badran, Philippe Wolf, François Durand, Rene Adam, Olivier Boillot, Claire Vanlemmens, Jean Gugenheim, Sébastien Dharancy, Pierre-Henri Bernard, Karim Boudjema, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges Philippe Pageaux, Marie-Noelle Hilleret, Olivier Chazouillères, Daniel Cherqui, Ariane Mallat, Christophe Duvoux. (2011) Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma. Liver International 31:6, 792-801
CrossRef132
Kheng-Choon Lim, Pierce Kah-Hoe Chow, John C. Allen, Ghim-Song Chia, Miaoshan Lim, Peng-Chung Cheow, Alexander Y.F. Chung, London L.P. Ooi, Say-Beng Tan. (2011) Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria. Annals of Surgery 254:1, 108-113
CrossRef133
Hongcheng Sun, Mujian Teng, Jie Liu, Dong Jin, Junyi Wu, Dongwang Yan, Junwei Fan, Xuebin Qin, Huamei Tang, Zhihai Peng. (2011) FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria. Cancer Letters 306:2, 214-222
CrossRef134
Hiroaki Yokomori, Masaya Oda, Kazunori Yoshimura, Fumihiko Kaneko, Toshifumi Hibi. (2011) Aquaporin-1 associated with hepatic arterial capillary proliferation on hepatic sinusoid in human cirrhotic liver. Liver Internationaln/a-n/a
CrossRef135
Hironobu Amano, Hirotaka Tashiro, Akihiko Oshita, Tsuyoshi Kobayashi, Yoshisato Tanimoto, Shintaro Kuroda, Hirofumi Tazawa, Toshiyuki Itamoto, Toshimasa Asahara, Hideki Ohdan. (2011) Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria. Journal of Gastrointestinal Surgery 15:7, 1173-1181
CrossRef136
David A. Bush, Zeid Kayali, Roger Grove, Jerry D. Slater. (2011) The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 117:13, 3053-3059
CrossRef137
Georgios C Sotiropoulos. (2011) Survival benefit in hepatocellular carcinoma: when an innovative transplant strategy might benefit oncology. The Lancet Oncology 12:7, 611-612
CrossRef138
Hiroki Haradome, Luigi Grazioli, Rita Tinti, Mario Morone, Utaroh Motosugi, Katsuhiro Sano, Tomoaki Ichikawa, Thomas C. Kwee, Stefano Colagrande. (2011) Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: Comparison with dynamic triple-phase multidetector CT imaging. Journal of Magnetic Resonance Imaging 34:1, 69-78
CrossRef139
Alessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, Fabio Farinati, Patrizia Burra, Paolo Angeli, Anna Chiara Frigo, Paolo Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, Umberto Cillo. (2011) Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. The Lancet Oncology 12:7, 654-662
CrossRef140
Robert A. Adair, Giles J. Toogood. (2011) Liver transplantation. Surgery (Oxford) 29:7, 325-329
CrossRef141
Shun-ichi Ariizumi, Koichi Kitagawa, Yoshihito Kotera, Yutaka Takahashi, Satoshi Katagiri, Ryohei Kuwatsuru, Masakazu Yamamoto. (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 18:4, 575-585
CrossRef142
Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Roongruedee Chaiteerakij, Felicity T. Enders, Terry M. Therneau, Lucinda Orsini, W. Ray Kim, Lewis R. Roberts. (2011) Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance. Clinical Gastroenterology and Hepatology 9:7, 617-623.e1
CrossRef143
Vinay Kumaran. (2011) Hepatocellular carcinoma: Resection versus transplantation. Indian Journal of Transplantation 5:2, 102-103
CrossRef144
Ben-Hur Ferraz-Neto, Guilherme Felga, Andréia Silva angelista, Marcelo Bruno de Rezende, Rogério Carballo Afonso. (2011) Patient selection and results of transplant for hepatocellular carcinoma: The Brazilian perspective. Indian Journal of Transplantation 5:2, 94-95
CrossRef145
Valentina Santi, Daniela Buccione, Antonio Di Micoli, Gianluca Fatti, Marta Frigerio, Fabio Farinati, Paolo Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Mauro Bernardi, Franco Trevisani. (2011) The changing scenario of hepatocellular carcinoma over the last two decades in Italy. Journal of Hepatology
CrossRef146
Mohammad A. B. Al-Freah, Edward J. Gane, Vicki Livingstone, John McCall, Stephen Munn. (2011) The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality. Hepatology International
CrossRef147
Ming-chun Lai, Zhe Yang, Lin Zhou, Qian-qian Zhu, Hai-yang Xie, Feng Zhang, Li-ming Wu, Lei-ming Chen, Shu-sen Zheng. (2011) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Medical Oncology
CrossRef148
Shinji Itoh, Yasuharu Ikeda, Hirofumi Kawanaka, Toshirou Okuyama, Katsumi Kawasaki, Daihiko Eguchi, Daisuke Korenaga, Kenji Takenaka. (2011) Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma. Annals of Surgical Oncology
CrossRef149
R.A. Adair, A.L. Young, G.J. Toogood. (2011) Advances in hepatobiliary surgery. Trends in Anaesthesia and Critical Care 1:3, 141-146
CrossRef150
Chang Hee Lee, Lauren M. Brubaker, David A. Gerber, Young Mi Ku, Young Hoon Kim, Sang Soo Shin, Richard C. Semelka. (2011) MRI Findings of recurrent hepatocellular carcinoma after liver transplantation: Preliminary results. Journal of Magnetic Resonance Imaging 33:6, 1399-1405
CrossRef151
Valentina Rosa Bertuzzo, Matteo Cescon, Matteo Ravaioli, Gian Luca Grazi, Giorgio Ercolani, Massimo Del Gaudio, Alessandro Cucchetti, Antonietta DʼErrico-Grigioni, Rita Golfieri, Antonio Daniele Pinna. (2011) Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers. Transplantation 91:11, 1279-1285
CrossRef152
José Velosa, Fátima Serejo, Rui Marinho, Joana Nunes, Helena Glória. (2011) Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis. Digestive Diseases and Sciences 56:6, 1853-1861
CrossRef153
Tommaso Stroffolini, Franco Trevisani, Giovanbattista Pinzello, Franco Brunello, Maurizio A. Tommasini, Massimo Iavarone, Vito Di Marco, Fabio Farinati, Paolo Del Poggio, Franco Borzio, Mauro Borzio, Eugenio Caturelli, Maria Anna Di Nolfo, Marta Frigerio, Giuseppina Brancaccio, Giovanni Battista Gaeta. (2011) Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. Digestive and Liver Disease
CrossRef154
Jennifer Urquhart, Jonathan M. Schwartz. (2011) Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports 10:2, 147-152
CrossRef155
David L. Andolino, Cynthia S. Johnson, Mary Maluccio, Paul Kwo, A. Joseph Tector, Jennifer Zook, Peter A.S. Johnstone, Higinia R. Cardenes. (2011) Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics
CrossRef156
Davendra P. S. Sohal, Weijing Sun. (2011) Hepatocellular Carcinoma: Prevention and Therapy. Current Oncology Reports 13:3, 186-194
CrossRef157
Kenneth Washburn, Glenn Halff. (2011) Hepatocellular carcinoma and liver transplantation. Current Opinion in Organ Transplantation 16:3, 297-300
CrossRef158
Jason M. Ali, Luca Bonomo, Rebecca Brais, William J.H. Griffiths, David J. Lomas, Emmanuel L. Huguet, Raaj K. Praseedom, Neville V. Jamieson, Asif Jah. (2011) Outcomes and Diagnostic Challenges Posed by Incidental Cholangiocarcinoma After Liver Transplantation. Transplantation 91:12, 1392-1397
CrossRef159
Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Young-Dong Yu, Pyoung-Jae Park, Young-Il Choi, Kyoung-Won Kim, Young-Suk Lim, Han Chu Lee, Eun-Sil Yu, Sung-Gyu Lee. (2011) Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation. Journal of Gastrointestinal Surgery 15:6, 971-981
CrossRef160
Toshimi Kaido, Akira Mori, Yasuhiro Ogura, Koichiro Hata, Atsushi Yoshizawa, Taku Iida, Shinji Uemoto. (2011) Recurrence of Hepatocellular Carcinoma after Living Donor Liver Transplantation: What is the Current Optimal Approach to Prevent Recurrence?. World Journal of Surgery 35:6, 1355-1359
CrossRef161
Takumi Kawaguchi, Tatsuyuki Kakuma, Hiroshi Yatsuhashi, Hiroshi Watanabe, Hideki Saitsu, Kazuhiko Nakao, Akinobu Taketomi, Satoshi Ohta, Akinari Tabaru, Kenji Takenaka, Toshihiko Mizuta, Kenji Nagata, Yasuji Komorizono, Kunitaka Fukuizumi, Masataka Seike, Shuichi Matsumoto, Tatsuji Maeshiro, Hirohito Tsubouchi, Toyokichi Muro, Osami Inoue, Motoo Akahoshi, Michio Sata. (2011) Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatology Research 41:6, 564-571
CrossRef162
L.L.-C. Tsang, C.-L. Chen, T.-L. Huang, T.-Y. Chen, H.-Y. Ou, H.-L. Eng, A. Concejero, C.-Y. Yu, H.-L. Chen, Y.-F. Cheng. (2011) Superparamagnectic Iron Oxide-Enhanced Magnetic Resonance for Tumor Surveillance in Cirrhotic Liver Before Liver Transplantation with Explanted Liver Correlation. Transplantation Proceedings 43:5, 1674-1677
CrossRef163
Michał Grąt, Wacław Hołówko, Karolina Grzegorczyk, Michał Skalski, Marek Krawczyk. (2011) Long-Term Results of Liver Resection in the Treatment of Patients with Hepatocellular Carcinoma. Polish Journal of Surgery 83:6, 319-324
CrossRef164
Mauro Bernardi, Stefano Gitto, Maurizio Biselli. (2011) The MELD score in patients awaiting liver transplant: Strengths and weaknesses. Journal of Hepatology 54:6, 1297-1306
CrossRef165
K. MEIJER, E. B. HAAGSMA. (2011) HCV-related liver cancer in people with haemophilia. Haemophiliano-no
CrossRef166
Renato Romagnoli, Damiano Patrono, Gianluca Paraluppi, Ezio David, Francesco Tandoi, Paolo Strignano, Francesco Lupo, Mauro Salizzoni. (2011) Liver transplantation for symptomatic centrohepatic biliary cystadenoma. Clinics and Research in Hepatology and Gastroenterology 35:5, 408-413
CrossRef167
Ming-Yuan Lee, Vincent P. Chuang, Chao-Jung Wei, Tsung-Yen Cheng, Ming-Tsu Cherng. (2011) Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes. European Journal of Radiology
CrossRef168
Augusto Villanueva, Josep M. Llovet. (2011) Targeted Therapies for Hepatocellular Carcinoma. Gastroenterology 140:5, 1410-1426
CrossRef169
A. Rossetto, G.L. Adani, U. Baccarani, V. Bresadola, D. Lorenzin, M. Sponza, A. Vit, D. De Anna, F. Bresadola. (2011) Necrosis Percentage of Radiologically Treated Hepatocellular Carcinoma at Hepatectomy for Liver Transplantation. Transplantation Proceedings 43:4, 1095-1097
CrossRef170
Takeo Toshima, Ken Shirabe, Kazuki Takeishi, Takashi Motomura, Youhei Mano, Hideaki Uchiyama, Tomoharu Yoshizumi, Yuji Soejima, Akinobu Taketomi, Yoshihiko Maehara. (2011) New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. Journal of Gastroenterology 46:5, 705-711
CrossRef171
Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton, . (2011) PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transplantation 17:5, 528-538
CrossRef172
Fabrice Muscari, Bertrand Foppa, Nicolas Carrere, Nassim Kamar, Jean-Marie Peron, Bertrand Suc. (2011) Resection of a Transplantable Single-Nodule Hepatocellular Carcinoma in Child-Pugh Class A Cirrhosis: Factors Affecting Survival and Recurrence. World Journal of Surgery 35:5, 1055-1062
CrossRef173
Howard C. Masuoka, Charles B. Rosen. (2011) Liver Transplantation for Hepatocellular Carcinoma: Expanding Frontiers and Building Bridges. Clinics in Liver Disease 15:2, 385-393
CrossRef174
Saleh A Alqahtani, Anne M Larson. (2011) Adult liver transplantation in the USA. Current Opinion in Gastroenterology 27:3, 240-247
CrossRef175
Óscar Núñez Martínez, Ana Matilla Peña, Beatriz Merino Rodríguez, Antonio Díaz Sánchez, Arturo Colón Rodríguez, Enrique Ramón Botella, Ismael Yepes Barreto, Marisa Prieto Martín, José María Tellado Rodríguez, Gerardo Clemente Ricote. (2011) Estudio descriptivo de la experiencia sobre carcinoma hepatocelular en hígado no cirrótico. Gastroenterología y Hepatología 34:5, 322-328
CrossRef176
Prashant Bhangui, Eric Vibert, Pietro Majno, Chady Salloum, Paola Andreani, Joao Zocrato, Philippe Ichai, Faouzi Saliba, Rene Adam, Denis Castaing, Daniel Azoulay. (2011) Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation. Hepatology 53:5, 1570-1579
CrossRef177
T. M. Earl, W. C. Chapman. (2011) Tumor Size Remains Key for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Annals of Surgical Oncology 18:5, 1217-1218
CrossRef178
T. Mark Earl, William C. Chapman. (2011) Conventional Surgical Treatment of Hepatocellular Carcinoma. Clinics in Liver Disease 15:2, 353-370
CrossRef179
Chia-Yang Hsu, Yi-Hsiang Huang, Yi-You Chiou, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Jen-Huey Chiang, Teh-Ia Huo, Fa-Yauh Lee, Shou-Dong Lee. (2011) Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis. Liver Transplantation 17:5, 556-566
CrossRef180
B. Nemes, F. Gelley, L. Piros, G. Zádori, D. Görög, I. Fehérvári, L. Kóbori, E. Sárváry, P. Nagy, A. Kiss, A. Doros. (2011) The Impact of Milan Criteria on Liver Transplantation for Hepatocellular Carcinoma: First 15 Years' Experience of the Hungarian Liver Transplant Program. Transplantation Proceedings 43:4, 1272-1274
CrossRef181
Jens Mittler, John W. McGillicuddy, Kenneth D. Chavin. (2011) Laparoscopic Liver Resection in the Treatment of Hepatocellular Carcinoma. Clinics in Liver Disease 15:2, 371-384
CrossRef182
Zhe Yang, Lin Zhou, Li-Ming Wu, Ming-Chun Lai, Hai-Yang Xie, Feng Zhang, Shu-Sen Zheng. (2011) Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation. Annals of Surgical Oncology 18:5, 1243-1250
CrossRef183
Morris Sherman. 2011. Primary Malignant Neoplasms of the Liver. , 681-703.
CrossRef184
Irene Bargellini. (2011) Hepatocellular carcinoma: MR staging and therapeutic decisions. Abdominal Imaging
CrossRef185
Shishir K. Maithel, Peter J. Kneuertz, David A. Kooby, Charles R. Scoggins, Sharon M. Weber, Robert C.G. Martin, Kelly M. McMasters, Clifford S. Cho, Emily R. Winslow, William C. Wood, Charles A. Staley. (2011) Importance of Low Preoperative Platelet Count in Selecting Patients for Resection of Hepatocellular Carcinoma: A Multi-Institutional Analysis. Journal of the American College of Surgeons 212:4, 638-648
CrossRef186
Irene Bargellini, Rodolfo Sacco, Elena Bozzi, Marco Bertini, Barbara Ginanni, Antonio Romano, Antonio Cicorelli, Emanuele Tumino, Graziana Federici, Roberto Cioni, Salvatore Metrangolo, Michele Bertoni, Giampaolo Bresci, Giuseppe Parisi, Emanuele Altomare, Alfonso Capria, Carlo Bartolozzi. (2011) Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. European Journal of Radiology
CrossRef187
Ahsun Riaz, Khairuddin Memon, Frank H. Miller, Paul Nikolaidis, Laura M. Kulik, Robert J. Lewandowski, Robert K. Ryu, Kent T. Sato, Vanessa L. Gates, Mary F. Mulcahy, Talia Baker, Ed Wang, Ramona Gupta, Ritu Nayar, Al B. Benson, Michael Abecassis, Reed Omary, Riad Salem. (2011) Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic–pathologic correlation. Journal of Hepatology 54:4, 695-704
CrossRef188
Mohamad R. Al Sibae, Mitchell S. Cappell. (2011) Accuracy of MELD Scores in Predicting Mortality in Decompensated Cirrhosis from Variceal Bleeding, Hepatorenal Syndrome, Alcoholic Hepatitis, or Acute Liver Failure As Well As Mortality After Non-transplant Surgery or TIPS. Digestive Diseases and Sciences 56:4, 977-987
CrossRef189
T. Takayama. (2011) Surgical Treatment for Hepatocellular Carcinoma. Japanese Journal of Clinical Oncology 41:4, 447-454
CrossRef190
Wei-Yu Kao, Chien-Wei Su, Gar-Yang Chau, Wing-Yiu Lui, Chew-Wun Wu, Jaw-Ching Wu. (2011) A Comparison of Prognosis between Patients with Hepatitis B and C Virus-related Hepatocellular Carcinoma Undergoing Resection Surgery. World Journal of Surgery 35:4, 858-867
CrossRef191
J.F. Castroagudín, E. Molina-Pérez, R. Ferreiro-Iglesias, E. Varo-Pérez. (2011) Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma. Transplantation Proceedings 43:3, 711-713
CrossRef192
Kyung Ah Kim, Myeong-Jin Kim, Jin-Young Choi, Yong Eun Chung. (2011) Development of hepatocellular carcinomas in patients with absence of tumors on a prior ultrasound examination. European Journal of Radiology
CrossRef193
Katrin Hoffmann, Ulf Hinz, Norbert Hillebrand, Boris A. Radeleff, Tom M. Ganten, Peter Schirmacher, Jan Schmidt, Markus W. Büchler, Peter Schemmer. (2011) Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis. Clinical Transplantationno-no
CrossRef194
Xian-Jie Shi, Xin Jin, Mao-Qiang Wang, Li-Xin Wei, Hui-Yi Ye, Yu-Rong Liang, Ying Luo, Jia-Hong Dong. (2011) Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation. Hepatobiliary & Pancreatic Diseases International 10:2, 143-150
CrossRef195
Ken Shirabe, Akinobu Taketomi, Kazutoyo Morita, Yuji Soejima, Hideaki Uchiyama, Hiroto Kayashima, Mizuki Ninomiya, Takeo Toshima, Yoshihiko Maehara. (2011) Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation. Clinical Transplantationno-no
CrossRef196
Luigi Addario, Giovanni Tritto, Enrico Cavaglià, Francesco Amodio, Eduardo Giannelli, Giovan Giuseppe Di Costanzo. (2011) Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma. Digestive and Liver Disease 43:4, 319-324
CrossRef197
R. Charco, M. Caralt, L. Lladó, A. Valdivieso, J. Fabregat, A. Matarranz, I. Gonzalez-Pinto, F. Pardo, E. Fábrega, I. Bilbao. (2011) A Prospective, Multicenter Study of Once-Daily Extended-Release Tacrolimus in De Novo Liver Transplant Recipients. Transplantation Proceedings 43:3, 718-723
CrossRef198
H.C. Addley, N. Griffin, A.S. Shaw, L. Mannelli, R.A. Parker, S. Aitken, H. Wood, S. Davies, G.J. Alexander, D.J. Lomas. (2011) Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clinical Radiology 66:4, 349-356
CrossRef199
Chen-Te Chou, Yao-Li Chen, Hwa-Koon Wu, Ran-Chou Chen. (2011) Characterization of hyperintense nodules on precontrast T1-weighted MRI: Utility of gadoxetic acid-enhanced hepatocyte-phase imaging. Journal of Magnetic Resonance Imaging 33:3, 625-632
CrossRef200
Steven-Huy Han, K. Rajender Reddy, Emmet B. Keeffe, Consuelo Soldevila-Pico, Robert Gish, Raymond T. Chung, Bulent Degertekin, Anna Lok, . (2011) Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clinical Transplantation 25:2, E152-E162
CrossRef201
Paulo N. Martins, Sue Chang, Basant Mahadevapa, Ann-Britt Martins, Patricia Sheiner. (2011) Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. HPB 13:3, 212-220
CrossRef202
Uri Ladabaum, Shan L. Cheng, Francis Y. Yao, John P. Roberts. (2011) Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. Clinical Transplantation 25:2, 283-291
CrossRef203
Miguel Bispo, Paulo Marcelino, Hugo Pinto Marques, Américo Martins, Rui Perdigoto, Maria João Aguiar, Luís Mourão, Eduardo Barroso. (2011) Domino versus deceased donor liver transplantation: Association with early graft function and perioperative bleeding. Liver Transplantation 17:3, 270-278
CrossRef204
Richard Kim, Federico Aucejo. (2011) Radiologic Complete Response with Sirolimus and Sorafenib in a Hepatocellular Carcinoma Patient who Relapsed After Orthotopic Liver Transplantation. Journal of Gastrointestinal Cancer 42:1, 50-53
CrossRef205
Nuh N. Rahbari, Arianeb Mehrabi, Nathan M. Mollberg, Sascha A. Müller, Moritz Koch, Markus W. Büchler, Jürgen Weitz. (2011) Hepatocellular Carcinoma. Annals of Surgery 253:3, 453-469
CrossRef206
Keishi Sugimachi, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Tomohiro Iguchi, Kazuki Takeishi, Takeo Toshima, Shinichi Aishima, Tsuyoshi Tajima, Yoshihiko Maehara. (2011) Prognostic Significance of Preoperative Imaging in Recipients of Living Donor Liver Transplantation for Hepatocellular Carcinoma. Transplantation 91:5, 570-574
CrossRef207
Shimul A. Shah, Jillian K. Smith, YouFu Li, Sing Chau Ng, James E. Carroll, Jennifer F. Tseng. (2011) Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer 117:5, 1019-1026
CrossRef208
Riad Salem, Robert J. Lewandowski, Vanessa L. Gates, Charles W. Nutting, Ravi Murthy, Steven C. Rose, Michael C. Soulen, Jean-Francois H. Geschwind, Laura Kulik, Yun Hwan Kim, Carlo Spreafico, Marco Maccauro, Lourens Bester, Daniel B. Brown, Robert K.W. Ryu, Daniel Y. Sze, William S. Rilling, Kent T. Sato, Bruno Sangro, Jose Ignacio Bilbao, Tobias F. Jakobs, Samer Ezziddin, Suyash Kulkarni, Aniruddha Kulkarni, David M. Liu, David Valenti, Philip Hilgard, Gerald Antoch, Stefan P. Muller, Hamad Alsuhaibani, Mary F. Mulcahy, Marta Burrel, Maria Isabel Real, Stewart Spies, Abdulredha A. Esmail, Jean-Luc Raoul, Etienne Garin, Mathew S. Johnson, Al B. Benson, Ricky A. Sharma, Harpreet Wasan, Bieke Lambert, Khairuddin Memon, Andrew S. Kennedy, Ahsun Riaz. (2011) Research Reporting Standards for Radioembolization of Hepatic Malignancies. Journal of Vascular and Interventional Radiology 22:3, 265-278
CrossRef209
R.P. Sutcliffe, D. Lewis, P.A. Kane, B.C. Portmann, J.G. O’Grady, J.B. Karani, M. Rela, N.D. Heaton. (2011) Manganese-enhanced MRI predicts the histological grade of hepatocellular carcinoma in potential surgical candidates. Clinical Radiology 66:3, 237-243
CrossRef210
Marlén Alvite Canosa, Salvador Pita Fernández, Julia Quintela Fandiño, Javier Aguirrezabalaga, Alejandra Otero, Francisco Suárez, Gerardo Corbal, Carlos Fernández, Manuel Gómez Gutiérrez. (2011) Tratamiento quirúrgico del hepatocarcinoma: experiencia del CHU A Coruña. Cirugía Española
CrossRef211
Romaric Loffroy, MingDe Lin, Pramod Rao, Nikhil Bhagat, Niels Noordhoek, Alessandro Radaelli, Järl Blijd, Jean-François Geschwind. (2011) Comparing the Detectability of Hepatocellular Carcinoma by C-Arm Dual-Phase Cone-Beam Computed Tomography During Hepatic Arteriography With Conventional Contrast-Enhanced Magnetic Resonance Imaging. CardioVascular and Interventional Radiology
CrossRef212
Kimberly A Brown, Mary Ann Huang, Marwan Kazimi, Dilip Moonka. 2011. Liver Transplantation. , 238-273.
CrossRef213
Xiuli Liu, Wei Jiang, Federico Aucejo, Richard Kim, Charles Miller, Michael Byrne, Rocio Lopez, Lisa Yerian. (2011) Insulin-like growth factor I receptor β expression in hepatocellular carcinoma. Human Pathology
CrossRef214
Jae Min Chun, Hyung Jun Kwon, Junho Sohn, Sang Geol Kim, Ji-Young Park, Han Ik Bae, Young Kook Yun, Yoon Jin Hwang. (2011) Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. Journal of Surgical Oncology 103:2, 148-151
CrossRef215
Hauke Sebastian Heinzow, Tobias Meister, Dominik Nass, Michael Köhler, Tilmann Spieker, Heiner Wolters, Wolfram Domschke, Dirk Domagk. (2011) Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 46:2, 201-210
CrossRef216
Ashok Raj, John McCall, Edward Gane. (2011) Validation of the “Metroticket” predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma. Journal of Hepatology
CrossRef217
Pratima Sharma, Sameer D. Saini, Latoya B. Kuhn, Joel H. Rubenstein, Darrell S. Pardi, Jorge A. Marrero, Philip S. Schoenfeld. (2011) Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among Gastroenterologists. Digestive Diseases and Sciences 56:2, 569-577
CrossRef218
Tokihiko Sawada, Keiichi Kubota, Junji Kita, Masato Kato, Takayuki Shiraki, KyungHwa Park, Mitsugi Shimoda. (2011) Clinical Outcome of Hepatectomy for Hepatocellular Carcinomas ≤2 cm. World Journal of Surgery 35:2, 377-385
CrossRef219
Georgios Tsoulfas, Tatsuo Kawai, Nahel Elias, S. C. Ko, Polyxeni Agorastou, A. Benedict Cosimi, Martin Hertl. (2011) Long-term experience with liver transplantation for hepatocellular carcinoma. Journal of Gastroenterology 46:2, 249-256
CrossRef220
Edoardo G. Giannini, Vincenzo Savarino, Domenico Risso, Maria A. Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Fabio Farinati, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, . (2011) Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study. Liver International 31:2, 192-196
CrossRef221
Masakazu Hirakawa, Kengo Yoshimitsu, Hiroyuki Irie, Tsuyoshi Tajima, Akihiro Nishie, Yoshiki Asayama, Kousei Ishigami, Daisuke Kakihara, Akinobu Taketomi, Shin-ichi Aishima, Hiroshi Honda. (2011) Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. Japanese Journal of Radiology 29:2, 129-137
CrossRef222
Shaheed Merani, Pietro Majno, Norman M. Kneteman, Thierry Berney, Philippe Morel, Gilles Mentha, Christian Toso. (2011) The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. Journal of Hepatology
CrossRef223
K. Shirabe, S. Aishima, A. Taketomi, Y. Soejima, H. Uchiyama, H. Kayashima, M. Ninomiya, Y. Mano, Y. Maehara. (2011) Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. British Journal of Surgery 98:2, 261-267
CrossRef224
Nsikak J. Umoh, Olufunmilayo A. Lesi, Maimuna Mendy, Ebrima Bah, Aliu Akano, Hilton Whittle, Pierre Hainaut, Gregory D. Kirk. (2011) Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver International 31:2, 215-221
CrossRef225
R. Lord, A. Suddle, P. J. Ross. (2011) Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies. International Journal of Clinical Practice 65:2, 182-188
CrossRef226
Nam C. Yu, Vinika Chaudhari, Steven S. Raman, Charles Lassman, Myron J. Tong, Ronald W. Busuttil, David S.K. Lu. (2011) CT and MRI Improve Detection of Hepatocellular Carcinoma, Compared With Ultrasound Alone, in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 9:2, 161-167
CrossRef227
Palak Jitendrakumar Trivedi, Sue Cullen. (2011) Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC). Digestive Diseases and Sciences 56:2, 276-278
CrossRef228
Eric Vibert, Jean-Charles Duclos-Vallée, Maria-Rosa Ghigna, Emir Hoti, Chady Salloum, Catherine Guettier, Denis Castaing, Didier Samuel, René Adam. (2011) Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection. Hepatology 53:2, 475-482
CrossRef229
Riad Salem, Robert J. Lewandowski, Laura Kulik, Edward Wang, Ahsun Riaz, Robert K. Ryu, Kent T. Sato, Ramona Gupta, Paul Nikolaidis, Frank H. Miller, Vahid Yaghmai, Saad M. Ibrahim, Seanthan Senthilnathan, Talia Baker, Vanessa L. Gates, Bassel Atassi, Steven Newman, Khairuddin Memon, Richard Chen, Robert L. Vogelzang, Albert A. Nemcek, Scott A. Resnick, Howard B. Chrisman, James Carr, Reed A. Omary, Michael Abecassis, Al B. Benson, Mary F. Mulcahy. (2011) Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. Gastroenterology 140:2, 497-507.e2
CrossRef230
Tracy R. Price, Susan M. Perkins, Kumar Sandrasegaran, Mark A. Henderson, Mary A. Maluccio, Jennifer E. Zook, A. Joseph Tector, Rodrigo M. Vianna, Peter A.S. Johnstone, Higinia R. Cardenes. (2011) Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancern/a-n/a
CrossRef231
Vincenzo Mazzaferro, Sherrie Bhoori, Carlo Sposito, Marco Bongini, Martin Langer, Rosalba Miceli, Luigi Mariani. (2011) Milan criteria in liver transplantation for HCC: An evidence-based analysis on 15 years of experience. Liver Transplantationn/a-n/a
CrossRef232
Anthony S. Robbins, Derrick D. Cox, Lynt B. Johnson, Elizabeth M. Ward. (2011) Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007. Cancern/a-n/a
CrossRef233
Jendana Chanyaputhipong, Su-Chong Albert Low, Pierce K. H. Chow. (2011) Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. International Journal of Hepatology 2011, 1-13
CrossRef234
Min-ru Li, Gui-hua Chen, Chang-jie Cai, Guo-ying Wang, Hui Zhao. (2011) High Hepatitis B Virus DNA Level in Serum before Liver Transplantation Increases the Risk of Hepatocellular Carcinoma Recurrence. Digestion 84:2, 134-141
CrossRef235
Massimo Colombo, Angelo Sangiovanni. (2011) How I manage my patients with hepatocellular carcinoma. Liver International 31, 145-150
CrossRef236
Derek A. DuBay, Charbel Sandroussi, John R. Kachura, Chia Sing Ho, J. Robert Beecroft, Charles M. Vollmer, Anand Ghanekar, Markus Guba, Mark S. Cattral, Ian D. McGilvray, David R. Grant, Paul D. Greig. (2011) Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB 13:1, 24-32
CrossRef237
L. Barbier, F. Muscari, S. Le Guellec, A. Pariente, P. Otal, B. Suc. (2011) Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib. International Journal of Hepatology 2011, 1-5
CrossRef238
Koji Uchino, Ryosuke Tateishi, Shuichiro Shiina, Miho Kanda, Ryota Masuzaki, Yuji Kondo, Tadashi Goto, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike. (2011) Hepatocellular carcinoma with extrahepatic metastasis. Cancern/a-n/a
CrossRef239
Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues. (2011) Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study. International Journal of Hepatology 2011, 1-7
CrossRef240
Cher Heng Tan, Su-Chong Albert Low, Choon Hua Thng. (2011) APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. International Journal of Hepatology 2011, 1-11
CrossRef241
Hari Nathan, Dorry L. Segev, Skye C. Mayo, Michael A. Choti, Andrew M. Cameron, Christopher L. Wolfgang, Kenzo Hirose, Barish H. Edil, Richard D. Schulick, Timothy M. Pawlik. (2011) National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancern/a-n/a
CrossRef242
Jean F. Botha, B. Daniel Campos. 2011. , 990.
CrossRef243
Jacques Belghiti, François Durand. (2011) Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome?. Liver International 31, 161-163
CrossRef244
Richard B. Freeman. 2011. , 1085.
CrossRef245
Mustafa Ozturk, Sukru Oter. (2011) Molecular approach to treatment of hepatocellular carcinoma: new hope for therapeutic targets. Journal of Experimental and Integrative Medicine83
CrossRef246
Tan To Cheung, See Ching Chan, Chi Lai Ho, Kenneth Siu Ho Chok, Albert Chi Yan Chan, William Wei Sharr, Kelvin Kwok Chai Ng, Ronnie Tung Ping Poon, Chung Mau Lo, Sheung Tat Fan. (2011) Can PET using dual-tracer 11C-acetate and 18F-FDG predict microvascular invasion in hepatocellular carcinoma?. Liver Transplantationn/a-n/a
CrossRef247
B. Jung, M. Cisse, G. Chanques, E. Arsac, M. Bismuth, F. Panaro, P.-F. Perrigault, B. Souche, B. Gallix, D. Verzilli. (2011) Mortalité trois mois après transplantation hépatique : étude monocentrique sur une période de vingt ans. Annales Françaises d Anesthésie et de Réanimation
CrossRef248
Ricardo Gehrau, Valeria Mas, Kellie J Archer, Daniel Maluf. (2011) Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation. Expert Review of Gastroenterology and Hepatology 5:4, 539
CrossRef249
Nishant Merchant, Calvin S. David, Steven C. Cunningham. (2011) Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. International Journal of Hepatology 2011, 1-7
CrossRef250
K Raj Prasad, Richard S Young, Patrizia Burra, Shu-Sen Zheng, Vincenzo Mazzaferro, DukBog Moon, Richard B Freeman. (2011) Summary of candidate selection and expanded criteria for liver transplantation for HCC: A review and consensus statement from the 2010 international consensus conference on liver transplantation for hepatocellular carcinoma. Liver Transplantationn/a-n/a
CrossRef251
Eun Kyoung Lee, Seong-Hwan Chang, Duk-Kyung Kim, Bo Sung Cheon, Young-Sang Hong, Byoung Joon Kang, Sang Eun Nam, Jae Hoon Sim, Hae-Won Lee, Ik Jin Yun. (2011) Outcomes of Early Liver Transplantation in a Hospital That Is Starting to Perform Liver Transplantation. The Journal of the Korean Society for Transplantation 25:3, 184
CrossRef252
J.-L. Raoul, M. Latournerie, A. Guillygomarc’h, K. Boudjema, O. Audrain, É. Boucher. (2011) Carcinoma hepatocelular. EMC - Tratado de Medicina 15:3, 1-9
CrossRef253
Mustafa Raoof, Steven A. Curley. (2011) Non-Invasive Radiofrequency-Induced Targeted Hyperthermia for the Treatment of Hepatocellular Carcinoma. International Journal of Hepatology 2011, 1-6
CrossRef254
C. T. Barry, M. D'Souza, M. McCall, S. Safadjou, C. Ryan, R. Kashyap, C. Marroquin, M. Orloff, A. Almudevar, T. E. Godfrey. (2011) Micro RNA Expression Profiles as Adjunctive Data to Assess the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation : miRNA Profiles Predicting HCC Recurrence. American Journal of Transplantationno
CrossRef255
Kim M. Olthoff, Alejandro Forner, Stefan Hübscher, John Fung. (2011) What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?. Liver Transplantationn/a-n/a
CrossRef256
Sae Byeol Choi, Hyungi Kim, Sung Hoon Kim, Young Nyun Park, Kyung Sik Kim. (2011) Solitary Extrahepatic Intraabdominal Metastasis from Hepatocellular Carcinoma after Liver Transplantation. Yonsei Medical Journal 52:1, 199
CrossRef257
Gitonga Munene, Jean-Nicolas Vauthey, Elijah Dixon. (2011) Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. International Journal of Hepatology 2011, 1-4
CrossRef258
Richard S. Mangus, A. Joseph. Tector. 2011. Clinical Aspects of Liver Transplantation. , 577-598.
CrossRef259
Yoji Kishi, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo. (2011) Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection. International Journal of Hepatology 2011, 1-10
CrossRef260
Antonio J. Ruiz-Alcaraz, María Martínez-Esparza, Rocío Caño, Trinidad Hernández-Caselles, Chiara Recarti, Lucía Llanos, Pedro Zapater, Ana Tapia, Elena Martín-Orozco, Miguel Pérez-Mateo, José Such, Pilar García-Peñarrubia, Rubén Francés. (2011) Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion. European Journal of Clinical Investigation 41:1, 8-15
CrossRef261
Massimo Iavarone, Massimo Colombo. (2011) HBV-related HCC, clinical issues and therapy. Digestive and Liver Disease 43, S32-S39
CrossRef262
Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo. (2011) Laser Ablation for Small Hepatocellular Carcinoma. Radiology Research and Practice 2011, 1-8
CrossRef263
Norm Kneteman. (2011) Tools to monitor HCC on the waiting list (aFP, size, biopsy, …) and monitoring after liver transplant. Liver Transplantationn/a-n/a
CrossRef264
Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, Simon D. Taylor-Robinson. 2011. , 24.
CrossRef265
Francis Y. Yao, Stefan Breitenstein, Christoph E. Broelsch, Jean-Francois Dufour, Morris Sherman. (2011) Does a patient qualify for liver transplantation after down-staging of hepatocellular carcinoma?. Liver Transplantationn/a-n/a
CrossRef266
Pierre Bedossa, Valérie Paradis. 2011. Hepatocellular Carcinoma. , 489-501.
CrossRef267
Vibha Varma, Naimish Mehta, Vinay Kumaran, Samiran Nundy. (2011) Indications and Contraindications for Liver Transplantation. International Journal of Hepatology 2011, 1-9
CrossRef268
Marlén Alvite Canosa, Salvador Pita Fernández, Julia Quintela Fandiño, Javier Aguirrezabalaga, Alejandra Otero, Francisco Suárez, Gerardo Corbal, Carlos Fernández, Manuel Gómez Gutiérrez. (2011) Surgical treatment of liver cancer: Experience of the A Coruña UHC (Spain). Cirugía Española (English Edition) 89:4, 223-229
CrossRef269
Derek DuBay, Charbel Sandroussi, Lakhbir Sandhu, Sean Cleary, Markus Guba, Mark S. Cattral, Ian McGilvray, Anand Ghanekar, Markus Selzner, Paul D. Greig, David R. Grant. (2011) Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion. Annals of Surgery 253:1, 166-172
CrossRef270
Rahul Deshpande, Derek O'Reilly, David Sherlock. (2011) Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. International Journal of Hepatology 2011, 1-9
CrossRef271
Hyun-Mi Bae, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim, Dae Seog Heo, Hyo-Suk Lee. (2011) Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation. BMC Cancer 11:1, 435
CrossRef272
Marcelo E. Facciuto, Manoj K. Singh, Caroline Rochon, Jyoti Sharma, Cecilia Gimenez, Umadevi Katta, Chitti R. Moorthy, Stuart Bentley-Hibbert, Manuel Rodriguez-Davalos, David C. Wolf. (2011) Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response. Journal of Surgical Oncologyn/a-n/a
CrossRef273
Alejandro Forner, Carmen Ayuso, Jordi Bruix. 2011. , 978.
CrossRef274
Myeong-Jin Kim. (2011) Current Limitations and Potential Breakthroughs for the Early Diagnosis of Hepatocellular Carcinoma. Gut and Liver 5:1, 15
CrossRef275
Yoshinori Inagaki, Wei Tang, Masatoshi Makuuchi, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo. (2011) Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin. Liver International 31:1, 22-35
CrossRef276
Wei-Chen Lee, Ting-Jung Wu, Hong-Shiue Chou, Ming-Chin Yu, Pao-Yueh Hsu, Hsiu-Ying Hsu, Chao-Ching Wang. (2011) The impact of CD4+CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery
CrossRef277
Irinel Popescu, Simona O. Dima. (2011) Domino liver transplantation: How far can we push the paradigm?. Liver Transplantationn/a-n/a
CrossRef278
Wenhua Liang, Dongping Wang, Xiaoting Ling, Andrew Allen Cao, Yuan Kong, Yushu Shang, Zhiyong Guo, Xiaoshun He. (2011) Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A Meta-analysis. Liver Transplantationn/a-n/a
CrossRef279
A. Kornberg, B. Küpper, A. Tannapfel, P. Büchler, B. Krause, U. Witt, D. Gottschild, H. Friess. (2011) Patients with 18F-FDG non-avid advanced HCC on clinical staging may achieve recurrence-free long-term survival after liver transplantation. Liver Transplantationn/a-n/a
CrossRef280
Takanobu HARA, Susumu EGUCHI, Mitsuhisa TAKATSUKI, Akihiko SOYAMA, Masaaki HIDAKA, Takashi KANEMATSU. (2011) A CASE OF HEPATOCELLULAR CARCINOMA UNDERGOING VARIOUS THERAPIES INCLUDING LIVING DONOR LIVER TRANSPLANTATION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 72:6, 1516-1520
CrossRef281
Jong Young Choi. (2011) Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea. Oncology 81:s1, 141-147
CrossRef282
Sumihito Tamura, Yasuhiko Sugawara, Norihiro Kokudo. (2011) Living Donor Liver Transplantation for Hepatocellular Carcinoma: The Japanese Experience. Oncology 81:s1, 111-115
CrossRef283
Suzanne M. Ryan, Maria E.K. Sellars, Paul S. Sidhu. 2011. Liver transplantation. , 199-224.
CrossRef284
David Fuks, Safi Dokmak, Valérie Paradis, Momar Diouf, Francois Durand, Jacques Belghiti. (2011) Benefit of initial resection of HCC followed by transplantation in case of recurrence: An intention-to-treat analysis. Hepatologyn/a-n/a
CrossRef285
Constantine Frangakis, Jean-Francois Geschwind, Daniel Kim, Yong Chen, Ayman Koteish, Kelvin Hong, Eleni Liapi, Christos S. Georgiades. (2010) Chemoembolization Decreases Drop-Off Risk of Hepatocellular Carcinoma Patients on the Liver Transplant List. CardioVascular and Interventional Radiology
CrossRef286
Janice H. Jou, Po-Hung Chen, Alison Jazwinski, Iliana Bouneva, Alastair D. Smith, Andrew J. Muir. (2010) Rates of Surveillance and Management of Hepatocellular Carcinoma in Patients Evaluated at a Liver Transplant Center. Digestive Diseases and Sciences 55:12, 3591-3596
CrossRef287
Luigi Grazioli, Jeong Min Lee, Peter Malfertheiner, Christoph J. Zech, Lennart Blomqvist, Elmar M. Merkle. (2010) Consensus Report of the Third International Forum for Liver Magnetic Resonance Imaging. Investigative Radiology 45, S1-S10
CrossRef288
Tito Livraghi, Giorgio Brambilla, Carlo Carnaghi, Maurizio A. Tommasini, Guido Torzilli. (2010) Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?. Journal of Surgical Oncology 102:7, 868-876
CrossRef289
Lu Wu, Ye-Fa Yang, Nai-Jian Ge, Shu-Qun Shen, Jun Liang, Yi Wang, Wei-Ping Zhou, Feng Shen, Meng-Chao Wu. (2010) Hepatic Arterial Iodine-131–Labeled Metuximab Injection Combined with Chemoembolization for Unresectable Hepatocellular Carcinoma: Interim Safety and Survival Data from 110 Patients. Cancer Biotherapy & Radiopharmaceuticals 25:6, 657-663
CrossRef290
Spiros G. Delis, Andreas Bakoyiannis, Nikos Tassopoulos, Kostas Athanassiou, Dimitrios Kelekis, Juan Madariaga, Christos Dervenis. (2010) Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surgical Oncology 19:4, 200-207
CrossRef291
Zhe Yang, Lin Zhou, Li-Ming Wu, Hai-Yang Xie, Feng Zhang, Shu-Sen Zheng. (2010) Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy. Clinical Chemistry and Laboratory Medicine 48:12, 1785-1791
CrossRef292
Parsia A. Vagefi, Ryutaro Hirose. (2010) Downstaging of Hepatocellular Carcinoma Prior to Liver Transplant: Is There a Role for Adjuvant Sorafenib in Locoregional Therapy?. Journal of Gastrointestinal Cancer 41:4, 217-220
CrossRef293
Ahsun Riaz, Robert J. Lewandowski, Laura Kulik, Robert K. Ryu, Mary F. Mulcahy, Talia Baker, Vanessa Gates, Ritu Nayar, Ed Wang, Frank H. Miller, Kent T. Sato, Reed A. Omary, Michael Abecassis, Riad Salem. (2010) Radiologic–Pathologic Correlation of Hepatocellular Carcinoma Treated with Chemoembolization. CardioVascular and Interventional Radiology 33:6, 1143-1152
CrossRef294
Ju Dong Yang, Lewis R. Roberts. (2010) Epidemiology and Management of Hepatocellular Carcinoma. Infectious Disease Clinics of North America 24:4, 899-919
CrossRef295
Korosh Khalili, Tae Kyoung Kim, Hyun-Jung Jang, Leyla Kochak Yazdi, Maha Guindi, Morris Sherman. (2010) Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?. Hepatology 54:6, 2048-2054
CrossRef296
Ivan Zendejas-Ruiz, Alan W. Hemming, Chaoru Chen, Jason J. Schwartz, John B. Sorensen, Robin D. Kim. (2010) Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients with Hepatitis C. Journal of Gastrointestinal Cancer
CrossRef297
Thomas Yau, Pierre Chan, Roberta Pang, Kelvin Ng, S. T. Fan, Ronnie T. Poon. (2010) Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma. Cancer 116:21, 5022-5029
CrossRef298
Andrea Ferrari, Michela Casanova, Maura Massimino, Iyad Sultan. (2010) Peculiar features and tailored management of adult cancers occurring in pediatric age. Expert Review of Anticancer Therapy 10:11, 1837-1851
CrossRef299
Janice H. Jou, Deborah A. Fisher. (2010) Predictive Algorithms: Uses and Limitations. Digestive Diseases and Sciences 55:11, 3016-3017
CrossRef300
Marek Krawczyk, Michał Grąt, Oskar Kornasiewicz, Krzysztof Zieniewicz, Paweł Nyckowski, Waldemar Patkowski, Ireneusz Grzelak, Krzysztof Dudek, Tadeusz Wróblewski, Rafał Paluszkiewicz. (2010) Liver transplantation in the treatment of patients with hepatocelular carcinoma. Polish Journal of Surgery 82:11, 596-602
CrossRef301
Chuanxing Li, Fujun Zhang, Weidong Zhang, Liang Zhang, Zilin Huang, Peihong Wu. (2010) Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 136:11, 1633-1640
CrossRef302
Zheng-Xin Wang, Shao-Hua Song, Fei Teng, Gui-Hua Wang, Wen-Yuan Guo, Xiao-Min Shi, Jun Ma, You-Min Wu, Guo-Shan Ding, Zhi-Ren Fu. (2010) A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma. Clinical Transplantation 24:6, 752-757
CrossRef303
Manuela Merli, Cristina Lucidi, Valerio Giannelli, Michela Giusto, Oliviero Riggio, Marco Falcone, Lorenzo Ridola, Adolfo Francesco Attili, Mario Venditti. (2010) Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections. Clinical Gastroenterology and Hepatology 8:11, 979-985.e1
CrossRef304
Y. Takuma, K. Nouso, Y. Makino, M. Hayashi, H. Takahashi. (2010) Clinical trial: oral zinc in hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 32:9, 1080-1090
CrossRef305
N.P. Malek, A. Vogel, M.P. Manns. (2010) Multimodale Therapie des hepatozellulären Karzinoms. Der Internist 51:11, 1374-1381
CrossRef306
Tsung-Jung Liang, King-Tong Mok, Shiuh-Inn Liu, Shiu-Feng Huang, Nan-Hua Chou, Cheng-Chung Tsai, I.-Shu Chen, Ming-Hsin Yeh, Yu-Chia Chen, Being-Whey Wang. (2010) Hepatitis B Genotype C Correlated with Poor Surgical Outcomes for Hepatocellular Carcinoma. Journal of the American College of Surgeons 211:5, 580-586
CrossRef307
Diane M. Settles, Rakesh Vinayek. (2010) Hepatitis C and End-stage Liver Disease. Current Hepatitis Reports 9:4, 243-252
CrossRef308
Andrew D. Hardie, John W. Nance, Daniel J. Boulter, Michael K. Kizziah. (2010) Assessment of the diagnostic accuracy of T2*-weighted MR imaging for identifying hepatocellular carcinoma with liver explant correlation. European Journal of Radiology
CrossRef309
Abby B. Siegel, Shuang Wang, Judith S. Jacobson, Dawn L. Hershman, Emerson A. Lim, Jeanette Yu, Lauren Ferrante, Kalpana M. Devaraj, Helen Remotti, Shannon Scrudato, Karim Halazun, Jean Emond, Lorna Dove, Robert S. Brown, Alfred I. Neugut. (2010) Obesity and Microvascular Invasion in Hepatocellular Carcinoma. Cancer Investigation 28:10, 1063-1069
CrossRef310
Peter Gassmann, Tilmann Spieker, Joerg Haier, Fabian Schmidt, Wolf Arif Mardin, Norbert Senninger. (2010) Prognostic Impact of Underlying Liver Fibrosis and Cirrhosis After Curative Resection of Hepatocellular Carcinoma. World Journal of Surgery 34:10, 2442-2451
CrossRef311
Masahito Nakano, Eiji Ando, Ryoko Kuromatsu, Takuji Torimura, Shuji Sumie, Akio Takata, Nobuyoshi Fukushima, Junichi Kurogi, Takashi Niizeki, Hideki Iwamoto, Masatoshi Tanaka, Michio Sata. (2010) Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan. Hepatology Research 40:10, 989-996
CrossRef312
F. Rauchfuss, H. Scheuerlein, M. Götz, Y. Dittmar, R. Voigt, M. Heise, U. Settmacher. (2010) Hepatozelluläres Karzinom und Cholangiokarzinom. Der Chirurg 81:10, 941-954
CrossRef313
Claire Francoz, Dominique Prié, Wael AbdelRazek, Richard Moreau, Ameet Mandot, Jacques Belghiti, Dominique Valla, François Durand. (2010) Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: Impact on the model for end-stage liver disease score. Liver Transplantation 16:10, 1169-1177
CrossRef314
E. S. Felekouras, D. C. Kaparelos, E. Papalambros. (2010) The history of liver surgery, hepatectomy and haemostasis. Hellenic Journal of Surgery 82:5, 280-296
CrossRef315
Masashi Mizumoto, Toshiyuki Okumura, Takayuki Hashimoto, Kuniaki Fukuda, Yoshiko Oshiro, Nobuyoshi Fukumitsu, Masato Abei, Atsushi Kawaguchi, Yasutaka Hayashi, Ayako Ookawa. (2010) Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols. International Journal of Radiation OncologyBiologyPhysics
CrossRef316
Sue V. McDiarmid. (2010) Liver transplantation for malignancies in children. Liver Transplantation 16:S2, S13-S21
CrossRef317
Masaki Kaibori, Morihiko Ishizaki, Kosuke Matsui, A-Hon Kwon. (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. Journal of Surgical Oncology 102:5, 462-468
CrossRef318
Willscott E. Naugler, Amnon Sonnenberg. (2010) Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transplantation 16:10, 1186-1194
CrossRef319
Robert J. Canter, Siddharth A. Patel, Timothy Kennedy, Michael I. DʼAngelica, William R. Jarnagin, Yuman Fong, Leslie H. Blumgart, Richard B. Freeman, Ronald P. DeMatteo, Peter L. Abt. (2010) Comparative Analysis of Outcome in Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria Treated With Liver Transplantation Versus Partial Hepatectomy. American Journal of Clinical Oncology1
CrossRef320
I. Popescu. (2010) Hepatocellular carcinoma – new trends. memo - Magazine of European Medical Oncology 3:3, 113-118
CrossRef321
Fabio Piscaglia, Simona Leoni, Giuseppe Cabibbo, Alberto Borghi, Grazia Imbriaco, Rita Golfieri, Luigi Bolondi. (2010) Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. Digestive and Liver Disease 42:10, 729-734
CrossRef322
Hirokazu Takahashi, Toshihiko Mizuta, Seiji Kawazoe, Yuichiro Eguchi, Yasunori Kawaguchi, Taiga Otuka, Satoshi Oeda, Keisuke Ario, Shinji Iwane, Takumi Akiyama, Iwata Ozaki, Kazuma Fujimoto. (2010) Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatology Research 40:10, 997-1005
CrossRef323
Konstantin Holzapfel, Melanie Bruegel, Matthias Eiber, Carl Ganter, Tibor Schuster, Petra Heinrich, Ernst J. Rummeny, Jochen Gaa. (2010) Characterization of small (≤10mm) focal liver lesions: Value of respiratory-triggered echo-planar diffusion-weighted MR imaging. European Journal of Radiology 76:1, 89-95
CrossRef324
Giuseppe Maria Ettorre, Roberto Santoro, Claudio Puoti, Rosa Sciuto, Livio Carpanese, Mario Antonini, Giorgio Antonucci, Carlo L. Maini, Lucia Miglioresi, Giovanni Vennarecci. (2010) Short-Term Follow-Up of Radioembolization With Yttrium-90 Microspheres Before Liver Transplantation: New Perspectives in Advanced Hepatocellular Carcinoma. Transplantation 90:8, 930-931
CrossRef325
Augusto Villanueva, Pippa Newell, Yujin Hoshida. (2010) Inherited hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 24:5, 725-734
CrossRef326
Toshimi Kaido, Shinji Uemoto. (2010) Does living donation have advantages over deceased donation in liver transplantation?. Journal of Gastroenterology and Hepatology 25:10, 1598-1603
CrossRef327
Saleh Alqahtani, Kymberly D. S. Watt. 2010. Indications and Selection of Patients for Liver Transplantation. , 297-304.
CrossRef328
Lewis R. Roberts. 2010. Hepatocellular Carcinoma. , 144-151.
CrossRef329
Massimo Colombo, Massimo Iavarone. 2010. Hepatocellular Carcinoma. , 650-660.
CrossRef330
U.P. Neumann, P. Neuhaus, M. Schmeding. (2010) Lebendspende-Lebertransplantation beim Erwachsenen. Der Chirurg 81:9, 804-812
CrossRef331
Konrad Mohnike, Gero Wieners, Franziska Schwartz, Max Seidensticker, Maciej Pech, Ricarda Ruehl, Peter Wust, Enrique Lopez-Hänninen, Günther Gademann, Nils Peters, Thomas Berg, Peter Malfertheiner, Jens Ricke. (2010) Computed Tomography–Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival. International Journal of Radiation Oncology*Biology*Physics 78:1, 172-179
CrossRef332
Gonzalo Sapisochin, Itxarone Bilbao, Joaquin Balsells, Cristina Dopazo, Mireia Caralt, Jose Luis Lázaro, Luis Castells, Helena Allende, Ramón Charco. (2010) Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series. World Journal of Surgery 34:9, 2146-2154
CrossRef333
Kelvin K. Ng, Chung Mau Lo, See Ching Chan, Kenneth S. Chok, Tan-To Cheung, Sheung Tat Fan. (2010) Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 548-554
CrossRef334
Ji Hoon Park, Se Hyung Kim, Hee Sun Park, Gi Hyeon Kim, Jae Young Lee, Jeong Min Lee, Joon Koo Han, Byung Ihn Choi. (2010) Added value of 80kVp images to averaged 120kVp images in the detection of hepatocellular carcinomas in liver transplantation candidates using dual-source dual-energy MDCT: Results of JAFROC analysis. European Journal of Radiology
CrossRef335
Alessandro Vitale, Francesco D’Amico, Anna Chiara Frigo, Francesco Grigoletto, Alberto Brolese, Giacomo Zanus, Daniele Neri, Amedeo Carraro, Francesco Enrico D’Amico, Patrizia Burra, Francesco Russo, Paolo Angeli, Umberto Cillo. (2010) Response to Therapy as a Criterion for Awarding Priority to Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. Annals of Surgical Oncology 17:9, 2290-2302
CrossRef336
Bobby Kalb, Abbas Chamsuddin, Lama Nazzal, Puneet Sharma, Diego R. Martin. (2010) Chemoembolization Follow-up of Hepatocellular Carcinoma with MR Imaging: Usefulness of Evaluating Enhancement Features on One-month Posttherapy MR Imaging for Predicting Residual Disease. Journal of Vascular and Interventional Radiology 21:9, 1396-1404
CrossRef337
Bruno Caspani, Anna Maria Ierardi, Fabio Motta, Piero Cecconi, Edoardo Fesce, Luca Belli. (2010) Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results. European Radiology 20:9, 2286-2292
CrossRef338
Olivier Scatton, Guido Liddo, Jacques Belghiti. (2010) Liver transplantation for hepatocellular carcinoma: current topics in France. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 567-573
CrossRef339
SungGyu Lee, ChulSoo Ahn, TaeYong Ha, DeokBog Moon, KunMoo Choi, GiWon Song, DongHwan Chung, GilChun Park, YoungDong Yu, NamKyu Choi, KwanWoo Kim, KiHun Kim, Shin Hwang. (2010) Liver transplantation for hepatocellular carcinoma: Korean experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 539-547
CrossRef340
Yasutsugu Takada, Shinji Uemoto. (2010) Liver transplantation for hepatocellular carcinoma: the Kyoto experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 527-532
CrossRef341
A. Thelen, C. Benckert, S. Jonas. (2010) Chirurgische Therapie des zentralen Gallengangskarzinoms. Der Onkologe 16:9, 880-892
CrossRef342
Umberto Cillo, Alessandro Vitale, Michael L. Volk, Anna Chiara Frigo, Francesco Grigoletto, Alberto Brolese, Giacomo Zanus, Francesco D’Amico, Fabio Farinati, Patrizia Burra, Francesco Russo, Paolo Angeli, Davide F. D’Amico. (2010) The survival benefit of liver transplantation in hepatocellular carcinoma patients. Digestive and Liver Disease 42:9, 642-649
CrossRef343
Nicholas Onaca, Goran B. Klintmalm. (2010) Liver transplantation for hepatocellular carcinoma: the Baylor experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 559-566
CrossRef344
E. Prakoso, D. Verran, P. Dilworth, G. Kyd, P. Tang, C. Tse, D. J. Koorey, S. I. Strasser, M. Stormon, A. Shun, G. Thomas, D. Joseph, H. Pleass, J. Gallagher, R. Allen, M. Crawford, G. W. McCaughan, N. A. Shackel. (2010) Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal 40:9, 619-625
CrossRef345
Jian Zhou, Zheng Wang, Shuang-Jian Qiu, Xiao-Wu Huang, Jian Sun, Wen Gu, Jia Fan. (2010) Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. Journal of Cancer Research and Clinical Oncology 136:9, 1453-1460
CrossRef346
Fabio Piscaglia, Alessandro Cucchetti, Luigi Bolondi. (2010) “Survival benefit”: The final destination, with still a long way to go. Digestive and Liver Disease 42:9, 608-610
CrossRef347
Hiroyuki Furukawa, Tsuyoshi Shimamura, Tomomi Suzuki, Masahiko Taniguchi, Kazuaki Nakanishi, Kenichiro Yamashita, Toshiya Kamiyama, Michiaki Matsushita, Satoru Todo. (2010) Liver transplantation for hepatocellular carcinoma: the Japanese experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, 533-538
CrossRef348
Hidekatsu Kuroda, Akira Ushio, Yasuhiro Miyamoto, Kei Sawara, Kanta Oikawa, Kazuhiro Kasai, Ryujin Endo, Yasuhiro Takikawa, Akinobu Kato, Kazuyuki Suzuki. (2010) Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one-year prospective trial. Journal of Gastroenterology and Hepatology 25:9, 1550-1555
CrossRef349
J. J. Guiteau, R. T. Cotton, W. K. Washburn, A. Harper, C. A. O’Mahony, A. Sebastian, S. Cheng, G. Klintmalm, M. Ghobrial, G. Halff, L. Mieles, J. Goss. (2010) An Early Regional Experience with Expansion of Milan Criteria for Liver Transplant Recipients. American Journal of Transplantation 10:9, 2092-2098
CrossRef350
Terence C. Chua, Akshat Saxena, Francis Chu, Winston Liauw, Jing Zhao, David L. Morris. (2010) Clinicopathological Determinants of Survival After Hepatic Resection of Hepatocellular Carcinoma in 97 Patients—Experience From an Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery 14:9, 1370-1380
CrossRef351
Hiroshi Imada, Hirotoshi Kato, Shigeo Yasuda, Shigeru Yamada, Takeshi Yanagi, Riwa Kishimoto, Susumu Kandatsu, Jun-etsu Mizoe, Tadashi Kamada, Osamu Yokosuka. (2010) Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiotherapy and Oncology 96:2, 231-235
CrossRef352
Justin P. McWilliams, Shota Yamamoto, Steven S. Raman, Christopher T. Loh, Edward W. Lee, David M. Liu, Stephen T. Kee. (2010) Percutaneous Ablation of Hepatocellular Carcinoma: Current Status. Journal of Vascular and Interventional Radiology 21:8, S204-S213
CrossRef353
Imre Fehérvári. (2010) Hepatocellularis carcinoma és májtranszplantáció. Orvosi Hetilap 151:32, 1285-1288
CrossRef354
Hsiu-Lung Fan, Teng-Wei Chen, Chung-Bao Hsieh, Hsiang-Chun Jan, Sheng-Chuan His, Chan De-Chuan, Chi-Hong Chu, Jyh-Cherng Yu. (2010) Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria. The American Journal of Surgery 200:2, 252-257
CrossRef355
John P. Roberts, Alan Venook, Robert Kerlan, Francis Yao. (2010) Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transplantation 16:8, 925-929
CrossRef356
Gaurav Khatri, Laura Merrick, Frank H. Miller. (2010) MR Imaging of Hepatocellular Carcinoma. Magnetic Resonance Imaging Clinics of North America 18:3, 421-450
CrossRef357
Ju Dong Yang, Lewis R. Roberts. (2010) Hepatocellular carcinoma: a global view. Nature Reviews Gastroenterology & Hepatology 7:8, 448-458
CrossRef358
Renumathy Dhanasekaran, Vinit Khanna, David A. Kooby, James R. Spivey, Samir Parekh, Stuart J. Knechtle, John D. Carew, John S. Kauh, Hyun S. Kim. (2010) The Effectiveness of Locoregional Therapies versus Supportive Care in Maintaining Survival within the Milan Criteria in Patients with Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 21:8, 1197-1204
CrossRef359
Amy C. McClune, Myron J. Tong. (2010) Chronic Hepatitis B and Hepatocellular Carcinoma. Clinics in Liver Disease 14:3, 461-476
CrossRef360
Peter Abrams, J. Wallis Marsh. (2010) Current Approach to Hepatocellular Carcinoma. Surgical Clinics of North America 90:4, 803-816
CrossRef361
David Sindram, Kwan N. Lau, John B. Martinie, David A. Iannitti. (2010) Hepatic Tumor Ablation. Surgical Clinics of North America 90:4, 863-876
CrossRef362
Asra S. Khan, Hero K. Hussain, Timothy D. Johnson, William J. Weadock, Shawn J. Pelletier, Jorge A. Marrero. (2010) Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. Journal of Magnetic Resonance Imaging 32:2, 360-366
CrossRef363
Valentina Santi, Franco Trevisani, Annagiulia Gramenzi, Alice Grignaschi, Federica Mirici-Cappa, Paolo Del Poggio, Maria Anna Di Nolfo, Luisa Benvegnù, Fabio Farinati, Marco Zoli, Edoardo Giovanni Giannini, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Mauro Bernardi. (2010) Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. Journal of Hepatology 53:2, 291-297
CrossRef364
D. H. Yoon, B.-Y. Ryoo, M.-H. Ryu, S.-G. Lee, S. Hwang, D. J. Suh, H. C. Lee, T. W. Kim, C.-S. Ahn, K.-H. Kim, D.-B. Moon, Y.-K. Kang. (2010) Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation. Japanese Journal of Clinical Oncology 40:8, 768-773
CrossRef365
Richard Kim, Narayanan Menon, Federico Aucejo. (2010) Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection. Medical Oncology
CrossRef366
Shin Hwang, Sung-Gyu Lee, Jacques Belghiti. (2010) Liver transplantation for HCC: its role. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, 443-448
CrossRef367
Peng-Ju Xu, Fu-Hua Yan, Jian-Hua Wang, Yan Shan, Yuan Ji, Cai-Zhong Chen. (2010) Contribution of Diffusion-Weighted Magnetic Resonance Imaging in the Characterization of Hepatocellular Carcinomas and Dysplastic Nodules in Cirrhotic Liver. Journal of Computer Assisted Tomography 34:4, 506-512
CrossRef368
Mauricio F Silva, Alan J Wigg. (2010) Current controversies surrounding liver transplantation for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 25:7, 1217-1226
CrossRef369
Eliano Bonaccorsi-Riani, Carlos Apestegui, Anne Jouret-Mourin, Christine Sempoux, Pierre Goffette, Olga Ciccarelli, Ivan Borbath, Catherine Hubert, Jean François Gigot, Ziad Hassoun, Jan Lerut. (2010) Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review. Transplant International 23:7, 668-678
CrossRef370
Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, Masatoshi Makuuchi. (2010) Single HCC between 2 and 5 cm: the grey zone. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, 430-433
CrossRef371
Sherrie Bhoori, Carlo Sposito, Alessandro Germini, Jorgelina Coppa, Vincenzo Mazzaferro. (2010) The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transplant International 23:7, 712-722
CrossRef372
Fabio Piscaglia, Luigi Bolondi. (2010) The intermediate hepatocellular carcinoma stage: Should treatment be expanded?. Digestive and Liver Disease 42, S258-S263
CrossRef373
Shin Hwang, Deok-Bog Moon, Sung-Gyu Lee. (2010) Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transplant International 23:7, 723-727
CrossRef374
Takanori Sakaguchi, Shohachi Suzuki, Yoshifumi Morita, Kousuke Oishi, Atsushi Suzuki, Kazuhiko Fukumoto, Keisuke Inaba, Satoshi Nakamura, Hiroyuki Konno. (2010) Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria. Surgery Today 40:7, 638-645
CrossRef375
Valérie Vilgrain. (2010) Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, 374-379
CrossRef376
Attila Doros. (2010) A hepatocellularis carcinoma intervenciós radiológiai kezelése. Orvosi Hetilap 151:30, 1204-1208
CrossRef377
Marcus A. Wörns, Peter R. Galle. (2010) Future perspectives in hepatocellular carcinoma. Digestive and Liver Disease 42, S302-S309
CrossRef378
Silvia Tremosini, María Reig, Carlos Rodríguez de Lope, Alejandro Forner, Jordi Bruix. (2010) Treatment of early hepatocellular carcinoma: Towards personalized therapy. Digestive and Liver Disease 42, S242-S248
CrossRef379
Lorenzo Andreana, Andrew K. Burroughs. (2010) Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence. Digestive and Liver Disease 42, S249-S257
CrossRef380
Hynek Mergental, Robert J. Porte. (2010) Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transplant International 23:7, 662-667
CrossRef381
Chia-Yang Hsu, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Che-Chuan Loong, Yi-You Chiou, Jen-Huey Chiang, Pui-Ching Lee, Teh-Ia Huo, Shou-Dong Lee. (2010) A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system. Journal of Hepatology 53:1, 108-117
CrossRef382
Paolo Caraceni, Antonella Viola, Fabiana Piscitelli, Ferdinando Giannone, Annalisa Berzigotti, Matteo Cescon, Marco Domenicali, Stefania Petrosino, Emanuela Giampalma, Anna Riili, Gianluca Grazi, Rita Golfieri, Marco Zoli, Mauro Bernardi, Vincenzo Di Marzo. (2010) Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Liver International 30:6, 816-825
CrossRef383
Shinji Tanaka, Shigeki Arii. (2010) Medical treatments: in association or alone, their role and their future perspectives. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, 413-419
CrossRef384
Byung Ihn Choi, Jeong Min Lee. (2010) Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, 369-373
CrossRef385
Shigeki Arii, Michio Sata, Michiie Sakamoto, Mitsuo Shimada, Takashi Kumada, Shuichiro Shiina, Tatsuya Yamashita, Norihiro Kokudo, Masatoshi Tanaka, Tadatoshi Takayama, Masatoshi Kudo. (2010) Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatology Research 40:7, 667-685
CrossRef386
K. Washburn, E. Edwards, A. Harper, R. Freeman. (2010) Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System. American Journal of Transplantation 10:7, 1643-1648
CrossRef387
Rohit Sharma, John F. Gibbs. (2010) Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome. Journal of Surgical Oncology 101:8, 745-754
CrossRef388
Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Pui-Ching Lee, Che-Chuan Loong, Jen-Huey Chiang, Teh-Ia Huo, Shou-Dong Lee. (2010) Selecting an optimal staging system for hepatocellular carcinoma. Cancer 116:12, 3006-3014
CrossRef389
Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatology International 4:2, 439-474
CrossRef390
Abdel-Rahman El-Zayadi, Hanaa M. Badran, Sherine Shawky, Sally Emara, Ashraf El-Bareedy, Mohammed Sobhi. (2010) Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients. Hepatology International 4:2, 500-506
CrossRef391
Jean-Bernard Otte. (2010) Progress in the surgical treatment of malignant liver tumors in children
. Cancer Treatment Reviews 36:4, 360-371
CrossRef392
S.-G. Lee. (2010) Living-donor liver transplantation in adults. British Medical Bulletin 94:1, 33-48
CrossRef393
Maurizio Pompili, Claudio Maurizio Pacella, Giampiero Francica, Mario Angelico, Giuseppe Tisone, Paolo Craboledda, Erica Nicolardi, Gian Ludovico Rapaccini, Giovanni Gasbarrini. (2010) Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. European Journal of Radiology 74:3, e6-e11
CrossRef394
Melissa Kennedy, Sophoclis P Alexopoulos. (2010) Hepatitis B virus infection and liver transplantation. Current Opinion in Organ Transplantation 15:3, 310-315
CrossRef395
Savino Bruno, Andrea Crosignani, Corinna Facciotto, Sonia Rossi, Luigi Roffi, Alessandro Redaelli, Roberto de Franchis, Piero Luigi Almasio, Patrick Maisonneuve. (2010) Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study. Hepatology 51:6, 2069-2076
CrossRef396
Yi Wang, Yan-Hui Liu, Shi-Juan Mai, Long-Jun He, Yi-Ji Liao, Hai-Xia Deng, Xin-Yuan Guan, Yi-Xin Zeng, Hsiang-Fu Kung, Dan Xie. (2010) Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Journal of Gastroenterology and Hepatology 25:6, 1123-1128
CrossRef397
(2010) Chapter 3: Surgery. Hepatology Research 40, 48-73
CrossRef398
(2010) Treatment algorithm for hepatocellular carcinoma. Hepatology Research 40, 8-9
CrossRef399
Alessandro Cucchetti, Fabio Piscaglia, Antonia D’Errico Grigioni, Matteo Ravaioli, Matteo Cescon, Matteo Zanello, Gian Luca Grazi, Rita Golfieri, Walter Franco Grigioni, Antonio Daniele Pinna. (2010) Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study. Journal of Hepatology 52:6, 880-888
CrossRef400
Richard S. Finn. (2010) Drug therapy: Sorafenib. Hepatology 51:5, 1843-1849
CrossRef401
Hiroji Shinkawa, Takahiro Uenishi, Shigekazu Takemura, Kazuki Ohba, Masao Ogawa, Tsuyoshi Ichikawa, Shintaro Kodai, Takatsugu Yamamoto, Hiromu Tanaka, Shoji Kubo. (2010) Risk factors for postoperative recurrence of non-B non-C hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 17:3, 291-295
CrossRef402
David M. Levi, Andreas G. Tzakis, Paul Martin, Seigo Nishida, Eddie Island, Jang Moon, Gennaro Selvaggi, Akin Tekin, Beatrice L. Madrazo, Govindarajan Narayanan, Monica T. Garcia, Lynn G. Feun, Panagiotis Tryphonopoulos, Nikolaos Skartsis, Alan S. Livingstone. (2010) Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era. Journal of the American College of Surgeons 210:5, 727-734
CrossRef403
C. Panjala, D. L. Senecal, M. D. Bridges, G. P. Kim, R. E. Nakhleh, J. H. H. Nguyen, D. M. Harnois. (2010) The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular-Cholangiocarcinoma. American Journal of Transplantation 10:5, 1263-1267
CrossRef404
Hidekatsu Kuroda, Kazuhiro Kasai, Keisuke Kakisaka, Yuki Yasumi, Koujiro Kataoka, Akira Ushio, Yasuhiro Miyamoto, Kei Sawara, Kanta Oikawa, Koryo Kondo, Yoshiaki Miura, Ryujin Endo, Yasuhiro Takikawa, Kazuyuki Suzuki. (2010) Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatology Research 40:5, 550-554
CrossRef405
William R. Jarnagin. (2010) Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation. Annals of Surgical Oncology 17:5, 1226-1233
CrossRef406
Susumu Eguchi, Mitsuhisa Takatsuki, Masaaki Hidaka, Akihiko Soyama, Tetsuo Tomonaga, Izumi Muraoka, Takashi Kanematsu. (2010) Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection. World Journal of Surgery 34:5, 1034-1038
CrossRef407
Franco Trevisani, Marta Frigerio, Valentina Santi, Alice Grignaschi, Mauro Bernardi. (2010) Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal. Digestive and Liver Disease 42:5, 341-347
CrossRef408
Takasuke Fukuhara, Akinobu Taketomi, Shinji Okano, Toru Ikegami, Yuji Soejima, Ken Shirabe, Yoshihiko Maehara. (2010) Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. Journal of Hepatology 52:5, 672-680
CrossRef409
Woo Young Shin, Kyung-Suk Suh, Hae Won Lee, Joohyun Kim, Taehoon Kim, Nam-Joon Yi, Kuhn Uk Lee. (2010) Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 16:5, 678-684
CrossRef410
Mark J. Truty, Jean-Nicolas Vauthey. (2010) Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique. Annals of Surgical Oncology 17:5, 1219-1225
CrossRef411
Shun-ichi Ariizumi, Yoshihito Kotera, Satoshi Katagiri, Masakazu Yamamoto. (2010) Favorable long-term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody. Journal of Surgical Oncology 101:6, 471-475
CrossRef412
Bernardino Rampone, Beniamino Schiavone, Giuseppe Confuorto. (2010) Current Management of Hepatocellular Cancer. Current Oncology Reports 12:3, 186-192
CrossRef413
Amit G Singal, Jorge A Marrero. (2010) Recent advances in the treatment of hepatocellular carcinoma. Current Opinion in Gastroenterology 26:3, 189-195
CrossRef414
S. Jelic, G. C. Sotiropoulos, . (2010) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21:Supplement 5, v59-v64
CrossRef415
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. (2010) Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 25:5, 951-956
CrossRef416
Emmanuel A. Tsochatzis, Giacomo Germani, Andrew K. Burroughs. (2010) Transarterial Chemoembolization, Transarterial Chemotherapy, and Intra-arterial Chemotherapy for Hepatocellular Carcinoma Treatment. Seminars in Oncology 37:2, 89-93
CrossRef417
Shumei Ma, Benzheng Jiao, Xin Liu, Heqing Yi, Dejuan Kong, Lin Gao, Guangtong Zhao, Yu Yang, Xiaodong Liu. (2010) Approach to radiation therapy in hepatocellular carcinoma. Cancer Treatment Reviews 36:2, 157-163
CrossRef418
Judith Kahn, Daniela Kniepeiss, Cord Langner, Doris Wagner, Florian Iberer, Karlheinz Tscheliessnigg. (2010) Oesophageal metastases of hepatocellular carcinoma after liver transplantation. Transplant International 23:4, 438-439
CrossRef419
Ahsun Riaz, Laura M. Kulik, Mary F. Mulcahy, Robert J. Lewandowski, Riad Salem. (2010) Yttrium-90 Radioembolization in the Management of Liver Malignancies. Seminars in Oncology 37:2, 94-101
CrossRef420
Jeanette C. Yu, Alfred I. Neugut, Shuang Wang, Judith S. Jacobson, Lauren Ferrante, Vandana Khungar, Emerson Lim, Dawn L. Hershman, Robert S. Brown, Abby B. Siegel. (2010) Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 116:7, 1801-1809
CrossRef421
Y. Miyake, A. Takaki, Y. Iwasaki, K. Yamamoto. (2010) Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Journal of Viral Hepatitis 17:4, 287-292
CrossRef422
Giuseppe Cabibbo, Marco Enea, Massimo Attanasio, Jordi Bruix, Antonio Craxì, Calogero Cammà. (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 51:4, 1274-1283
CrossRef423
Christopher Soll, Pierre-Alain Clavien. (2010) Inhibition of mammalian target of rapamycin: The janus face of immunosuppression?. Hepatology 51:4, 1113-1115
CrossRef424
Christian Toso, Shaheed Merani, David L. Bigam, A.M. James Shapiro, Norman M. Kneteman. (2010) Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology 51:4, 1237-1243
CrossRef425
Emilio Ramos Rubio, Laura Llado Garriga. (2010) Utilidad de la biopsia preoperatoria en la selección de pacientes con hepatocarcinoma para el trasplante hepático. Cirugía Española 87:3, 133-138
CrossRef426
A. Kornberg, B. Küpper, A. Tannapfel, K. Katenkamp, K. Thrum, O. Habrecht, J. Wilberg. (2010) Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables. European Journal of Surgical Oncology (EJSO) 36:3, 275-280
CrossRef427
Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Ryosuke Tateishi, Haruhiko Yoshida, Junichi Kaneko, Yuichi Matsui, Junichi Togashi, Masaaki Akahane, Masatoshi Makuuchi, Masao Omata, Norihiro Kokudo. (2010) Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma. Hepatology Research 40:3, 278-286
CrossRef428
Higinia R. Cárdenes, Tracy R. Price, Susan M. Perkins, Mary Maluccio, P. Kwo, T. E. Breen, Mark A. Henderson, Tracey E. Schefter, Kathy Tudor, Jill Deluca, Peter A. S. Johnstone. (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clinical and Translational Oncology 12:3, 218-225
CrossRef429
Antonio Díaz-Sánchez, Ana Matilla, Oscar Núñez, Beatriz Merino, Isabel Peligros, Diego Rincón, Magdalena Salcedo, Oreste Lo Iacono, María Vega Catalina, Gerardo Clemente. (2010) Influencia del tratamiento del hepatocarcinoma antes del trasplante hepático en la recurrencia tumoral y supervivencia postrasplante. Gastroenterología y Hepatología 33:3, 155-164
CrossRef430
Shinji Tanaka, Kaoru Mogushi, Mahmut Yasen, Norio Noguchi, Atsushi Kudo, Noriaki Nakamura, Koji Ito, Yoshio Miki, Johji Inazawa, Hiroshi Tanaka, Shigeki Arii. (2010) Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas. Surgery 147:3, 405-414
CrossRef431
Ahsun Riaz, Riad Salem. (2010) Yttrium-90 radioembolization in the management of liver tumors: expanding the global experience. European Journal of Nuclear Medicine and Molecular Imaging 37:3, 451-452
CrossRef432
Shugo Mizuno, Hajime Yokoi, Katsuya Shiraki, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Kazushi Sugimoto, Yoshiyuki Takei, Koichiro Yamakado, Kan Takeda, Shinji Uemoto, Shuji Isaji. (2010) Prospective Study on the Outcome of Patients With Hepatocellular Carcinoma Registered for Living Donor Liver Transplantation: How Long Can They Wait?. Transplantation 89:6, 650-654
CrossRef433
Tao Zhang, Xin Ding, Dong Wei, Peng Cheng, Xiaomei Su, Huanyi Liu, Daoyuan Wang, Hui Gao. (2010) Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials. Anti-Cancer Drugs 21:3, 326-332
CrossRef434
Elizabeth A. Pomfret, Kenneth Washburn, Christoph Wald, Michael A. Nalesnik, David Douglas, Mark Russo, John Roberts, David J. Reich, Myron E. Schwartz, Luis Mieles, Fred T. Lee, Sander Florman, Francis Yao, Ann Harper, Erick Edwards, Richard Freeman, John Lake. (2010) Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transplantation 16:3, 262-278
CrossRef435
Philipp Dutkowski, Olivier De Rougemont, Beat Müllhaupt, Pierre—Alain Clavien. (2010) Current and Future Trends in Liver Transplantation in Europe. Gastroenterology 138:3, 802-809.e4
CrossRef436
Alejandro Forner, Jordi Bruix. (2010) Ablation for hepatocellular carcinoma: Is there need to have a winning technique?. Journal of Hepatology 52:3, 310-312
CrossRef437
Aileen E. Marshall, Simon M. Rushbrook, Sarah L. Vowler, Christopher R. Palmer, R. Justin Davies, Paul Gibbs, Susan E. Davies, Nicholas Coleman, Graeme J. M. Alexander. (2010) Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status. Liver Transplantation 16:3, 279-288
CrossRef438
Charbel Sandroussi, Laura A. Dawson, Mark Lee, Maha Guindi, Sandra Fischer, Anand Ghanekar, Mark S. Cattral, Ian D. McGilvray, Gary A. Levy, Eberhard Renner, Paul D. Greig, David Grant. (2010) Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Transplant International 23:3, 299-306
CrossRef439
C. Boutros, P. Somasundar, S. Garrean, A. Saied, N.J. Espat. (2010) Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis. Surgical Oncology 19:1, e22-e32
CrossRef440
Ju Hyun Shim, Kang Mo Kim, Young-Joo Lee, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Kwang-Min Park, Sung-Gyu Lee, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh. (2010) Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection. Annals of Surgical Oncology 17:3, 869-877
CrossRef441
Fabrizio Di Benedetto, Stefano Di Sandro, Nicola De Ruvo, Roberto Montalti, Roberto Ballarin, Gian Piero Guerrini, Mario Spaggiari, Giovanni Guaraldi, Giorgio Gerunda. (2010) First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation. Transplantation 89:6, 733-738
CrossRef442
A. Cucchetti, A. Vitale, M. Del Gaudio, M. Ravaioli, G. Ercolani, M. Cescon, M. Zanello, M. C. Morelli, U. Cillo, G. L. Grazi, A. D. Pinna. (2010) Harm and Benefits of Primary Liver Resection and Salvage Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 10:3, 619-627
CrossRef443
Antonio Nicolini, Laura Martinetti, Silvia Crespi, Marco Maggioni, Angelo Sangiovanni. (2010) Transarterial Chemoembolization with Epirubicin-eluting Beads versus Transarterial Embolization before Liver Transplantation for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 21:3, 327-332
CrossRef444
Ana L. Gleisner, Alvaro Muñoz, Ajacio Brandao, Claudio Marroni, Maria Lucia Zanotelli, Guido Gracco Cantisani, Leila Beltrami Moreira, Michael A. Choti, Timothy M. Pawlik. (2010) Survival benefit of liver transplantation and the effect of underlying liver disease. Surgery 147:3, 392-404
CrossRef445
Avo Artinyan, Brian Mailey, Nicelio Sanchez-Luege, Joshua Khalili, Can-Lan Sun, Smita Bhatia, Lawrence D. Wagman, Nicholas Nissen, Steven D. Colquhoun, Joseph Kim. (2010) Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 116:5, 1367-1377
CrossRef446
David A. Kooby, Vasili Egnatashvili, Swetha Srinivasan, Abbas Chamsuddin, Keith A. Delman, John Kauh, Charles A. Staley III, Hyun S. Kim. (2010) Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 21:2, 224-230
CrossRef447
Atsushi Hiraoka, Kojiro Michitaka, Norio Horiike, Satoshi Hidaka, Takahide Uehara, Soichi Ichikawa, Aki Hasebe, Yasunao Miyamoto, Tomoyuki Ninomiya, Ichiro Sogabe, Yoshihiro Ishimaru, Hideki Kawasaki, Yohei Koizumi, Masashi Hirooka, Yoshimasa Yamashita, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji. (2010) Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. Journal of Gastroenterology and Hepatology 25:2, 403-407
CrossRef448
E. G. GIANNINI, G. BODINI, M. CORBO, V. SAVARINO, D. RISSO, M. A. DI NOLFO, P. DEL POGGIO, L. BENVEGNÃ, F. FARINATI, M. ZOLI, F. BORZIO, E. CATURELLI, M. CHIARAMONTE, F. TREVISANI, . (2010) Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 31:4, 493-501
CrossRef449
Patrick P. McHugh, Jeffrey Gilbert, Santiago Vera, Alvaro Koch, Dinesh Ranjan, Roberto Gedaly. (2010) Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB 12:1, 56-61
CrossRef450
Mark Lee Fernandes, Chen-Chun Lin, Chun-Jung Lin, Wei-Ting Chen, Shi-Ming Lin. (2010) Prospective Study of a ‘Popping' Sound during Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 21:2, 237-244
CrossRef451
J. W. JANG, C. R. YOU, C. W. KIM, S. H. BAE, S. K. YOON, Y. K. YOO, D. G. KIM, J. Y. CHOI. (2010) Benefit of downsizing hepatocellular carcinoma in a liver transplant population. Alimentary Pharmacology & Therapeutics 31:3, 415-423
CrossRef452
R. CABRERA, D. R. NELSON. (2010) Review article: the management of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 31:4, 461-476
CrossRef453
Toshiya Kamiyama, Kazuaki Nakanishi, Hideki Yokoo, Hirofumi Kamachi, Michiaki Matsushita, Satoru Todo. (2010) The impact of anatomical resection for hepatocellular carcinoma that meets the milan criteria. Journal of Surgical Oncology 101:1, 54-60
CrossRef454
Yasumasa Shirouzu, Eduard Ryschich, Olga Salnikova, Vachtang Kerkadze, Jan Schmidt, Guido Engelmann. (2010) Rapamycin Inhibits Proliferation and Migration of Hepatoma Cells In Vitro. Journal of Surgical Research 159:2, 705
CrossRef455
Hokkaido Liver Transplantation Stud, Masahiko Taniguchi, Hiroyuki Furukawa, Tsuyoshi Shimamura, Tomomi Suzuki, Kenichiro Yamashita, Satoru Todo. (2010) Deceased donor liver transplantation. Kanzo 51:4, 143-162
CrossRef456
Ki Hoon Kim, Jin Su Kim, Jeong Ik Park, Kwang Hee Kim, Chang Soo Choi, Young Kil Choi. (2010) Outcome of Hepatic Resection for Hepatocellular Carcinoma within the Milan Criteria in Child-Pugh Class A Patients. Journal of the Korean Surgical Society 79:1, 49
CrossRef457
Gudrun Zulehner, Mario Mikula, Doris Schneller, Franziska van Zijl, Heidemarie Huber, Wolfgang Sieghart, Bettina Grasl-Kraupp, Thomas Waldhör, Markus Peck-Radosavljevic, Hartmut Beug, Wolfgang Mikulits. (2010) Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence. The American Journal of Pathology 176:1, 472-481
CrossRef458
Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli, Umberto Cillo. (2010) Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety. Hepatology 51:1, 165-173
CrossRef459
Randall S. Sung, Elizabeth A. Pomfret, Kenneth A. Andreoni, Talia B. Baker, Thomas G. Peters. (2010) The high-risk recipient: the Eighth Annual American Society of Transplant Surgeons’ State-of-the-Art Winter Symposium. Clinical Transplantation 24:1, 23-28
CrossRef460
Jue Wang, Fenwei Wang, Anne Kessinger. (2010) Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver. Journal of Oncology 2010, 1-7
CrossRef461
Gi-Won Song, Shin Hwang, Sung-Gyu Lee. (2010) Liver Transplantation in Patients with Hepatocellular Carcinoma. The Korean Journal of Gastroenterology 55:6, 350
CrossRef462
Kwang-Woong Lee, Kyung-Suk Suh. (2010) Liver Transplantation for Advanced Hepatocellular Carcinoma. The Journal of the Korean Society for Transplantation 24:1, 4
CrossRef463
Kyung Keun Lee, Dong Goo Kim, In Sung Moon, Myung Duk Lee, Jung Hyun Park. (2010) Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. Journal of Surgical Oncology 101:1, 47-53
CrossRef464
Riad Salem, Robert J. Lewandowski, Mary F. Mulcahy, Ahsun Riaz, Robert K. Ryu, Saad Ibrahim, Bassel Atassi, Talia Baker, Vanessa Gates, Frank H. Miller, Kent T. Sato, Ed Wang, Ramona Gupta, Al B. Benson, Steven B. Newman, Reed A. Omary, Michael Abecassis, Laura Kulik. (2010) Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes. Gastroenterology 138:1, 52-64
CrossRef465
Marco Vivarelli, Alessandro Dazzi, Matteo Zanello, Alessandro Cucchetti, Matteo Cescon, Matteo Ravaioli, Massimo Del Gaudio, Augusto Lauro, Gian Luca Grazi, Antonio Daniele Pinna. (2010) Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 89:2, 227-231
CrossRef466
Matteo Cescon, Matteo Ravaioli, Gian Luca Grazi, Giorgio Ercolani, Alessandro Cucchetti, Valentina Bertuzzo, Gaetano Vetrone, Massimo Del Gaudio, Marco Vivarelli, Antonietta D'Errico-Grigioni, Alessandro Dazzi, Paolo Di Gioia, Augusto Lauro, Antonio Daniele Pinna. (2010) Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma. Journal of Transplantation 2010, 1-8
CrossRef467
Ikue Noda, Mikiya Kitamoto, Hideki Nakahara, Ryohei Hayashi, Tomoaki Okimoto, Yoshio Monzen, Hiroyasu Yamada, Masaru Imagawa, Nobuhiko Hiraga, Junko Tanaka, Kazuaki Chayama. (2010) Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. Journal of Gastroenterology 45:1, 105-112
CrossRef468
Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber. (2010) Hepatocellular Carcinoma: Current Management. Current Problems in Surgery 47:1, 10-67
CrossRef469
E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel, C. Salloum, A. Lemoine, H. Bismuth, D. Castaing, R. Adam. (2010) Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor. American Journal of Transplantation 10:1, 129-137
CrossRef470
Emilio Ramos Rubio, Laura Llado Garriga. (2010) Usefulness of pre-surgical biopsy in selecting patients with hepatocellular carcinoma for liver transplant. Cirugía Española (English Edition) 87:3, 133-138
CrossRef471
B. Filloux, R. Robert. 2010. Critères d'admission d'un malade cirrhotique en réanimation. , 117-126.
CrossRef472
Srikanth Padma, John B. Martinie, David A. Iannitti. (2009) Liver tumor ablation: Percutaneous and open approaches. Journal of Surgical Oncology 100:8, 619-634
CrossRef473
Jordi Bruix, Keith Lindor. (2009) The need for novel and interesting data in liver cancer research. Hepatology 50:6, 1690-1691
CrossRef474
Andr
Schaudt, Susanne Kriener, Wolfram Schwarz, Christoph Wullstein, Stephan Zangos, Thomas Vogl, Arianeb Mehrabi, Hamidreza Fonouni, Wolf O. Bechstein, Markus Golling. (2009) Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis. Clinical Transplantation 23, 61-67
CrossRef475
Khashayar Vakili, James J. Pomposelli, Yee Lee Cheah, Mohamed Akoad, W. David Lewis, Urmila Khettry, Fredric Gordon, Khalid Khwaja, Roger Jenkins, Elizabeth A. Pomfret. (2009) Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Liver Transplantation 15:12, 1861-1866
CrossRef476
José Guilherme Tralhão, Emir Hoti, Bárbara Oliveiros, Ana M. Abrantes, M. Filomena Botelho, F. Castro-Sousa. (2009) Intermittent Pringle Maneuver and Hepatic Function: Perioperative Monitoring by Noninvasive ICG-Clearance. World Journal of Surgery 33:12, 2627-2634
CrossRef477
Hye Jin Yoo, Jeong Min Lee, Jae Young Lee, Se Hyung Kim, Soo Jin Kim, Joon Koo Han, Byung Ihn Choi. (2009) Additional Value of SPIO-Enhanced MR Imaging for the Noninvasive Imaging Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver. Investigative Radiology 44:12, 800-807
CrossRef478
P. Merle, F. Mornex, C. Trepo. (2009) Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy. Cancer Letters 286:1, 129-133
CrossRef479
Thomas Yau, Tzy Jyun Yao, Pierre Chan, Richard John Epstein, Kelvin K. Ng, Siu Ho Chok, Tan Teo Cheung, Sheung Tat Fan, Ronnie Tung Ping Poon. (2009) The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer 115:23, 5507-5515
CrossRef480
U. Cillo, A. Vitale. (2009) Benefit and harm of deceased- or living-donor liver transplantation for hepatocellular carcinoma. Digestive and Liver Disease Supplements 3:4, 88-92
CrossRef481
John A. Stauffer, Jeffery L. Steers, Hugo Bonatti, Marjorie K. Dougherty, Jaime Aranda-Michel, Rolland C. Dickson, Denise M. Harnois, Justin H. Nguyen. (2009) Liver transplantation and pancreatic resection: A single-center experience and a review of the literature. Liver Transplantation 15:12, 1728-1737
CrossRef482
Seong Hoon Kim, Seong Yeon Cho, Sang-Jae Park, Kwang Woong Lee, Sung-Sik Han, Soon-ae Lee, Joong-Won Park, Chang-Min Kim. (2009) Learning curve for living-donor liver transplantation in a fledgling cancer center. Transplant International 22:12, 1164-1171
CrossRef483
A. Qasim, M. B. Zaman, D. Maguire, J. Geoghegan, R. Gibney, N. Nolan, O. Traynor, J. Hegarty, P. A. McCormick. (2009) Hepatic transplantation outcomes for carefully selected cirrhotic patients with hepatocellular carcinoma: experience at a small- to medium-volume centre. Irish Journal of Medical Science 178:4, 469-472
CrossRef484
E. Hartmann, A. Németh, Gy. Juharosi, Zs. Lénárd, P. Á. Deák, V. Kozma, P. Nagy, Zs. Gerlei, I. Fehérvári, B. Nemes, D. Görög, J. Fazakas, L. Kóbori, A. Doros. (2009) Downstaging of hepatocellular carcinoma with radiofrequency ablation on the Hungarian liver transplantation waiting list — Early results and learned lessons. Interventional Medicine and Applied Science 1:1, 41-45
CrossRef485
Srinath Chinnakotla, Gary L. Davis, Sugam Vasani, Peter Kim, Koji Tomiyama, Edmund Sanchez, Nicholas Onaca, Robert Goldstein, Marlon Levy, Göran B. Klintmalm. (2009) Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation 15:12, 1834-1842
CrossRef486
S.H. Kerr, D.J. Kerr. (2009) Novel treatments for hepatocellular cancer. Cancer Letters 286:1, 114-120
CrossRef487
M. Yeganeh, R. S. Finn, S. Saab. (2009) Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib. American Journal of Transplantation 9:12, 2851-2854
CrossRef488
Sven Jonas, Houssein Al-Abadi, Christoph Benckert, Armin Thelen, M Hippler-Benscheid, Kaya Saribeyoglu, Birgit Radtke, Johann Pratschke, Peter Neuhaus. (2009) Prognostic Significance of the DNA-Index in Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis. Annals of Surgery 250:6, 1008-1013
CrossRef489
Ronald Koschny, Jan Schmidt, Tom M. Ganten. (2009) Beyond Milan criteria
CrossRef490
G. Morris-Stiff, D. Gomez, N. de Liguori Carino, K.R. Prasad. (2009) Surgical management of hepatocellular carcinoma: Is the jury still out?. Surgical Oncology 18:4, 298-321
CrossRef491
Daniel Seehofer, Armin Thelen, Ulf P. Neumann, Winfried Veltzke-Schlieker, Timm Denecke, Carsten Kamphues, Johann Pratschke, Sven Jonas, Peter Neuhaus. (2009) Extended bile duct resection liver and transplantation in patients with hilar cholangiocarcinoma: Long-term results. Liver Transplantation 15:11, 1499-1507
CrossRef492
Oliver B. Lao, Jennifer Weissman, James D. Perkins. (2009) Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clinical Transplantation 23:6, 874-881
CrossRef493
Sammy Saab, Melina Yeganeh, Kelvin Nguyen, Francisco Durazo, Steven Han, Hasan Yersiz, Douglas G. Farmer, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busuttil. (2009) Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transplantation 15:11, 1525-1534
CrossRef494
Geraldine C. Diaz, Thomas Boyer, John F. Renz. (2009) Survival of Clostridium perfringens sepsis in a liver transplant recipient. Liver Transplantation 15:11, 1469-1472
CrossRef495
Daisuke Ban, Kazuaki Shimada, Yusuke Yamamoto, Satoshi Nara, Minoru Esaki, Yoshihiro Sakamoto, Tomoo Kosuge. (2009) Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein. Journal of Gastrointestinal Surgery 13:11, 1921-1928
CrossRef496
Spiros G. Delis, Andreas Bakoyiannis, Nikos Tassopoulos, Kostas Athanassiou, Aristotelis Kechagias, Dimitrios Kelekis, Juan Madariaga, Christos Dervenis. (2009) Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB 11:7, 551-558
CrossRef497
Laura E. Moreno Luna, Paul Y. Kwo, Lewis R. Roberts, Teresa A. Mettler, Denise N. Gansen, James C. Andrews, Gregory A. Wiseman, Vijay Laxmi Misra. (2009) Liver transplantation after radioembolization in a patient with unresectable HCC. Nature Reviews Gastroenterology & Hepatology 6:11, 679-683
CrossRef498
Nagisa Hara, Motoh Iwasa, Kazuko Iwata, Hirohide Miyachi, Hideaki Tanaka, Masaki Takeo, Naoki Fujita, Yoshinao Kobayashi, Yoshiyuki Takei. (2009) Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatology Research 39:11, 1072-1079
CrossRef499
Kazutoyo Morita, Akinobu Taketomi, Yuji Soejima, Toru Ikegami, Takasuke Fukuhara, Tomohiro Iguchi, Shigeyuki Nagata, Keishi Sugimachi, Tomonobu Gion, Ken Shirabe, Yoshihiko Maehara. (2009) De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation. Liver Transplantation 15:11, 1412-1416
CrossRef500
Wei-Ting Kuo, Cheng-Yuan Hsia, Che-Chuan Loong, Chin-Su Liu, Hsin-Lin Tsai, Hsiou-Shan Tseng, Rheun-Chuan Lee, Mei-Yung Tsou, Chew-Wun Wu, Wing-Yiu Lui. (2009) Outcome of foreign residents undergoing deceased donor liver transplantation in China: A single-center experience in Taiwan. Liver Transplantation 15:11, 1579-1585
CrossRef501
C.P. Strassburg. (2009) Lebertransplantation im Zeitalter von MELD. Der Gastroenterologe 4:6, 501-512
CrossRef502
Toshimi Kaido, Hiroto Egawa, Hiroaki Tsuji, Eishi Ashihara, Taira Maekawa, Shinji Uemoto. (2009) In-hospital mortality in adult recipients of living donor liver transplantation: Experience of 576 consecutive cases at a single center. Liver Transplantation 15:11, 1420-1425
CrossRef503
Ka-Kit Li, James Neuberger. (2009) The management of patients awaiting liver transplantation. Nature Reviews Gastroenterology & Hepatology 6:11, 648-659
CrossRef504
Daniel Cherqui, Alexis Laurent, Nicolas Mocellin, Claude Tayar, Alain Luciani, Jeanne Tran Van Nhieu, Thomas Decaens, Monika Hurtova, Riccardo Memeo, Ariane Mallat, Christophe Duvoux. (2009) Liver Resection for Transplantable Hepatocellular Carcinoma. Annals of Surgery 250:5, 738-746
CrossRef505
Donald Poon, Benjamin O Anderson, Li-Tzong Chen, Koichi Tanaka, Wan Yee Lau, Eric Van Cutsem, Harjit Singh, Wan Cheng Chow, London Lucien Ooi, Pierce Chow, Maung Win Khin, Wen Hsin Koo. (2009) Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology 10:11, 1111-1118
CrossRef506
Hui-Chun Huang, Fa-Yauh Lee, Teh-Ia Huo. (2009) Major adverse events, pretransplant assessment and outcome prediction. Journal of Gastroenterology and Hepatology 24:11, 1716-1724
CrossRef507
M. Fujiki, Y. Takada, Y. Ogura, F. Oike, T. Kaido, S. Teramukai, S. Uemoto. (2009) Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 9:10, 2362-2371
CrossRef508
Ae Lyoung Min, Jong Young Choi, Hyun Young Woo, Jin Dong Kim, Jung Hyun Kwon, Si Hyun Bae, Seung Kew Yoon, Seung Hun Shin, Yeun Jun Chung, Chan Kwon Jung. (2009) High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clinical & Experimental Metastasis 26:7, 759-767
CrossRef509
Aya Kamaya, Katherine E. Maturen, Grace A. Tye, Yueyi I. Liu, Naveen N. Parti, Terry S. Desser. (2009) Hypervascular Liver Lesions. Seminars in Ultrasound, CT, and MRI 30:5, 387-407
CrossRef510
Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Marlen Doskali, Yuka Igarashi, Hirotaka Tashiro, Nobuhiko Hiraga, Michio Imamura, Naoya Sakamoto, Toshimasa Asahara, Kazuaki Chayama, Hideki Ohdan. (2009) Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. Journal of Clinical Investigation
CrossRef511
Kiyoshi Hasegawa, Norihiro Kokudo. (2009) Surgical treatment of hepatocellular carcinoma. Surgery Today 39:10, 833-843
CrossRef512
Min A. Yoon, Se Hyung Kim, Hee Sun Park, Dong Ho Lee, Jae Young Lee, Joon Koo Han, Byung Ihn Choi. (2009) Value of Dual Contrast Liver MRI at 3.0 T in Differentiating Well-Differentiated Hepatocellular Carcinomas From Dysplastic Nodules. Investigative Radiology 44:10, 641-649
CrossRef513
Evangelia M Fatourou, John S Koskinas. (2009) Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Review of Anticancer Therapy 9:10, 1499-1510
CrossRef514
Yuichiro Ushitora, Hirotaka Tashiro, Takayuki Ogawa, Yoshisato Tanimoto, Shintaro Kuroda, Tsuyoshi Kobayashi, Yoshihiro Miyata, Toshiyuki Itamoto, Toshimasa Asahara, Hideki Ohdan. (2009) Suppression of Hepatocellular Carcinoma Recurrence After Rat Liver Transplantation by FTY720, a Sphingosine-1-Phosphate Analog. Transplantation 88:8, 980-986
CrossRef515
Francesco D'Amico, Myron Schwartz, Alessandro Vitale, Parissa Tabrizian, Sasan Roayaie, Swan Thung, Maria Guido, Juan del Rio Martin, Thomas Schiano, Umberto Cillo. (2009) Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transplantation 15:10, 1278-1287
CrossRef516
S. Gitto, S. Lorenzini, M. Biselli, F. Conti, P. Andreone, M. Bernardi. (2009) Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Digestive and Liver Disease 41:10, 700-706
CrossRef517
Georgios C. Sotiropoulos, Nina Drühe, George Sgourakis, Ernesto P. Molmenti, Susanne Beckebaum, Hideo A. Baba, Gerald Antoch, Philip Hilgard, Arnold Radtke, Fuat H. Saner, Silvio Nadalin, Andreas Paul, Massimo Malagó, Christoph E. Broelsch, Hauke Lang. (2009) Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?. Digestive Diseases and Sciences 54:10, 2264-2273
CrossRef518
Jia Fan, Guang-Shun Yang, Zhi-Ren Fu, Zhi-Hai Peng, Qiang Xia, Chen-Hong Peng, Jian-Ming Qian, Jian Zhou, Yang Xu, Shuang-Jian Qiu, Lin Zhong, Guang-Wen Zhou, Jian-Jun Zhang. (2009) Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. Journal of Cancer Research and Clinical Oncology 135:10, 1403-1412
CrossRef519
C.-C. Wu, S.-B. Cheng, D.-C. Yeh, J. Wang, F.-K. P'eng. (2009) Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. British Journal of Surgery 96:9, 1049-1057
CrossRef520
Natalie Bzowej, Steven Han, Bulent Degertekin, Emmet B. Keeffe, Sukru Emre, Robert Brown, Rajender Reddy, Anna S. Lok, . (2009) Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B. Liver Transplantation 15:9, 1010-1020
CrossRef521
Christian Toso, Norman M. Kneteman, A. M. James Shapiro, David L. Bigam. (2009) The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria. Transplant International 22:9, 869-875
CrossRef522
S. Breitenstein, D. Dimitroulis, H. Petrowsky, M. A. Puhan, B. Müllhaupt, P.-A. Clavien. (2009) Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. British Journal of Surgery 96:9, 975-981
CrossRef523
Teh-Ia Huo, Cheng-Yuan Hsia, Yi-Hsiang Huang, Han-Chieh Lin, Pui-Ching Lee, Wing-Yiu Lui, Jen-Huei Chiang, Yi-You Chiou, Che-Chuan Loong, Shou-Dong Lee. (2009) Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 43:8, 773-781
CrossRef524
Ashraf Thabet, Sanjeeva Kalva, Debra A. Gervais. (2009) Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response. Abdominal Imaging 34:5, 593-609
CrossRef525
Evandra Cristina Vieira da Rocha, Elbio Antonio D'Amico, Stephen Hugh Caldwell, Tania Rubia Flores da Rocha, Cristina Simões Solon Soares E Silva, Valdinelia Dos Santos Bomfim, Guilherme Felga, Walnei Fernandes Barbosa, Fabio Kassab, Demerson Andre Polli, Flair Jose Carrilho, Alberto Queiroz Farias. (2009) A Prospective Study of Conventional and Expanded Coagulation Indices in Predicting Ulcer Bleeding After Variceal Band Ligation. Clinical Gastroenterology and Hepatology 7:9, 988-993
CrossRef526
Piotr Kaliciński, Jean Bernard Otte. (2009) Liver transplantation for hepatic malignancies in children - We all need more information. Pediatric Transplantation 13:6, 657-658
CrossRef527
Michele Molinari, Scott Helton. (2009) Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis. The American Journal of Surgery 198:3, 396-406
CrossRef528
H. Ismail, D. Broniszczak, P. Kaliciński, M. Markiewicz-Kijewska, J. Teisseyre, M. Stefanowicz, M. Szymczak, B. Dembowska-Bagińska, P. Kluge, D. Perek, A. Kościesza, E. Dzik, A. Lembas, M. Teisserye. (2009) Liver transplantation in children with hepatocellular carcinoma Do Milan criteria apply to pediatric patients?. Pediatric Transplantation 13:6, 682-692
CrossRef529
Ahsun Riaz, Robert J. Lewandowski, Laura M. Kulik, Mary F. Mulcahy, Kent T. Sato, Robert K. Ryu, Reed A. Omary, Riad Salem. (2009) Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature Review. Journal of Vascular and Interventional Radiology 20:9, 1121-1130
CrossRef530
Marcelo E. Facciuto, Caroline Rochon, Mahima Pandey, Manuel Rodriguez-Davalos, Susana Samaniego, David C. Wolf, Leona Kim-Schluger, Grigory Rozenblit, Patricia A. Sheiner. (2009) Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB 11:5, 398-404
CrossRef531
P. Lee, S. Kee, R. Busuttil. (2009) Is Downstaging Prior to Liver Transplantation Important in Hepatocellular Carcinoma?. American Journal of Transplantation 9:8, 1703-1704
CrossRef532
R. J. Lewandowski, L. M. Kulik, A. Riaz, S. Senthilnathan, M. F. Mulcahy, R. K. Ryu, S. M. Ibrahim, K. T. Sato, T. Baker, F. H. Miller, R. Omary, M. Abecassis, R. Salem. (2009) A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization. American Journal of Transplantation 9:8, 1920-1928
CrossRef533
Shawn J. Pelletier, Sherry Fu, Veena Thyagarajan, Carlos Romero-Marrero, Mashal J. Batheja, Jeffrey D. Punch, John C. Magee, Anna S. Lok, Robert J. Fontana, Jorge A. Marrero. (2009) An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transplantation 15:8, 859-868
CrossRef534
Mohamed IF Shariff, I Jane Cox, Asmaa I Gomaa, Shahid A Khan, Wladyslaw Gedroyc, Simon D Taylor-Robinson. (2009) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 3:4, 353-367
CrossRef535
Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, Giorgio Ercolani, Antonio Daniele Pinna, Fabio Piscaglia, Franco Trevisani. (2009) Down-Staging of Hepatocellular Carcinoma Before Liver Transplantation: Should We Change Our Clinical Practice?. Annals of Surgery 250:2, 348
CrossRef536
Irinel Popescu, Nagy Habib, Simona Dima, Nicolae Hancu, Liana Gheorghe, Speranta Iacob, Mariana Mihaila, Bogdan Dorobantu, Emil Matei, Florin Botea. (2009) Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. Clinical Transplantation 23:4, 565-570
CrossRef537
Jason J. Schwartz, William R. Hutson, Timothy J. Gayowski, John B. Sorensen. (2009) Liver Transplantation for Cholangiocarcinoma. Transplantation 88:3, 295-298
CrossRef538
Konrad Schoppmeyer, Sebastian Weis, Joachim Mössner, Wolfgang E. Fleig, Konrad Schoppmeyer. 2009. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. .
CrossRef539
Guadalupe Garcia-Tsao, Joseph Lim. (2009) Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. The American Journal of Gastroenterology 104:7, 1802-1829
CrossRef540
Geoffrey C. Nguyen, Nimisha P. Thuluvath, Dorry L. Segev, Paul J. Thuluvath. (2009) Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transplantation 15:7, 776-781
CrossRef541
Steven C. Cunningham, Susan Tsai, Hugo P. Marques, Paulo Mira, Andrew Cameron, Eduardo Barroso, Benjamin Philosophe, Timothy M. Pawlik. (2009) Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis. Annals of Surgical Oncology 16:7, 1820-1831
CrossRef542
Oliver B. Lao, Farhood Farjah, David R. Flum, Raymond S. Yeung. (2009) Adverse events after radiofrequency ablation of unresectable liver tumors: a single-center experience. The American Journal of Surgery 198:1, 76-82
CrossRef543
M. L. Fernandes, C.-C. Lin, C.-J. Lin, W.-T. Chen, S.-M. Lin. (2009) Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation. British Journal of Surgery 96:7, 756-762
CrossRef544
Juan F. Gallegos-Orozco, Hugo E. Vargas. (2009) Liver Transplantation: From Child to MELD. Medical Clinics of North America 93:4, 931-950
CrossRef545
Etsushi Kawamura, Daiki Habu, Hiroyasu Morikawa, Masaru Enomoto, Joji Kawabe, Akihiro Tamori, Hiroki Sakaguchi, Shigeru Saeki, Norifumi Kawada, Susumu Shiomi. (2009) A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: Validation using prognostic markers for pre-liver transplant status. Liver Transplantation 15:7, 790-797
CrossRef546
Richard Bryant, Alexis Laurent, Claude Tayar, Daniel Cherqui. (2009) Laparoscopic Liver Resection—Understanding its Role in Current Practice. Annals of Surgery 250:1, 103-111
CrossRef547
Paul J. Thuluvath, Anurag Maheshwari, Nimisha P. Thuluvath, Geoffrey C. Nguyen, Dorry L. Segev. (2009) Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Liver Transplantation 15:7, 754-762
CrossRef548
Maxime Audet, Fabrizio Panaro, Tullio Piardi, Philippe Wolf. (2009) Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?. Liver Transplantation 15:7, 822-823
CrossRef549
Manuel Mendizabal, K. Rajender Reddy. (2009) Current Management of Hepatocellular Carcinoma. Medical Clinics of North America 93:4, 885-900
CrossRef550
Chih-Chi Wang, Shridhar G. Iyer, Jee Keem Low, Chih-Yun Lin, Shih-Ho Wang, Sen-Nan Lu, Chao-Long Chen. (2009) Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Annals of Surgical Oncology 16:7, 1832-1842
CrossRef551
C. Kuhl. (2009) Transarterielle Chemoembolisation bei hepatozellulärem Karzinom – neue Entwicklungen. Der Gastroenterologe 4:4, 330-339
CrossRef552
A. SINGAL, M. L. VOLK, A. WALJEE, R. SALGIA, P. HIGGINS, M. A. M. ROGERS, J. A. MARRERO. (2009) Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Alimentary Pharmacology & Therapeutics 30:1, 37-47
CrossRef553
H.C. Spangenberg, O. Drognitz, R. Thimme, U. Hopt. (2009) Das hepatozelluläre Karzinom aus der Sicht des Internisten und des Chirurgen. Der Gastroenterologe 4:4, 301-311
CrossRef554
Karim J. Halazun, Mark A. Hardy, Abbas A. Rana, David C. Woodland, Elijah J. Luyten, Suhari Mahadev, Piotr Witkowski, Abbey B. Siegel, Robert S. Brown, Jean C. Emond. (2009) Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 250:1, 141-151
CrossRef555
Mauricio Silva, José Mir. (2009) Beyond the milan criteria: Is it the right time?. Liver Transplantation 15:7, 824-826
CrossRef556
F. Muscari, B. Foppa, N. Kamar, J. M. Peron, J. Selves, B. Suc. (2009) Liberal selection criteria for liver transplantation for hepatocellular carcinoma. British Journal of Surgery 96:7, 785-791
CrossRef557
Debra A. Gervais, S. Nahum Goldberg, Daniel B. Brown, Michael C. Soulen, Steven F. Millward, Dheeraj K. Rajan. (2009) Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors. Journal of Vascular and Interventional Radiology 20:7, S342-S347
CrossRef558
Huamao Wang, Hua Jiang, Min Zhou, Zhibing Xu, Shiguo Liu, Bizhi Shi, Xiao Yao, Ming Yao, JianRen Gu, Zonghai Li. (2009) Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma. Cancer Letters 279:1, 30-38
CrossRef559
Zhi Dai, Lei Yu, Jian Zhou, Shuang-Jian Qiu, Jia Fan. (2009) Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?. Expert Review of Gastroenterology & Hepatology 3:3, 211-213
CrossRef560
Robin D. Kim, Alan W. Hemming. (2009) Hepatocellular Carcinoma: Resection or Transplantation. Journal of Gastrointestinal Surgery 13:6, 1023-1025
CrossRef561
Nicholas Onaca, Gary L. Davis, Linda W. Jennings, Robert M. Goldstein, Goran B. Klintmalm. (2009) Improved results of transplantation for hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation. Liver Transplantation 15:6, 574-580
CrossRef562
U. Settmacher, A. Altendorf-Hofmann, K. Jandt, M. Heise. (2009) Lebertransplantation bei Patienten mit hepatozellulärem Karzinom. Der Onkologe 15:6, 575-588
CrossRef563
Dong Ho Lee, Se Hyung Kim, Jeong Min Lee, Hee Sun Park, Jae Young Lee, Nam-Joon Yi, Kyung-Suk Suh, Ja June Jang, Joon Koo Han, Byung Ihn Choi. (2009) Diagnostic Performance of Multidetector Row Computed Tomography, Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging, and Dual-Contrast Magnetic Resonance Imaging in Predicting the Appropriateness of a Transplant Recipient Based on Milan Criteria. Investigative Radiology 44:6, 311-321
CrossRef564
Susumu Eguchi, Masaaki Hidaka, Tetsuo Tomonaga, Kensuke Miyazaki, Takamitsu Inokuma, Mitsuhisa Takatsuki, Sadayuki Okudaira, Kosho Yamanouchi, Hisamitsu Miyaaki, Tatsuki Ichikawa, Yoshitsugu Tajima, Takashi Kanematsu. (2009) Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation. Journal of Gastroenterology 44:6, 624-629
CrossRef565
Michael A. Choti. (2009) Transplantation Versus Resection for Hepatocellular Carcinoma in the Mild Cirrhotic: Framing the Debate. Journal of Gastrointestinal Surgery 13:6, 1021-1022
CrossRef566
Higinia R. Cárdenes. (2009) Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results. Clinical and Translational Oncology 11:5, 276-283
CrossRef567
Edoardo Giovanni Giannini, Elisa Marabotto, Vincenzo Savarino, Franco Trevisani, Maria Anna di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Fabio Farinati, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte. (2009) Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis. Clinical Gastroenterology and Hepatology 7:5, 580-585
CrossRef568
W. De Luna, D. Y. Sze, A. Ahmed, B. Y. Ha, W. Ayoub, E. B. Keeffe, A. Cooper, C. Esquivel, M. H. Nguyen. (2009) Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation. American Journal of Transplantation 9:5, 1158-1168
CrossRef569
Richard Kinh Gian Do, Henry Rusinek, Bachir Taouli. (2009) Dynamic Contrast-Enhanced MR Imaging of the Liver: Current Status and Future Directions. Magnetic Resonance Imaging Clinics of North America 17:2, 339-349
CrossRef570
S. Jelic, . (2009) Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20:Supplement 4, iv41-iv45
CrossRef571
Jeong-Ok Lee, Dae-Young Kim, Joo Han Lim, Myung-Deok Seo, Hyeon Gyu Yi, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang. (2009) Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation. Journal of Gastroenterology and Hepatology 24:5, 800-805
CrossRef572
Savino Bruno, Massimo Zuin, Andrea Crosignani, Sonia Rossi, Felice Zadra, Luigi Roffi, Mauro Borzio, Alessandro Redaelli, Alberto Chiesa, Enrico Maria Silini, Piero Luigi Almasio, Patrick Maisonneuve. (2009) Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study. The American Journal of Gastroenterology 104:5, 1147-1158
CrossRef573
Jorge A. Marrero, Theodore Welling. (2009) Modern Diagnosis and Management of Hepatocellular Carcinoma. Clinics in Liver Disease 13:2, 233-247
CrossRef574
C.P. Strassburg, M.P. Manns. (2009) Lebertransplantation. Der Internist 50:5, 550-560
CrossRef575
Sheung Tat Fan, Haibo Wang, Banny K. Lam. (2009) Follow-up of Chinese liver transplant recipients in Hong Kong. Liver Transplantation 15:5, 544-550
CrossRef576
Richard B. Freeman, Neville Jamieson, Douglas E. Schaubel, Robert J. Porte, Federico G. Villamil. (2009) Who should get a liver graft?. Journal of Hepatology 50:4, 664-673
CrossRef577
Sascha A. Müller, Bruno M. Schmied, Arianeb Mehrabi, Thilo Welsch, Peter Schemmer, Ulf Hinz, Jürgen Weitz, Jens Werner, Markus W. Büchler, Jan Schmidt. (2009) Feasibility and Effectiveness of a New Algorithm in Preventing Hepatic Artery Thrombosis after Liver Transplantation. Journal of Gastrointestinal Surgery 13:4, 702-712
CrossRef578
Jacqueline G. O'Leary, Henry Randall, Nicholas Onaca, Linda Jennings, Göran B. Klintmalm, Gary L. Davis. (2009) Post-liver transplant survival in hepatitis C patients is improving over time. Liver Transplantation 15:4, 360-368
CrossRef579
Xiao-Yu Yin, Ming-De Lu. (2009) Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 3:2, 121-130
CrossRef580
C. L. Berg, D. E. Steffick, E. B. Edwards, J. K. Heimbach, J. C. Magee, W. K. Washburn, G. V. Mazariegos. (2009) Liver and Intestine Transplantation in the United States 1998-2007. American Journal of Transplantation 9:4p2, 907-931
CrossRef581
Ahsun Riaz, Laura Kulik, Robert J. Lewandowski, Robert K. Ryu, Georgia Giakoumis Spear, Mary F. Mulcahy, Michael Abecassis, Talia Baker, Vanessa Gates, Ritu Nayar, Frank H. Miller, Kent T. Sato, Reed A. Omary, Riad Salem. (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49:4, 1185-1193
CrossRef582
Puneeta Tandon, Guadalupe Garcia-Tsao. (2009) Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver International 29:4, 502-510
CrossRef583
Timm Denecke, Christian Grieser, Vera Fröling, Ingo G. Steffen, Birgit Rudolph, Lars Stelter, Lukas Lehmkuhl, Florian Streitparth, Jan Langrehr, Peter Neuhaus, Enrique Lopez Hänninen. (2009) Multislice computed tomography using a triple-phase contrast protocol for preoperative assessment of hepatic tumor load in patients with hepatocellular carcinoma before liver transplantation. Transplant International 22:4, 395-402
CrossRef584
Yasuhiro Asahina, Hiroyuki Nakanishi, Namiki Izumi. (2009) LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA. Digestive Endoscopy 21:2, 67-72
CrossRef585
Wolfgang Sieghart, Markus Peck-Radosavljevic. (2009) Das hepatozelluläre Karzinom. Wiener klinische Wochenschrift Education 4:1, 33-41
CrossRef586
Ming-Chih Ho, Guan-Tarn Huang, Yuk-Ming Tsang, Po-Huang Lee, Ding-Shinn Chen, Jin-Chuan Sheu, Chien-Hung Chen. (2009) Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas. Annals of Surgical Oncology 16:4, 848-855
CrossRef587
Charles E. Woodall, Charles R. Scoggins, Susan F. Ellis, Clifton M. Tatum, Michael J. Hahl, Kadiyala V. Ravindra, Kelly M. McMasters, Robert C.G. Martin. (2009) Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?. Journal of the American College of Surgeons 208:3, 375-382
CrossRef588
Giuseppe Cabibbo, Federica Latteri, Michela Antonucci, Antonio Craxì. (2009) Multimodal approaches to the treatment of hepatocellular carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 6:3, 159-169
CrossRef589
Christian Toso, Sonal Asthana, David L. Bigam, A. M. James Shapiro, Norman M. Kneteman. (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database. Hepatology 49:3, 832-838
CrossRef590
Masaki Kaibori, Kosuke Matsui, Morihiko Ishizaki, Takamichi Saito, Hiroaki Kitade, Yoichi Matsui, A-Hon Kwon. (2009) Hepatic resection for hepatocellular carcinoma in the elderly. Journal of Surgical Oncology 99:3, 154-160
CrossRef591
William Sanchez. (2009) Expanding transplant criteria for hepatocellular carcinoma: Small steps down a long road. Hepatology 49:3, 724-725
CrossRef592
Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, Franco Trevisani, Fabio Piscaglia, Giorgio Ercolani, Antonio Daniele Pinna. (2009) Down-staging of hepatocellular carcinoma prior to liver transplantation: The power of selection. Hepatology 49:3, 1056-1056
CrossRef593
Susanne Beckebaum, Georgios C. Sotiropoulos, Christian G. Klein, Christoph E. Broelsch, Fuat Saner, Andreas Paul, Guido Gerken, Vito R. Cicinnati. (2009) Predictive Factors of Outcome in Patients Transplanted for Hepatitis B. Transplantation 87:6, 872-881
CrossRef594
A. Kornberg, M. Freesmeyer, E. Bärthel, K. Jandt, K. Katenkamp, J. Steenbeck, A. Sappler, O. Habrecht, D. Gottschild. (2009) 18 F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients. American Journal of Transplantation 9:3, 592-600
CrossRef595
Xiao Xu, Qing-Hong Ke, Zhe-Xin Shao, Jian Wu, Jun Chen, Lin Zhou, Shu-Sen Zheng. (2009) The Value of Serum α-Fetoprotein in Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Digestive Diseases and Sciences 54:2, 385-388
CrossRef596
Akinobu Taketomi, Kensaku Sanefuji, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uhciyama, Toru Ikegami, Noboru Harada, Yoichi Yamashita, Keishi Sugimachi, Hiroto Kayashima, Tomohiro Iguchi, Yoshihko Maehara. (2009) Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation. Transplantation 87:4, 531-537
CrossRef597
Federico Aucejo, Richard Kim, Nizar Zein, Cristiano Quintini, Teresa Diago Uso, Rocio Lopez, Bijan Eghtesad, John Fung, Charles Miller, Lisa Yerian. (2009) Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond milan criteria. Liver Transplantation 15:2, 169-176
CrossRef598
Masaaki Hidaka, Susumu Eguchi, Sadayuki Okudaira, Mitsuhisa Takatsuki, Hirotaka Tokai, Akihiko Soyama, Shigeki Nagayoshi, Satoshi Mochizuki, Koji Hamasaki, Yoshitsugu Tajima, Takashi Kanematsu. (2009) Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver. Hepatology Research 39:2, 143-148
CrossRef599
Alejandro Forner, Carmen Ayuso, María Isabel Real, Javier Sastre, Ricardo Robles, Bruno Sangro, María Varela, Manuel de la Mata, María Buti, Luís Martí-Bonmatí, Concepció Bru, Josep Tabernero, Josep M Llovet, Jordi Bruix. (2009) Diagnóstico y tratamiento del carcinoma hepatocelular. Medicina Clínica 132:7, 272-287
CrossRef600
Luciana O.O. Kikuchi, Denise C. Paranaguá-Vezozzo, Aline L. Chagas, Evandro S. Mello, Venancio A.F. Alves, Alberto Q. Farias, Ricardo Pietrobon, Flair J. Carrilho. (2009) Nodules Less Than 20 mm and Vascular Invasion are Predictors of Survival in Small Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 43:2, 191-195
CrossRef601
J. B. Halldorson, R. Bakthavatsalam, O. Fix, J. D. Reyes, J. D. Perkins. (2009) D-MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching. American Journal of Transplantation 9:2, 318-326
CrossRef602
Hee Sun Park, Jeong-Min Lee, Se Hyung Kim, Samuel Chang, Soo Jin Kim, Joon Koo Han, Byung Ihn Choi. (2009) Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: Value of SPIO-enhanced MR imaging at 3.0 Tesla. Journal of Magnetic Resonance Imaging 29:2, 328-335
CrossRef603
Ambrogio Orlando, Gioacchino Leandro, Mirko Olivo, Angelo Andriulli, Mario Cottone. (2009) Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials. The American Journal of Gastroenterology 104:2, 514-524
CrossRef604
John W.C. Chen, Lilian Kow, Deborah J. Verran, John L. McCall, Stephen Munn, Glenda A. Balderson, Jonathan W. Fawcett, Paul J. Gow, Robert M. Jones, Gary P. Jeffrey, Anthony K. House, Simone I. Strasser. (2009) Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. HPB 11:1, 81-89
CrossRef605
Jeanetta W Frye, Roman E Perri. (2009) Perioperative risk assessment for patients with cirrhosis and liver disease. Expert Review of Gastroenterology & Hepatology 3:1, 65-75
CrossRef606
Masahiro Kobayashi, Kenji Ikeda, Yusuke Kawamura, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada. (2009) High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 115:3, 571-580
CrossRef607
Georgios C. Sotiropoulos, Hauke Lang, George Sgourakis, Silvio Nadalin, Ernesto P. Molmenti, Arnold Radtke, Andreas Paul, Susanne Beckebaum, Fuat H. Saner, Hideo A. Baba, Guido Gerken, Massimo Malagó, Christoph E. Broelsch. (2009) Liberal Policy in Living Donor Liver Transplantation for Hepatocellular Carcinoma: Lessons Learned. Digestive Diseases and Sciences 54:2, 377-384
CrossRef608
(2009) Practice guidelines for management of hepatocellular carcinoma 2009. The Korean Journal of Hepatology 15:3, 391
CrossRef609
Shin Ishikawa, Jun Kato, Motoaki Kuriyama, Koji Takemoto, Toshio Uraoka, Akinobu Takaki, Takahito Yagi, Kohsaku Sakaguchi. (2009) Feasibility and Findings of Colonoscopy for Living-donor Liver Transplant Candidates. Journal of Clinical Gastroenterology 43:1, 69-74
CrossRef610
Nobuhiko Taniai, Koho Akimaru, Hiroshi Yoshida, Takashi Tajiri. (2009) Living Donor Liver Transplantation in Japan. Nihon Ika Daigaku Igakkai Zasshi 5:1, 13-21
CrossRef611
Hiroko Oka, Osamu Yamazaki, Katsuhiko Horii, Takao Manabe, Kiyohide Kioka, Yasuko Kawasaki, Takashi Nakai, Akishige Kanazawa, Sadatoshi Shimizu, Katsuko Murata, Youichi Kouda, Takeshi Inoue. (2009) A case of hepatocellular carcinoma relapsed 44 months after living donor liver transplantation, with a 50-month survival thereafter by multimodal treatments. Kanzo 50:4, 192-200
CrossRef612
Dong-Shik Lee, Sung-Su Yun, Hong-Jin Kim. (2009) Results of Hepatectomy as First Treatment for Hepatocellular Carcinoma within the Milan Criteria with Preserved Liver Function. Journal of the Korean Surgical Society 77:4, 267
CrossRef613
Sue Jin Kim, Moon Seok Choi, Ja Young Kang, Dong Il Choi, Cheol Keun Park, Geum Youn Gwak, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. (2009) Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation. Gut and Liver 3:4, 285
CrossRef614
James Neuberger. (2009) Liver-cell cancer and transplantation. The Lancet Oncology 10:1, 5-7
CrossRef615
Ryosuke Tateishi, Shuichiro Shiina, Takamasa Ohki, Takahisa Sato, Ryota Masuzaki, Jun Imamura, Eriko Goto, Tadashi Goto, Hideo Yoshida, Shuntaro Obi, Shinpei Sato, Fumihiko Kanai, Haruhiko Yoshida, Masao Omata. (2009) Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. Journal of Gastroenterology 44:S19, 142-146
CrossRef616
Eishiro Mizukoshi, Yasunari Nakamoto, Kuniaki Arai, Tatsuya Yamashita, Naofumi Mukaida, Kouji Matsushima, Osamu Matsui, Shuichi Kaneko. (2009) Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma. International Journal of CancerNA-NA
CrossRef617
Adrian P. Martin. (2009) Management of hepatocellular carcinoma in the age of liver transplantation. International Journal of Surgery 7:4, 324-329
CrossRef618
C CHOU, R CHEN, W CHEN, J LII. (2009) Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging. Clinical Radiology 64:1, 22-29
CrossRef619
Alejandro Forner, Jordi Bruix. (2009) East meets the West—portal pressure predicts outcome of surgical resection for hepatocellular carcinoma. Nature Clinical Practice Gastroenterology & Hepatology 6:1, 14-15
CrossRef620
Anthony P. Monaco. (2009) The Role of mTOR Inhibitors in the Management of Posttransplant Malignancy. Transplantation 87:2, 157-163
CrossRef621
Jacques Belghiti. (2009) Resection and liver transplantation for HCC. Journal of Gastroenterology 44:S19, 132-135
CrossRef622
Deok-Bog Moon, Sung-Gyu Lee. (2009) Liver Transplantation. Gut and Liver 3:3, 145
CrossRef623
Héctor Daniel González, Joan Figueras. (2009) Surgical treatment for hepatocellular carcinoma in cirrhotic patients. Guide to the selection and decision-making process in a context of multimodal strategy. Clinical and Translational Oncology 11:1, 20-27
CrossRef624
Shuichiro Shiina. (2009) Image-guided percutaneous ablation therapies for hepatocellular carcinoma. Journal of Gastroenterology 44:S19, 122-131
CrossRef625
Hidetsugu Saito, Tetsuya Masuda, Shinichiro Tada, Hirotoshi Ebinuma, Yoshiyuki Yamagishi, KeiSuke Ojiro, Mika Inoue, Toshifumi Hibi. (2009) Hepatocellular Carcinoma in Keio Affiliated Hospitals — Diagnosis, Treatment, and Prognosis of this Disease —. The Keio Journal of Medicine 58:3, 161-175
CrossRef626
Suzanne C. Schiffman, Charles E. Woodall, David A. Kooby, Robert C.G. Martin, Charles A. Staley, Vasili Egnatashvili, Kelly M. McMasters, Charles R. Scoggins. (2009) Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: A multicenter analysis. Journal of Surgical Oncologyn/a-n/a
CrossRef627
Daniel Benten, Katharina Staufer, Martina Sterneck. (2009) Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nature Clinical Practice Gastroenterology & Hepatology 6:1, 23-36
CrossRef628
Wan Yee Lau, Eric C. H. Lai. (2009) The Current Role of Radiofrequency Ablation in the Management of Hepatocellular Carcinoma. Annals of Surgery 249:1, 20-25
CrossRef629
Norihiro Kokudo, Masatoshi Makuuchi. (2009) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. Journal of Gastroenterology 44:S19, 119-121
CrossRef630
Vincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron E Schwartz, Gian Luca Grazi, René Adam, Peter Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K Burroughs, Roberto Troisi, Massimo Rossi, Giorgio E Gerunda, Jan Lerut, Jacques Belghiti, Ilka Boin, Jean Gugenheim, Fedja Rochling, Bart Van Hoek, Pietro Majno. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. The Lancet Oncology 10:1, 35-43
CrossRef631
D GERVAIS, S GOLDBERG, D BROWN, M SOULEN, S MILLWARD, D RAJAN. (2009) Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors. Journal of Vascular and Interventional Radiology 20:1, 3-8
CrossRef632
Ronald Koschny, Carsten Grüllich, Tom Michael Ganten. (2008) Standards und neue Aspekte der Diagnostik und Therapie des hepatozellulären Karzinoms. Onkopipeline 1:3, 109-119
CrossRef633
M. Ravaioli, G. L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, G. Ercolani, M. Vivarelli, R. Golfieri, A. D'Errico Grigioni, I. Panzini, C. Morelli, M. Bernardi, L. Bolondi, A. D. Pinna. (2008) Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria. American Journal of Transplantation 8:12, 2547-2557
CrossRef634
L. Marelli, A. Grasso, M. Pleguezuelo, H. Martines, R. Stigliano, A. P. Dhillon, D. Patch, B. R. Davidson, D. Sharma, K. Rolles, A. K. Burroughs. (2008) Tumour Size and Differentiation in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation: External Validation of a New Prognostic Score. Annals of Surgical Oncology 15:12, 3503-3511
CrossRef635
Laura Gramantieri, Francesca Fornari, Elisa Callegari, Silvia Sabbioni, Giovanni Lanza, Carlo M. Croce, Luigi Bolondi, Massimo Negrini. (2008) MicroRNA involvement in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 12:6a, 2189-2204
CrossRef636
Luigi Manzione, Antonio Maria Grimaldi, Rosangela Romano, Domenica Ferrara, Angelo Dinota. (2008) Hepatocarcinoma: from pathogenic mechanisms to target therapy. Oncology Reviews 2:4, 214-222
CrossRef637
Ryota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Masao Omata. (2008) Hepatocellular carcinoma in viral hepatitis: Improving standard therapy. Best Practice & Research Clinical Gastroenterology 22:6, 1137-1151
CrossRef638
Jun Imamura, Ryosuke Tateishi, Shuichiro Shiina, Eriko Goto, Takahisa Sato, Takamasa Ohki, Ryota Masuzaki, Tadashi Goto, Hideo Yoshida, Fumihiko Kanai, Keisuke Hamamura, Shuntaro Obi, Haruhiko Yoshida, Masao Omata. (2008) Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 103:12, 3057-3062
CrossRef639
K ANDERSSON, J SALOMON, S GOLDIE, R CHUNG. (2008) Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 6:12, 1418-1424
CrossRef640
Frédéric Borie, Anne-Marie Bouvier, Astrid Herrero, Jean Faivre, Guy Launoy, Patricia Delafosse, Michel Velten, Antoine Buemi, Jun Peng, Pascale Grosclaude, Brigitte Trétarre. (2008) Treatment and prognosis of hepatocellular carcinoma: A population based study in France. Journal of Surgical Oncology 98:7, 505-509
CrossRef641
Simon P. Dawson. (2008) Hepatocellular carcinoma and the ubiquitin–proteasome system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1782:12, 775-784
CrossRef642
ChungMau Lo. (2008) Downstaging of Hepatocellular Carcinoma Before Transplantation: An Advance in Therapy or Just Another Selection Criterion. American Journal of Transplantation 8:12, 2485-2486
CrossRef643
Marco Casaccia, Enzo Andorno, Ilaria Nardi, Bianca Troilo, Gabriele Barabino, Gregorio Santori, Umberto Valente. (2008) Laparoscopic US-Guided Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Liver Cirrhosis: Feasibility and Clinical Outcome. Journal of Laparoendoscopic & Advanced Surgical Techniques 18:6, 797-801
CrossRef644
Emir Hoti, Rene Adam. (2008) Liver transplantation for primary and metastatic liver cancers. Transplant International 21:12, 1107-1117
CrossRef645
Reeti Sahni, Suchit Aggarwal. (2008) Ultrasound Imaging in Liver Transplantation. Apollo Medicine 5:4, 348-357
CrossRef646
Thomas Yau, Tzy Jyun Yao, Pierre Chan, Kelvin Ng, Sheung Tat Fan, Ronnie T. P. Poon. (2008) A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy. Cancer 113:10, 2742-2751
CrossRef647
Ashraf Thabet, Sanjeeva Kalva, Debra A. Gervais. (2008) Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response. Abdominal Imaging
CrossRef648
Masaki Kaibori, Sang Kil Ha-Kawa, Morihiko Ishizaki, Kosuke Matsui, Takamichi Saito, A-Hon Kwon, Yasuo Kamiyama. (2008) HA/GSA-Rmax Ratio as a Predictor of Postoperative Liver Failure. World Journal of Surgery 32:11, 2410-2418
CrossRef649
Milton J. Finegold, Rachel A. Egler, John A. Goss, R. Paul Guillerman, Saul J. Karpen, Rajesh Krishnamurthy, Christine Ann O'Mahony. (2008) Liver tumors: Pediatric population. Liver Transplantation 14:11, 1545-1556
CrossRef650
Jason T. Heckman, Michael B. deVera, J. Wallis Marsh, Paulo Fontes, Nikhil B. Amesur, Shane E. Holloway, Michael Nalesnik, David A. Geller, Jennifer L. Steel, T. Clark Gamblin. (2008) Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation. Annals of Surgical Oncology 15:11, 3169-3177
CrossRef651
Marco Vivarelli, Alessandro Cucchetti, Giuliano La Barba, Matteo Ravaioli, Massimo Del Gaudio, Augusto Lauro, Gian Luca Grazi, Antonio Daniele Pinna. (2008) Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors. Annals of Surgery 248:5, 857-862
CrossRef652
Patricia Roxburgh, T. R. Jeffry Evans. (2008) Systemic therapy of hepatocellular carcinoma: Are we making progress?. Advances in Therapy 25:11, 1089-1104
CrossRef653
Ying Jiang, Paul J. Villeneuve, Stanley S. A. Fenton, Douglas E. Schaubel, Les Lilly, Yang Mao. (2008) Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort study. Liver Transplantation 14:11, 1588-1597
CrossRef654
Anthony S. Robbins, Michael F. Daily, Christopher A. Aoki, Moon S. Chen, Christoph Troppmann, Richard V. Perez. (2008) Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma. Cancer 113:8, 2173-2179
CrossRef655
Philippe Compagnon, Stéphane Grandadam, Richard Lorho, Bruno Turlin, Christophe Camus, Yang Jianrong, Fabrice Lainé, Bernard Meunier, Yves Deugnier, Karim Boudjema. (2008) Liver Transplantation for Hepatocellular Carcinoma Without Preoperative Tumor Biopsy. Transplantation 86:8, 1068-1076
CrossRef656
Maria Pleguezuelo, Laura Marelli, Maria Misseri, Giacomo Germani, Vincenza Calvaruso, Elias Xiruochakis, Manousou Pinelopi, Andrew K Burroughs. (2008) TACE versus TAE as therapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy 8:10, 1623-1641
CrossRef657
E VIBERT, D SAMUEL. (2008) Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
CrossRef658
Francisco A Durazo, Lawrence M Blatt, William G Corey, Jiing-Huey Lin, Steven Han, Sammy Saab, Ronald W Busuttil, Myron J Tong. (2008) Des-γ-carboxyprothrombin, α-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:10, 1541-1548
CrossRef659
Miho Kanda, Ryosuke Tateishi, Haruhiko Yoshida, Takahisa Sato, Ryota Masuzaki, Takamasa Ohki, Jun Imamura, Tadashi Goto, Hideo Yoshida, Keisuke Hamamura, Shuntaro Obi, Fumihiko Kanai, Shuichiro Shiina, Masao Omata. (2008) Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver International 28:9, 1256-1263
CrossRef660
Christian Müller, Maximilian Schöniger-Hekele, Rüdiger Schernthaner, Barbara Renner, Markus Peck-Radosavljevic, Andrea Brichta, Fritz Wrba, Martin Posch, Peter Bauer, Peter Ferenci, Alfred Gangl. (2008) Percutaneous ethanol instillation therapy for hepatocellular carcinoma – a randomized controlled trial. Wiener klinische Wochenschrift 120:19-20, 608-618
CrossRef661
F. Y. Yao. (2008) Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria. American Journal of Transplantation 8:10, 1982-1989
CrossRef662
Emily C. Bellavance, Kimberly M. Lumpkins, Gilles Mentha, Hugo P. Marques, Lorenzo Capussotti, Carlo Pulitano, Pietro Majno, Paulo Mira, Laura Rubbia-Brandt, Alessandro Ferrero, Luca Aldrighetti, Steven Cunningham, Nadia Russolillo, Benjamin Philosophe, Eduardo Barroso, Timothy M. Pawlik. (2008) Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation?. Journal of Gastrointestinal Surgery 12:10, 1699-1708
CrossRef663
M SCHWARTZ, I DVORCHIK, S ROAYAIE, M ISABELFIEL, S FINKELSTEIN, J WALLISMARSH, J MARTIGNETTI, J LLOVET. (2008) Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers
CrossRef664
Kenneth K. Tanabe. (2008) The past 60 years in liver surgery. Cancer 113:S7, 1888-1896
CrossRef665
Takahiro Uenishi, Shuhei Nishiguchi, Shogo Tanaka, Takatsugu Yamamoto, Shigekazu Takemura, Shoji Kubo. (2008) Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Journal of Surgical Oncology 98:5, 358-362
CrossRef666
Mauricio Silva, Angel Moya, Marina Berenguer, Fernando Sanjuan, Rafael López-Andujar, Eugenia Pareja, Rodrigo Torres-Quevedo, Victoria Aguilera, Eva Montalva, Manuel De Juan, Angelo Mattos, Martín Prieto, José Mir. (2008) Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transplantation 14:10, 1449-1460
CrossRef667
Yasuhiko Nagano, Hiroshi Shimada, Kazuhisa Takeda, Michio Ueda, Kenichi Matsuo, Kuniya Tanaka, Itaru Endo, Chikara Kunisaki, Shinji Togo. (2008) Predictive Factors of Microvascular Invasion in Patients with Hepatocellular Carcinoma Larger Than 5 cm. World Journal of Surgery 32:10, 2218-2222
CrossRef668
Stephanie Ma, Kwok Wah Chan, Xin-Yuan Guan. (2008) In Search of Liver Cancer Stem Cells. Stem Cell Reviews 4:3, 179-192
CrossRef669
Toru Ikegami, Mitsuo Shimada, Satoru Imura, Tomoharu Yoshizumi, Yusuke Arakawa, Takuya Tokunaga, Yuji Morine, Hirofumi Kanemura. (2008) The Timing of Liver Transplantation After Primary Hepatectomy for Hepatocellular Carcinoma: A Special Reference to Recurrence Pattern and Milan Criteria. Transplantation 86:5, 641-646
CrossRef670
Dieter C. Broering, Jessica Walter, Felix Braun, Xavier Rogiers. (2008) Current Status of Hepatic Transplantation. Current Problems in Surgery 45:9, 587-661
CrossRef671
A MOYAHERRAIZ. (2008) Trasplante hepático en pacientes con carcinoma hepatocelular. Cirugía Española 84:3, 117-124
CrossRef672
Georgios C. Sotiropoulos, Hilmar Kuehl, George Sgourakis, Ernesto P. Molmenti, Susanne Beckebaum, Vito R. Cicinnati, Hideo A. Baba, Klaus J. Schmitz, Christoph E. Broelsch, Hauke Lang. (2008) Pulmonary nodules at risk in patients undergoing liver transplantation for hepatocellular carcinoma. Transplant International 21:9, 850-856
CrossRef673
Mark A Feitelson, Marcia M Clayton, Helena MGPV Reis, Guoyi Wu, Eva Ping Lu. (2008) Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 9:13, 2233-2245
CrossRef674
Hyun Young Woo, Jeong Won Jang, Jong Young Choi, Chan Ran You, Soung Won Jeong, Si Hyun Bae, Seung Kew Yoon, Young Sok Lee, Dong Goo Kim. (2008) Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Liver International 28:8, 1120-1128
CrossRef675
E RAMOSRUBIO. (2008) Problemas, interrogantes y controversias en el trasplante hepático por hepatocarcinoma. Cirugía Española 84:3, 115-116
CrossRef676
Wan-Jiang Xue, Chun Li, Xiao-Jun Zhou, Hong-Geng Guan, Lei Qin, Peng Li, Zhi-Wei Wang, Hai-Xin Qian. (2008) RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. Journal of Gastroenterology and Hepatology 23:9, 1448-1458
CrossRef677
Francis Y. Yao, Robert K. Kerlan, Ryutaro Hirose, Timothy J. Davern, Nathan M. Bass, Sandy Feng, Marion Peters, Norah Terrault, Chris E. Freise, Nancy L. Ascher, John P. Roberts. (2008) Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis. Hepatology 48:3, 819-827
CrossRef678
M. Abu-Hilal, J. N. Primrose, A. Casaril, M. J. W. McPhail, N. W. Pearce, N. Nicoli. (2008) Surgical Resection Versus Radiofrequency Ablation in the Treatment of Small Unifocal Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 12:9, 1521-1526
CrossRef679
Tomoharu Yoshizumi, Akinobu Taketomi, Yuji Soejima, Toru Ikegami, Hideaki Uchiyama, Hiroto Kayashima, Noboru Harada, Yo-ichi Yamashita, Hirofumi Kawanaka, Takashi Nishizak, Yoshihiko Maehara. (2008) The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transplant International 21:9, 833-842
CrossRef680
T.F. Jakobs, R.T. Hoffmann, K. Tatsch, C. Trumm, M.F. Reiser. (2008) Therapieresponse von Lebertumoren nach selektiver interner Radiotherapie. Der Radiologe 48:9, 839-849
CrossRef681
Manav Wadhawan, Nishant Wadhwa, Anupam Sibal, Vivek Vij, Neerav Goyal, Ajitabh Srivastava, Subash Gupta. (2008) Liver Transplantation in a Large Pediatric Liver Tumor : A Case Report. Apollo Medicine 5:3, 232-233
CrossRef682
Yukio Kamohara, Naotsugu Haraguchi, Koshi Mimori, Fumiaki Tanaka, Hiroshi Inoue, Masaki Mori, Takashi Kanematsu. (2008) The search for cancer stem cells in hepatocellular carcinoma. Surgery 144:2, 119-124
CrossRef683
David A. Kooby, Vasili Egnatashvili, Michael Graiser, Keith A. Delman, John Kauh, William C. Wood, Charles A. Staley III. (2008) Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center. Journal of Surgical Oncology 98:2, 81-88
CrossRef684
Dariusz Zadrożny, Zbigniew Śledziński, Michał Studniarek, Sebastian Dobrowolski, Tomasz Gorycki, Walenty Adamonis, Kamil Bury. (2008) Percutaneus Thermoablation in Patients with Primary and Secondary Liver Cancer - Early Results. Polish Journal of Surgery 80:8, 387-393
CrossRef685
Frank T. C. Tschirch, Anja Struwe, Henrik Petrowsky, Irini Kakales, Borut Marincek, Dominik Weishaupt. (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. European Radiology 18:8, 1577-1586
CrossRef686
Charles R. Scoggins. (2008) More options and improved outcomes for hepatocellular carcinoma. Journal of Surgical Oncology 98:2, 74-74
CrossRef687
W. T. Kassahun, J. Hauss. (2008) Management of combined hepatocellular and cholangiocarcinoma. International Journal of Clinical Practice 62:8, 1271-1278
CrossRef688
C.-B. Hsieh, S.-J. Chou, M.-L. Shih, H.-C. Chu, C.-H. Chu, J.-C. Yu, N.-S. Yao. (2008) Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 34:8, 906-910
CrossRef689
Teppei Matsui, Hidenari Nagai, Yasukiyo Sumino, Kazumasa Miki. (2008) Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis. Cancer Chemotherapy and Pharmacology 62:3, 401-406
CrossRef690
Christian Toso, James Trotter, Alice Wei, David L. Bigam, Shimul Shah, Joshua Lancaster, David R. Grant, Paul D. Greig, A. M. James Shapiro, Norman M. Kneteman. (2008) Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation 14:8, 1107-1115
CrossRef691
Franck Bonnetain, Xavier Paoletti, Sandra Collette, Michel Doffoel, Olivia Bouché, Jean Luc Raoul, Philippe Rougier, Fadil Masskouri, Jean Claude Barbare, Laurent Bedenne. (2008) Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Quality of Life Research 17:6, 831-843
CrossRef692
Yeon Seok Seo, Young Jin Kim, Soon Ho Um, Hanna Yoo, Jae Won Lee, Yong Sik Kim, Yoon Tae Jeen, Hoon Jai Chun, Chang Duck Kim, Ho Sang Ryu. (2008) Evaluation of the prognostic powers of various tumor status grading scales in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:8pt1, 1267-1275
CrossRef693
Sasan Roayaie, Myron E. Schwartz. (2008) Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transplantation 14:8, 1071-1072
CrossRef694
Ying-Hong Shi, Wen-Xing Ding, Jian Zhou, Jun-Yi He, Yang Xu, Andrea A. Gambotto, Hannah Rabinowich, Jia Fan, Xiao-Ming Yin. (2008) Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology 48:2, 497-507
CrossRef695
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura, Masaru Miyazaki. (2008) Clinical significance of -fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:7pt2, e189-e197
CrossRef696
Luigi Addario, Giovan Giuseppe Di Costanzo, Giovanni Tritto, Enrico Cavaglià, Basilio Angrisani, Antonio Ascione. (2008) Fatal ischemic acute pancreatitis complicating trans-catheter arterial embolization of small hepatocellular carcinoma: Do the risks outweigh the benefits?. Journal of Hepatology 49:1, 149-152
CrossRef697
Alan Koffron, Julie A. Stein. (2008) Liver Transplantation: Indications, Pretransplant Evaluation, Surgery, and Posttransplant Complications. Medical Clinics of North America 92:4, 861-888
CrossRef698
S. Herber, S. Biesterfeld, U. Franz, J. Schneider, J. Thies, M. Schuchmann, C. Düber, M. B. Pitton, G. Otto. (2008) Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome. CardioVascular and Interventional Radiology 31:4, 768-777
CrossRef699
C. CAMMÀ, V. DI MARCO, G. CABIBBO, F. LATTERI, L. SANDONATO, P. PARISI, M. ENEA, M. ATTANASIO, M. GALIA, N. ALESSI, A. LICATA, M. A. LATTERI, A. CRAXÌ. (2008) Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Alimentary Pharmacology & Therapeutics 28:1, 62-75
CrossRef700
Richard Bryant, Alexis Laurent, Claude Tayar, Jeanne Tran Van Nhieu, Alain Luciani, Daniel Cherqui. (2008) Liver Resection for Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 17:3, 607-633
CrossRef701
Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge. (2008) Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbeck's Archives of Surgery 393:4, 521-526
CrossRef702
Juan C. Rodríguez-Sanjuán, Francisco González, Carlos Juanco, Luis A. Herrera, Mercedes López-Bautista, Mónica González-Noriega, Elena García-Somacarrera, Javier Figols, Manuel Gómez-Fleitas, Martín Silván. (2008) Radiological and Pathological Assessment of Hepatocellular Carcinoma Response to Radiofrequency. A Study on Removed Liver after Transplantation. World Journal of Surgery 32:7, 1489-1494
CrossRef703
Markus Weber, Pierre-Alain Clavien. (2008) Hepatocellular carcinoma and liver transplantation: Entering the area after the Milan and University of California at San Francisco criteria?. Liver Transplantation 14:7, 911-914
CrossRef704
Edie Y. Chan, Anne M. Larson, Oren K. Fix, Matthew M. Yeh, Adam E. Levy, Ramasamy Bakthavatsalam, Jeffrey B. Halldorson, Jorge D. Reyes, James D. Perkins. (2008) Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies. Liver Transplantation 14:7, 956-965
CrossRef705
Pere Ginès, Florence Wong, Hugh Watson, Slobodan Milutinovic, Luis Ruiz del Arbol, Dan Olteanu, . (2008) Effects of satavaptan, a selective vasopressin V 2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial. Hepatology 48:1, 204-213
CrossRef706
Sung-Gyu Lee, Shin Hwang, Deok-Bog Moon, Chul-Soo Ahn, Ki-Hun Kim, Kyu-Bo Sung, Gi-Young Ko, Kwang-Min Park, Tae-Yong Ha, Gi-Won Song. (2008) Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transplantation 14:7, 935-945
CrossRef707
Willscott E. Naugler, Jonathan M. Schwartz. (2008) Hepatocellular Carcinoma. Disease-a-Month 54:7, 432-444
CrossRef708
Teh-Ia Huo, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Jen-Huei Chiang, Yi-You Chiou, Samantha C. Huo, Pui-Ching Lee, Shou-Dong Lee. (2008) Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy. Clinical Transplantation 22:4, 469-475
CrossRef709
Georgios C. Sotiropoulos, Arnold Radtke, Klaus J. Schmitz, Ernesto P. Molmenti, Tobias Schroeder, Fuat H. Saner, Hideo A. Baba, Ioannis Fouzas, Christoph E. Broelsch, Massimo Malagó, Hauke Lang. (2008) Liver Transplantation in the Setting of Hepatocellular Carcinoma and Portal Vein Thrombosis: A Challenging Dilemma?. Digestive Diseases and Sciences 53:7, 1994-1999
CrossRef710
Shu-Sen Zheng, Xiao Xu, Jian Wu, Jun Chen, Wei-Lin Wang, Min Zhang, Ting-Bo Liang, Li-Ming Wu. (2008) Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences. Transplantation 85:12, 1726-1732
CrossRef711
Luciana C. Faria, Michelle Gigou, Anne M. Roque–Afonso, Mylene Sebagh, Bruno Roche, Guillaume Fallot, Teresa C.A. Ferrari, Catherine Guettier, Elisabeth Dussaix, Denis Castaing, Christian Brechot, Didier Samuel. (2008) Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation. Gastroenterology 134:7, 1890-1899
CrossRef712
A James Hanje, Francis Y Yao. (2008) Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation. Current Opinion in Organ Transplantation 13:3, 234-240
CrossRef713
A. Casaril, M. Abu Hilal, A. Harb, T. Campagnaro, G. Mansueto, N. Nicoli. (2008) The safety of radiofrequency thermal ablation in the treatment of liver malignancies. European Journal of Surgical Oncology (EJSO) 34:6, 668-672
CrossRef714
Ann Walia, Roman Schumann. (2008) The evolution of liver transplantation practices. Current Opinion in Organ Transplantation 13:3, 275-279
CrossRef715
M. Peck-Radosavljevic. (2008) Update on the treatment of hepatocellular carcinoma. memo - Magazine of European Medical Oncology 1:2, 111-115
CrossRef716
Yixing Jiang, Eric T Kimchi, Alberto J Montero, Kevin F Staveley-O’Carroll, Jaffer A Ajani. (2008) Upper gastrointestinal tumors: current status and future perspectives. Expert Review of Anticancer Therapy 8:6, 975-991
CrossRef717
E. Fraga Rivas, P. Barrera Baena, P. López Cillero, M. de la Mata García. (2008) Trasplante hepático. Indicaciones. Cronograma de complicaciones. Tratamiento inmunosupresor. Medicine - Programa de Formación Médica Continuada Acreditado 10:12, 784-792
CrossRef718
F. Pons Renedo, J. de la Revilla Negro, J.L. Calleja Panero. (2008) Carcinoma hepatocelular. Medicine - Programa de Formación Médica Continuada Acreditado 10:12, 770-776
CrossRef719
Olivier Scatton, Stéphane Zalinski, Benoit Terris, Jérémie H. Lefevre, Alessandra Casali, Pierre-Philippe Massault, Filomena Conti, Yvon Calmus, Olivier Soubrane. (2008) Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantation. Liver Transplantation 14:6, 779-788
CrossRef720
J.F. Botha, B.D. Campos. (2008) Salvage Transplantation: Does Saving Livers Save Lives?. American Journal of Transplantation 8:6, 1085-1086
CrossRef721
M. Del Gaudio, G. Ercolani, M. Ravaioli, M. Cescon, A. Lauro, M. Vivarelli, M. Zanello, A. Cucchetti, G. Vetrone, F. Tuci, G. Ramacciato, G. L. Grazi, A. D. Pinna. (2008) Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience. American Journal of Transplantation 8:6, 1177-1185
CrossRef722
Victor W Xia, Masahiko Taniguchi, Randolph H Steadman. (2008) The changing face of patients presenting for liver transplantation. Current Opinion in Organ Transplantation 13:3, 280-284
CrossRef723
Takeaki Ishizawa, Kiyoshi Hasegawa, Taku Aoki, Michiro Takahashi, Yosuke Inoue, Keiji Sano, Hiroshi Imamura, Yasuhiko Sugawara, Norihiro Kokudo, Masatoshi Makuuchi. (2008) Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma. Gastroenterology 134:7, 1908-1916
CrossRef724
Masashi Mizumoto, Koichi Tokuuye, Shinji Sugahara, Hidetsugu Nakayama, Nobuyoshi Fukumitsu, Kiyoshi Ohara, Masato Abei, Junichi Shoda, Eriko Tohno, Manabu Minami. (2008) Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Porta Hepatis. International Journal of Radiation Oncology*Biology*Physics 71:2, 462-467
CrossRef725
J. M. Llovet, A. M. Di Bisceglie, J. Bruix, B. S. Kramer, R. Lencioni, A. X. Zhu, M. Sherman, M. Schwartz, M. Lotze, J. Talwalkar, G. J. Gores, . (2008) Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute 100:10, 698-711
CrossRef726
Michael Volk, Jorge A. Marrero. (2008) Liver Transplantation for Hepatocellular Carcinoma: Who Benefits and Who Is Harmed?. Gastroenterology 134:5, 1612-1614
CrossRef727
Adnan Said, Michael R Lucey. (2008) Liver transplantation: an update 2008. Current Opinion in Gastroenterology 24:3, 339-345
CrossRef728
J.J. Noguera, A. Martínez-Cuesta, B. Sangro, J.I. Bilbao. (2008) Embolismo pulmonar fatal tras la embolización con microsferas de un hepatocarcinoma. Radiología 50:3, 248-250
CrossRef729
Nikhil B. Amesur, Albert B. Zajko, Brian I. Carr. (2008) Chemo-embolization for Unresectable Hepatocellular Carcinoma with Different Sizes of Embolization Particles. Digestive Diseases and Sciences 53:5, 1400-1404
CrossRef730
Kiyoshi Hasegawa, Hiroshi Imamura, Masayoshi Ijichi, Yutaka Matsuyama, Keiji Sano, Yasuhiko Sugawara, Norihiro Kokudo, Masatoshi Makuuchi. (2008) Inclusion of Tumor Markers Improves the Correlation of the Milan Criteria with Vascular Invasion and Tumor Cell Differentiation in Patients with Hepatocellular Carcinoma Undergoing Liver Resection (#JGSU-D-07–00462). Journal of Gastrointestinal Surgery 12:5, 858-866
CrossRef731
S. Tanaka, S. Arii, M. Yasen, K. Mogushi, N. T. Su, C. Zhao, I. Imoto, Y. Eishi, J. Inazawa, Y. Miki, H. Tanaka. (2008) Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. British Journal of Surgery 95:5, 611-619
CrossRef732
George N. Ioannou, James D. Perkins, Robert L. Carithers. (2008) Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival. Gastroenterology 134:5, 1342-1351
CrossRef733
Tae Jun Park, Ji Yeon Kim, S. Paul Oh, So Young Kang, Bong Wan Kim, Hee Jung Wang, Kye Yong Song, Hyoung Chin Kim, In Kyoung Lim. (2008) TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology 47:5, 1533-1543
CrossRef734
Ian A Rowe, Kerry Webb, Bridget K Gunson, Naimish Mehta, Sayeed Haque, James Neuberger. (2008) The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transplant International 21:5, 459-465
CrossRef735
Hashem B. El-Serag, Jorge A. Marrero, Lenhard Rudolph, K. Rajender Reddy. (2008) Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterology 134:6, 1752-1763
CrossRef736
Marcelo E. Facciuto, Baburao Koneru, Juan P. Rocca, David C. Wolf, Leona Kim-Schluger, Paul Visintainer, Kenneth M. Klein, Hoo Chun, Michael Marvin, Grigory Rozenblit, Manuel Rodriguez-Davalos, Patricia A. Sheiner. (2008) Surgical Treatment of Hepatocellular Carcinoma beyond Milan Criteria. Results of Liver Resection, Salvage Transplantation, and Primary Liver Transplantation. Annals of Surgical Oncology 15:5, 1383-1391
CrossRef737
M RODRIGUEZFRAMIL. (2008) Influencia de la edad del donante y del sexo del receptor en la supervivencia de los pacientes trasplantados por hepatocarcinoma. Gastroenterología y Hepatología 31:5, 293-294
CrossRef738
Jacqueline G. O'Leary, Rita Lepe, Gary L. Davis. (2008) Indications for Liver Transplantation. Gastroenterology 134:6, 1764-1776
CrossRef739
Marta Martín–Llahí, Marie–Noëlle Pépin, Mónica Guevara, Fernando Díaz, Aldo Torre, Alberto Monescillo, Germán Soriano, Carlos Terra, Emilio Fábrega, Vicente Arroyo, Juan Rodés, Pere Ginès. (2008) Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study. Gastroenterology 134:5, 1352-1359
CrossRef740
Yoshiaki Kita, Katsuhiko Yanaga. (2008) Management of De novo Hepatocellular Carcinoma Developing in a Transplanted Liver. Digestive Diseases and Sciences 53:5, 1424-1425
CrossRef741
M. L. Volk, S. Vijan, J. A. Marrero. (2008) A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria. American Journal of Transplantation 8:4, 839-846
CrossRef742
R. B. Freeman, D. E. Steffick, M. K. Guidinger, D. G. Farmer, C. L. Berg, R. M. Merion. (2008) Liver and Intestine Transplantation in the United States, 1997–2006. American Journal of Transplantation 8:4p2, 958-976
CrossRef743
Dario Ribero, Steven A. Curley, Hiroshi Imamura, David C. Madoff, David M. Nagorney, Kelvin K. Ng, Matteo Donadon, Valerie Vilgrain, Guido Torzilli, Mark Roh, Jean-Nicolas Vauthey. (2008) Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection. Annals of Surgical Oncology 15:4, 986-992
CrossRef744
Igor Dvorchik, Myron Schwartz, M. Isabel Fiel, Sydney D. Finkelstein, J. Wallis Marsh. (2008) Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transplantation 14:4, 443-450
CrossRef745
Vincenzo Mazzaferro, Yun Shin Chun, Ronnie T. P. Poon, Myron E. Schwartz, Francis Y. Yao, J. Wallis Marsh, Sherrie Bhoori, Sung-Gyu Lee. (2008) Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology 15:4, 1001-1007
CrossRef746
Travis Kidner, Menghua Dai, Prasad S. Adusumilli, Yuman Fong. (2008) Advances in Experimental and Translational Research in the Treatment of Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 17:2, 377-389
CrossRef747
Filomena Morisco, Rosa Stigliano, Andrew Godfrey, Gioacchino Leandro, David Patch, Brian Davidson, Keith Rolles, Arjun Dhillon, Amar Paul Dhillon, Alberto Quaglia, Andrew Kenneth Burroughs. (2008) Efficacy of Loco-Regional Ablation Therapy of HCC in a Population of Liver Transplanted Patients. Digestive Diseases and Sciences 53:4, 1131-1137
CrossRef748
Shin Hwang, Sung-Gyu Lee, Young-Joo Lee, Chul-Soo Ahn, Ki-Hun Kim, Kwang-Min Park, Ki-Myung Moon, Deok-Bog Moon, Tae-Yong Ha, Eun-Sil Yu, Ga-Won Choi. (2008) Prognostic Impact of Sarcomatous Change of Hepatocellular Carcinoma in Patients Undergoing Liver Resection and Liver Transplantation. Journal of Gastrointestinal Surgery 12:4, 718-724
CrossRef749
J. Belghiti, B. I. Carr, P. D. Greig, R. Lencioni, R. T. Poon. (2008) Treatment before Liver Transplantation for HCC. Annals of Surgical Oncology 15:4, 993-1000
CrossRef750
F. Di Benedetto, N. De Ruvo, M. Berretta, M. Masetti, R. Montalti, S. Di Sandro, R. Ballarin, M. Codeluppi, G. Guaraldi, G.E. Gerunda. (2008) Hepatocellular carcinoma in HIV patients treated by liver transplantation. European Journal of Surgical Oncology (EJSO) 34:4, 422-427
CrossRef751
Albert C. Y. Chan, Ronnie T. P. Poon, Kelvin K. C. Ng, Chung Mau Lo, Sheung Tat Fan, John Wong. (2008) Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening. Annals of Surgery 247:4, 666-673
CrossRef752
Sunil Krishnan, Laura A. Dawson, Jinsil Seong, Yasuyuki Akine, Sam Beddar, Tina M. Briere, Christopher H. Crane, Francoise Mornex. (2008) Radiotherapy for Hepatocellular Carcinoma: An Overview. Annals of Surgical Oncology 15:4, 1015-1024
CrossRef753
Eddie K. Abdalla, Alban Denys, Kiyoshi Hasegawa, Thomas W. T. Leung, Masatoshi Makuuchi, Ravi Murthy, Dario Ribero, Daria Zorzi, Jean-Nicolas Vauthey, Guido Torzilli. (2008) Treatment of Large and Advanced Hepatocellular Carcinoma. Annals of Surgical Oncology 15:4, 979-985
CrossRef754
Philip Rosenthal. (2008) Hepatocarcinoma in Viral and Metabolic Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 46:4, 370-375
CrossRef755
Michael Adler, Filip De Pauw, Pierre Vereerstraeten, Agnese Fancello, Jan Lerut, Peter Starkel, Hans Van Vlierberghe, Roberto Troisi, Vincent Donckier, Olivier Detry, Jean Delwaide, Peter Michielsen, Thierry Chapelle, Jacques Pirenne, Frederik Nevens. (2008) Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transplantation 14:4, 526-533
CrossRef756
J. Ignacio Herrero, Bruno Sangro, Fernando Pardo, Jorge Quiroga, Mercedes Iñarrairaegui, Fernando Rotellar, Custodia Montiel, Felix Alegre, Jesus Prieto. (2008) Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transplantation 14:3, 272-278
CrossRef757
Aiman Obed, Tung-Yu Tsui, Andreas A. Schnitzbauer, Manal Obed, Hans J. Schlitt, Heinz Becker, Thomas Lorf. (2008) Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?. Langenbeck's Archives of Surgery 393:2, 141-147
CrossRef758
Ting-Bo Liang, Dong-Lin Li, Liang Liang, Jun-Jian Li, Xue-Li Bai, Wei Yu, Wei-Lin Wang, Yan Shen, Min Zhang, Shu-Sen Zheng. (2008) Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: Efficiency of Leukocyte Depletion Filters in the Removal of Tumor Cells. Transplantation 85:6, 863-869
CrossRef759
M.E. Schwartz, F. D'Amico, A. Vitale, S. Emre, U. Cillo. (2008) Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?. European Journal of Surgical Oncology (EJSO) 34:3, 256-262
CrossRef760
M.B. Nicholl, A.J. Bilchik. (2008) Thermal ablation of hepatic malignancy: Useful but still not optimal. European Journal of Surgical Oncology (EJSO) 34:3, 318-323
CrossRef761
Jung Im Kim, Jeong Min Lee, Jin Young Choi, Young Kon Kim, Se Hyung Kim, Jae Young Lee, Joon Koo Han, Byung Ihn Choi. (2008) The Value of Gadobenate Dimeglumine-Enhanced Delayed Phase MR Imaging for Characterization of Hepatocellular Nodules in the Cirrhotic Liver. Investigative Radiology 43:3, 202-210
CrossRef762
Beom Kyung Kim, Kwang Hyub Han, Young Nyun Park, Mi Suk Park, Kyung Sik Kim, Jin Sub Choi, Byung Soo Moon, Chae Yoon Chon, Young Myoung Moon, Sang Hoon Ahn. (2008) Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. Journal of Surgical Oncology 97:3, 246-252
CrossRef763
Richard B. Freeman. (2008) Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card. Hepatology 47:3, 1052-1057
CrossRef764
Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uchiyama, Yo-Ichi Yamashita, Yoshihiko Maehara. (2008) Liver transplantation for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 15:2, 124-130
CrossRef765
Robert Pfitzmann, Natascha C. Nüssler, Michael Hippler-Benscheidt, Ruth Neuhaus, Peter Neuhaus. (2008) Long-term results after liver transplantation. Transplant International 21:3, 234-246
CrossRef766
John P. Duffy, Jonathan R. Hiatt, Ronald W. Busuttil. (2008) Surgical Resection of Hepatocellular Carcinoma. The Cancer Journal 14:2, 100-110
CrossRef767
Umberto Baccarani, Miriam Isola, Gian L. Adani, Enrico Benzoni, Claudio Avellini, Dario Lorenzin, Fabrizio Bresadola, Alessandro Uzzau, Andrea Risaliti, Antonio P. Beltrami, Franca Soldano, Dino De Anna, Vittorio Bresadola. (2008) Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transplant International 21:3, 247-254
CrossRef768
Jean-Luc Raoul. (2008) Natural History of Hepatocellular Carcinoma and Current Treatment Options. Seminars in Nuclear Medicine 38:2, S13-S18
CrossRef769
Zhen Fan Yang, Patricia Ngai, David W. Ho, Wan Ching Yu, Michael N.P. Ng, Chi Keung Lau, Mandy L. Y. Li, Ka Ho Tam, Chi Tat Lam, Ronnie T. P. Poon, Sheung Tat Fan. (2008) Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47:3, 919-928
CrossRef770
Zhen Fan Yang, David W. Ho, Michael N. Ng, Chi Keung Lau, Wan Ching Yu, Patricia Ngai, Patrick W.K. Chu, Chi Tat Lam, Ronnie T.P. Poon, Sheung Tat Fan. (2008) Significance of CD90+ Cancer Stem Cells in Human Liver Cancer. Cancer Cell 13:2, 153-166
CrossRef771
G. B. Klintmalm. (2008) Primum Non Nocere. American Journal of Transplantation 8:2, 275-276
CrossRef772
Gi-Hong Choi, Dong-Hyun Kim, Chang-Moo Kang, Kyung-Sik Kim, Jin-Sub Choi, Woo-Jung Lee, Byong-Ro Kim. (2008) Prognostic Factors and Optimal Treatment Strategy for Intrahepatic Nodular Recurrence After Curative Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 15:2, 618-629
CrossRef773
Michael L. Volk, Jorge A. Marrero. (2008) Early detection of liver cancer: Diagnosis and management. Current Gastroenterology Reports 10:1, 60-66
CrossRef774
Jean-Bernard Otte. (2008) Should the selection of children with hepatocellular carcinoma be based on Milan criteria?. Pediatric Transplantation 12:1, 1-3
CrossRef775
Richard Todd Stravitz, Douglas M. Heuman, Nisha Chand, Richard K. Sterling, Mitchell L. Shiffman, Velimir A. Luketic, Arun J. Sanyal, Adil Habib, Anastasios A. Mihas, Ho-Chong S. Giles, Daniel G. Maluf, Adrian H. Cotterell, Marc P. Posner, Robert A. Fisher. (2008) Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome. The American Journal of Medicine 121:2, 119-126
CrossRef776
Clifford S. Cho, Mithat Gonen, Jinru Shia, Michael W. Kattan, David S. Klimstra, William R. Jarnagin, Michael I. D’Angelica, Leslie H. Blumgart, Ronald P. DeMatteo. (2008) A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular Carcinoma. Journal of the American College of Surgeons 206:2, 281-291
CrossRef777
Sinasi Sevmis, Hamdi Karakayali, Figen Özçay, Oğuz Canan, Banu Bilezikci, Adnan Torgay, Mehmet Haberal. (2008) Liver transplantation for hepatocellular carcinoma in children. Pediatric Transplantation 12:1, 52-56
CrossRef778
Roberto Mazzanti, Laura Gramantieri, Luigi Bolondi. (2008) Hepatocellular carcinoma: Epidemiology and clinical aspects. Molecular Aspects of Medicine 29:1-2, 130-143
CrossRef779
Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, Lewis R Roberts. (2008) Treatment options for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2:1, 81-92
CrossRef780
Nyingi Kemmer, Guy Neff, Michelle Secic, Victoria Zacharias, Tiffany Kaiser, Joseph Buell. (2008) Ethnic Differences in Hepatocellular Carcinoma: Implications for Liver Transplantation. Digestive Diseases and Sciences 53:2, 551-555
CrossRef781
Jaime Aranda-Michel, Rolland C. Dickson, Hugo Bonatti, John R. Crossfield, Andrew P. Keaveny, Adriana R. Vasquez. (2008) Patient Selection for Liver Transplant: 1-Year Experience With 555 Patients at a Single Center. Mayo Clinic Proceedings 83:2, 165-168
CrossRef782
Gennaro Selvaggi. (2008) Patient Selection in Liver Transplant: When Is It the Right Time to List?. Mayo Clinic Proceedings 83:2, 140-142
CrossRef783
J. Aranda-Michel, R. C. Dickson, H. Bonatti, J. R. Crossfield, A. P. Keaveny, A. R. Vasquez. (2008) Patient Selection for Liver Transplant: 1-Year Experience With 555 Patients at a Single Center. Mayo Clinic Proceedings 83:2, 165-168
CrossRef784
G. Selvaggi. (2008) Patient Selection in Liver Transplant: When Is It the Right Time to List?. Mayo Clinic Proceedings 83:2, 140-142
CrossRef785
Amir Abrishami, Siavosh Nasseri-Moghaddam, Bijan Eghtesad, Morris Sherman, Amir Abrishami. 2008. Surgical resection for hepatocellular carcinoma. .
CrossRef786
William C. Chapman, M B. Majella Doyle, Jourdan E. Stuart, Neeta Vachharajani, Jeffrey S. Crippin, Christopher D. Anderson, Jeffrey A. Lowell, Surendra Shenoy, Michael D. Darcy, Daniel B. Brown. (2008) Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation. Transactions of the ... Meeting of the American Surgical Association 126, 260-268
CrossRef787
See Ching Chan, Sheung Tat Fan, Chung Mau Lo, Chi Leung Liu, William I. Wei, Barbara Hsia-Ying Chik, John Wong. (2008) A Decade of Right Liver Adult-to-Adult Living Donor Liver Transplantation. Transactions of the ... Meeting of the American Surgical Association 126, 61-69
CrossRef788
Se Hyung Kim, Byung Ihn Choi, Jae Young Lee, Soo Jin Kim, Young Ho So, Hyo Won Eun, Jeong Min Lee, Joon Koo Han. (2008) Diagnostic Accuracy of Multi-/Single-Detector Row CT and Contrast-Enhanced MRI in the Detection of Hepatocellular Carcinomas Meeting the Milan Criteria before Liver Transplantation. Intervirology 51:1, 52-60
CrossRef789
Toru IKEGAMI, Mitsuo SHIMADA, Yuji MORINE, Satoru IMURA, Hirofumi KANEMURA, Akira NII. (2008) A CASE OF FAR ADVANCED HEPATOCELLULAR CARCINOMA, TREATED BY MULTIDISCIPLINARY TREATMENT STRATEGY INCLUDING IFN/FP CHEMOTHERAPY AND LIVER TRANSPLANTATION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 69:6, 1475-1480
CrossRef790
Kyung-Suk Suy, Nam-Joon Yi. (2008) Indication and Outcome of Liver Transplantation In Patients with Hepatocellular Carcinoma. Journal of the Korean Medical Association 51:8, 708
CrossRef791
Si Hyun Bae. (2008) Up-to-date Information for Hepatocellular Carcinoma Treatment. Journal of the Korean Medical Association 51:5, 457
CrossRef792
Masatoshi Makuuchi, Norihiro Kokudo, Shigeki Arii, Shunji Futagawa, Shuichi Kaneko, Seiji Kawasaki, Yutaka Matsuyama, Masatoshi Okazaki, Kiwamu Okita, Masao Omata, Yukihisa Saida, Tadatoshi Takayama, Yoshio Yamaoka. (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatology Research 38:1, 37-51
CrossRef793
Nevin Yilmaz, Mitchell L. Shiffman, R. Todd Stravitz, Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, Daniel Maluf, Adrian Coterell, Marc P. Posner, Robert A. Fisher. (2008) Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years. Liver International 28:1, 72-78
CrossRef794
Monika Lanthaler, Matthias Biebl, Annemarie Weissenbacher, Raimund Margreiter, Hermann Nehoda. (2008) Recurrence after Liver Resection for Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients. Chirurgische Gastroenterologie 24:1, 51-54
CrossRef795
Shin Hwang, Deok-Bog Moon, Sung-Gyu Lee. (2008) Current Status and Perspectives of Living Donor Liver Transplantation. Journal of the Korean Medical Association 51:8, 700
CrossRef796
Abby B Siegel, Russell B McBride, Hashem B El-Serag, Dawn L Hershman, Robert S Brown, John F Renz, Jean Emond, Alfred I Neugut. (2008) Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002. The American Journal of Gastroenterology 103:1, 120-127
CrossRef797
Robert M. Eisele, Guido Schumacher, Sven Jonas, Peter Neuhaus. (2008) Radiofrequency ablation prior to liver transplantation: focus on complications and on a rare but severe case. Clinical Transplantation 22:1, 20-28
CrossRef798
Takahito Yagi. (2008) Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 120:1, 63-67
CrossRef799
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Guang-Ming Tan, Ka-Ian Ip, Wing-Kwan Lai, Yuk-Wah Li, Mercedes Shun-Chi Mak, Paul Bo-San Lai, Joseph Jao-Yiu Sung, Henry Lik-Yuen Chan. (2008) Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver International 28:1, 79-87
CrossRef800
Joseph F. Buell, Mark T. Thomas, Steven Rudich, Michael Marvin, Ravi Nagubandi, Kadiyala V. Ravindra, Guy Brock, Kelly M. McMasters. (2008) Experience With More Than 500 Minimally Invasive Hepatic Procedures. Transactions of the ... Meeting of the American Surgical Association 126, 125-136
CrossRef801
Yoichi Ishizaki, Seiji Kawasaki. (2008) The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). Journal of Gastroenterology 43:1, 18-26
CrossRef802
Hui Xu, Jing-Xia Xie, Xuan Li, Zheng-Han Yang, Zhuo-Zhao Zheng, Bin Wang, Zheng Wang. (2008) Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model. Journal of Magnetic Resonance Imaging 27:1, 102-109
CrossRef803
Siu Tim Cheung, Sheung Tat Fan, Yuk Ting Lee, Jeremy P. Chow, Irene O. Ng, Daniel Y. Fong, Chung Mau Lo. (2008) Albumin mRNA in Plasma Predicts Post-Transplant Recurrence of Patients With Hepatocellular Carcinoma. Transplantation 85:1, 81-87
CrossRef804
Mark W Russo. (2007) Current concepts in the evaluation of patients for liver transplantation. Expert Review of Gastroenterology & Hepatology 1:2, 307-320
CrossRef805
Espen Melum, Styrbjörn Friman, Kristian Bjøro, Allan Rasmussen, Helena Isoniemi, Henrik Gjertsen, Lars Bäckman, Antti Oksanen, Michael Olausson, Frans F. Duraj, Bo-Göran Ericzon. (2007) Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. Journal of Hepatology 47:6, 777-783
CrossRef806
A. Lubienski, M. Simon, K. Lubienski, J. Gellissen, R.-T. Hoffmann, T.F. Jakobs, T. Helmberger. (2007) Update Chemoperfusion und -embolisation. Der Radiologe 47:12, 1097-1108
CrossRef807
Noriyo Yamashiki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Takuma Teratani, Hideo Yoshida, Yuji Kondo, Takamasa Oki, Takao Kawabe, Masao Omata. (2007) Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Journal of Gastroenterology and Hepatology 22:12, 2155-2160
CrossRef808
Takashi Ito, Yasutsugu Takada, Mikiko Ueda, Hironori Haga, Yoji Maetani, Fumitaka Oike, Kohei Ogawa, Seisuke Sakamoto, Yasuhiro Ogura, Hiroto Egawa, Koichi Tanaka, Shinji Uemoto. (2007) Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transplantation 13:12, 1637-1644
CrossRef809
T.F. Jakobs, R.-T. Hoffmann, K. Tatsch, C. Trumm, M.F. Reiser, T.K. Helmberger. (2007) Entwicklungen und Perspektiven radioablativer Verfahren. Der Radiologe 47:12, 1083-1088
CrossRef810
Nishita Kothary, Joshua L. Weintraub, Jonathan Susman, John H. Rundback. (2007) Transarterial Chemoembolization for Primary Hepatocellular Carcinoma in Patients at High Risk. Journal of Vascular and Interventional Radiology 18:12, 1517-1526
CrossRef811
Christopher J. Sonnenday, Justin B. Dimick, Richard D. Schulick, Michael A. Choti. (2007) Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 11:12, 1636-1646
CrossRef812
Vincenzo Mazzaferro. (2007) Results of liver transplantation: With or without milan criteria?. Liver Transplantation 13:S2, S44-S47
CrossRef813
Satoru Todo, Hiroyuki Furukawa, Mitsuhiro Tada, . (2007) Extending indication: Role of living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 13:S2, S48-S54
CrossRef814
Kojiro Taura, Iwao Ikai, Etsuro Hatano, Kentaro Yasuchika, Akio Nakajima, Masaharu Tada, Satoru Seo, Takafumi Machimoto, Shinji Uemoto. (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: An analysis of 293 patients. Surgery 142:5, 685-694
CrossRef815
Julio D. Vorobioff. (2007) Hepatic Venous Pressure in Practice. Journal of Clinical Gastroenterology 41:Supplement 3, S336-S343
CrossRef816
Georgios C. Sotiropoulos, Hauke Lang, Silvio Nadalin, Markus Neuhäuser, Ernesto P. Molmenti, Hideo A. Baba, Andreas Paul, Fuat H. Saner, Frank Weber, Philipp Hilgard, Andrea Frilling, Christoph E. Broelsch, Massimo Malagó. (2007) Liver Transplantation for Hepatocellular Carcinoma: University Hospital Essen Experience and Metaanalysis of Prognostic Factors. Journal of the American College of Surgeons 205:5, 661-675
CrossRef817
S. R. Knight, P. J. Friend, P. J. Morris. (2007) Role of transplantation in the management of hepatic malignancy. British Journal of Surgery 94:11, 1319-1330
CrossRef818
Pietro Majno, Emiliano Giostra, Gilles Mentha. (2007) Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?. Liver Transplantation 13:S2, S27-S35
CrossRef819
Todd C Schirmang, Damian E Dupuy. (2007) Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip™ radiofrequency ablation system. Expert Review of Medical Devices 4:6, 803-814
CrossRef820
P BORENTAIN, V GEROLAMI, P ANANIAN, S GARCIA, A NOUNDOU, D BOTTAFRIDLUND, Y LETREUT, J BERGELEFRANC, R GEROLAMI. (2007) DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. European Journal of Cancer 43:17, 2479-2486
CrossRef821
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth C. Yanek, Robert A. Fisher. (2007) Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 84:10, 1262-1271
CrossRef822
Shinji Yamamoto, Henryk E. Wilczek, Takashi Iwata, Marie Larsson, Henrik Gjertsen, Gunnar Söderdahl, Göran Solders, Bo-Göran Ericzon. (2007) Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts. Transplant International 20:11, 926-933
CrossRef823
F. Y. Yao, L. Xiao, N. M. Bass, R. Kerlan, N. L. Ascher, J. P. Roberts. (2007) Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF-Expanded Criteria Based on Preoperative Imaging. American Journal of Transplantation 7:11, 2587-2596
CrossRef824
Tae Hoon Lee, Nilay Shah, Rachel A. Pedersen, Walter K. Kremers, Charles B. Rosen, Goran B. Klintmalm, W. Ray Kim. (2007) Survival after liver transplantation: Is racial disparity inevitable?. Hepatology 46:5, 1491-1497
CrossRef825
M BORZIO, G COLLOREDO, P PIOLTELLI, M QUAGLIUOLO. (2007) Epidemiology and outcome of hepatocellular carcinoma in Lombardy. Digestive and Liver Disease 39:11, 1011-1017
CrossRef826
Franco Trevisani, Valentina Santi, Annagiulia Gramenzi, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gianludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Mauro Bernardi, . (2007) Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis?. The American Journal of Gastroenterology 102:11, 2448-2457
CrossRef827
Kayvan Roayaie, Sandy Feng. (2007) Allocation policy for hepatocellular carcinoma in the MELD era: Room for improvement?. Liver Transplantation 13:S2, S36-S43
CrossRef828
François Durand, Jacques Belghiti, Valérie Paradis. (2007) Liver transplantation for hepatocellular carcinoma: Role of biopsy. Liver Transplantation 13:S2, S17-S23
CrossRef829
N. SNOWBERGER, S. CHINNAKOTLA, R. M. LEPE, J. PEATTIE, R. GOLDSTEIN, G. B. KLINTMALM, G. L. DAVIS. (2007) Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Alimentary Pharmacology & Therapeutics 26:9, 1187-1194
CrossRef830
Rebecca Kristeleit, Yujo Chua, David Cunningham. 2007. Multidisciplinary Team Management of Upper Gastrointestinal, Hepatic, Pancreatic, and Biliary Cancers. .
CrossRef831
Jean-Bernard Otte. (2007) Should the selection of children with hepatocellular carcinoma be based on Milan criteria?. Pediatric Transplantationno-no
CrossRef832
Laura M. Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. (2007) Emerging Approaches in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 41:9, 839-854
CrossRef833
Mercedes Iñarrairaegui, Bruno Sangro. (2007) Diagnóstico del hepatocarcinoma de pequeño tamaño. Gastroenterología y Hepatología 30:8, 498-505
CrossRef834
A DIAZSANCHEZ. (2007) Factores pronósticos en pacientes con carcinoma hepatocelular desestimado para tratamiento. Gastroenterología y Hepatología 30:8, 441-448
CrossRef835
Sakae Nagaoka, Takafumi Yoshida, Junji Akiyoshi, Jun Akiba, Takuji Torimura, Hisashi Adachi, Junichi Kurogi, Nobuyoshi Tajiri, Kinya Inoue, Takashi Niizeki, Hironori Koga, Tsutomu Imaizumi, Masamichi Kojiro, Michio Sata. (2007) Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver International 27:8, 1091-1097
CrossRef836
A. Kornberg, B. Küpper, A. Tannapfel, K. Thrum, J. Wilberg, E. Bärthel, U. Settmacher. (2007) Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma – preliminary results. Transplant International 0:0, 071012050037002-???
CrossRef837
A. H. Stockland, E. M. Walser, R. Paz-Fumagalli, J. M. McKinney, G. R. May. (2007) Preoperative Chemoembolization in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Influence of Emergent Versus Elective Procedures on Patient Survival and Tumor Recurrence Rate. CardioVascular and Interventional Radiology 30:5, 888-893
CrossRef838
Shimul A. Shah, Sean P. Cleary, Jensen C. C. Tan, Alice C. Wei, Steve Gallinger, David R. Grant, Paul D. Greig. (2007) An Analysis of Resection vs Transplantation for Early Hepatocellular Carcinoma: Defining the Optimal Therapy at a Single Institution. Annals of Surgical Oncology 14:9, 2608-2614
CrossRef839
John F. Perry, Barbara Charlton, David J. Koorey, Richard C. Waugh, P. James Gallagher, Michael D. Crawford, Deborah J. Verran, Geoffrey W. McCaughan, Simone I. Strasser. (2007) Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International 0:0, 070908015728001-???
CrossRef840
Francis Y. Yao. (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S267-S274
CrossRef841
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas Bak, Jeffrey Campsen, Franklin Wright, Tracy Steinberg, William Bennett, Igal Kam. (2007) Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transplant International 20:9, 747-753
CrossRef842
Sheung Tat Fan. (2007) Live-donor liver transplantation for hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S275-S276
CrossRef843
Patricia M. Lopez, Pruthvi Patel, Pablo Uva, Augusto Villanueva, Josep M. Llovet. (2007) Current management of liver cancer. European Journal of Cancer Supplements 5:5, 444-446
CrossRef844
L.A. Kondili, A. Lala, B. Gunson, S. Hubscher, S. Olliff, E. Elias, S. Bramhall, D. Mutimer. (2007) Primary hepatocellular cancer in the explanted liver: Outcome of transplantation and risk factors for HCC recurrence. European Journal of Surgical Oncology (EJSO) 33:7, 868-873
CrossRef845
Massimo Colombo. (2007) Screening. Hepatology Research 37:s2 Fourth JSH S, S146-S151
CrossRef846
Shuichiro Shiina. (2007) Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S223-S229
CrossRef847
John P. Duffy, Andrew Vardanian, Elizabeth Benjamin, Melissa Watson, Douglas G. Farmer, Rafik M. Ghobrial, Gerald Lipshutz, Hasan Yersiz, David S. K. Lu, Charles Lassman, Myron J. Tong, Jonathan R. Hiatt, Ronald W. Busuttil. (2007) Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded. Annals of Surgery 246:3, 502-511
CrossRef848
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. (2007) New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine 45:9, 1169-1179
CrossRef849
Fabio Piscaglia, Luigi Bolondi. (2007) Recent advances in the diagnosis of hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S178-S192
CrossRef850
Alastair L. Young, Hassan Z. Malik, Mohammed Abu-Hilal, J. Ashley Guthrie, Judy Wyatt, K. Rajendra Prasad, Giles J. Toogood, J. Peter A. Lodge. (2007) Large Hepatocellular Carcinoma: Time to Stop Preoperative Biopsy. Journal of the American College of Surgeons 205:3, 453-462
CrossRef851
Umut Sarpel, Myron Schwartz. (2007) Liver transplantation for hepatocellular carcinoma. Hepatology Research 37:s2 Fourth JSH S, S264-S266
CrossRef852
Mona Beaunoyer, Jason M. Vanatta, Makoto Ogihara, Debra Strichartz, Gary Dahl, William E. Berquist, Ricardo O. Castillo, Kenneth L. Cox, Carlos O. Esquivel. (2007) Outcomes of transplantation in children with primary hepatic malignancy. Pediatric Transplantation 11:6, 655-660
CrossRef853
Eric R. Kallwitz, Scott J. Cotler. (2007) Screening for Hepatocellular Carcinoma in Clinical Practice. Journal of Clinical Gastroenterology 41:8, 729-730
CrossRef854
Thomas A. Aloia, René Adam, Didier Samuel, Daniel Azoulay, Denis Castaing. (2007) A Decision Analysis Model Identifies the Interval of Efficacy for Transarterial Chemoembolization (TACE) in Cirrhotic Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation. Journal of Gastrointestinal Surgery 11:10, 1328-1332
CrossRef855
Pankaj Singh, Richard A. Erickson, Phalguni Mukhopadhyay, Shanthi Gopal, Alex Kiss, Ahmed Khan, T. Ulf Westblom. (2007) EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointestinal Endoscopy 66:2, 265-273
CrossRef856
L. Gellert, B. Jalaludin, M. Levy. (2007) Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Internal Medicine Journal 37:8, 516-522
CrossRef857
D. Koorey. (2007) Hepatocellular carcinoma: prevention, detection and treatment
CrossRef858
Lei Yu, George N. Ioannou. (2007) Survival of Liver Transplant Recipients With Hemochromatosis in the United States. Gastroenterology 133:2, 489-495
CrossRef859
Valerie Byrnes, Hongyu Shi, Shigeru Kiryu, Neil M. Rofsky, Nezam H. Afdhal. (2007) The Clinical Outcome of Small (<20 mm) Arterially Enhancing Nodules on MRI in the Cirrhotic Liver. The American Journal of Gastroenterology 102:8, 1654-1659
CrossRef860
M. Schwartz, S. Roayaie, P. Uva. (2007) Treatment of HCC in Patients Awaiting Liver Transplantation. American Journal of Transplantation 7:8, 1875-1881
CrossRef861
Giulio Belli, Alberto D??Agostino, Corrado Fantini, Luigi Cioffi, Andrea Belli, Nadia Russolillo, Serena Langella. (2007) Laparoscopic Radiofrequency Ablation Combined With Laparoscopic Liver Resection for More Than One HCC on Cirrhosis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 17:4, 331-334
CrossRef862
H. SHEN, D. AGARWAL, R. QI, N. CHALASANI, S. LIANGPUNSAKUL, L. LUMENG, H. YOO, P. KWO. (2007) Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Alimentary Pharmacology & Therapeutics 26:3, 393-400
CrossRef863
Fabio Piscaglia, Alice Gianstefani, Roberto Righini, Luigi Bolondi. (2007) Selecting patients with hepatocellular carcinoma for transplantation. Liver Transplantation 13:8, 1203-1203
CrossRef864
Paul J. Thuluvath. (2007) EUS-guided FNA could be another important tool for the early diagnosis of hepatocellular carcinoma. Gastrointestinal Endoscopy 66:2, 274-276
CrossRef865
Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge, Chigusa Morizane, Masafumi Ikeda, Hideki Ueno, Takuji Okusaka, Yasuaki Arai, Kenichi Takayasu. (2007) Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma. Annals of Surgical Oncology 14:8, 2337-2347
CrossRef866
Yasuharu Imai, Takamichi Murakami, Masatoshi Hori, Kazuto Fukuda, Tonsok Kim, Taro Marukawa, Hisashi Abe, Masatomo Kuwabara, Hiromitu Onishi, Kyo Tsuda, Yoshiyuki Sawai, Masanori Kurokawa, Norio Hayashi, Morito Monden, Hironobu Nakamura. (2007) Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP. Hepatology Research 0:0, 070720190824002-???
CrossRef867
Konrad Schoppmeyer, Anna Dorothea ADW Wagner, Joachim Mössner, Wolfgang E. Fleig, Konrad Schoppmeyer. 2007. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. .
CrossRef868
Robin D. Kim, Alan I. Reed, Shiro Fujita, David P. Foley, Kristin L. Mekeel, Alan W. Hemming. (2007) Consensus and Controversy in the Management of Hepatocellular Carcinoma. Journal of the American College of Surgeons 205:1, 108-123
CrossRef869
Myron Schwartz, Sasan Roayaie, Manousos Konstadoulakis. (2007) Strategies for the management of hepatocellular carcinoma. Nature Clinical Practice Oncology 4:7, 424-432
CrossRef870
Shigeru Marubashi, Keizo Dono, Hiroaki Nagano, Yukari Sugita, Tadafumi Asaoka, Naoki Hama, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Morito Monden. (2007) Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation. Transplant International 20:7, 576-582
CrossRef871
J. W. JANG, J. Y. CHOI, S. H. BAE, C. W. KIM, S. H. CHO, S. K. YOON, J. M. YANG, J. Y. HAN, Y. S. LEE, D. G. KIM. (2007) The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times. Alimentary Pharmacology & Therapeutics 26:1, 87-94
CrossRef872
Salleh Ibrahim, Anupama Roychowdhury, Tay Khoon Hean. (2007) Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. The American Journal of Surgery 194:1, 17-22
CrossRef873
C LO. (2007) Editorial on “A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor liver transplantation in hepatocellular carcinoma”. Surgery 142:1, 119-120
CrossRef874
Hiroshi Wada, Hiroaki Nagano, Takehiro Noda, Bazarragchaa Damdinsuren, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Keizo Dono, Masato Sakon, Kenichi Wakasa, Morito Monden. (2007) Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-α combination therapy following hepatic resection. Journal of Gastroenterology 42:6, 501-506
CrossRef875
Robert A. Fisher, Daniel G. Maluf, Luke Wolfe, Bridgette Williams, Adrian Cotterell, R. Todd Stravitz, Douglas Heuman, Marc Posner. (2007) Is hepatic transplantation justified for primary liver cancer?. Journal of Surgical Oncology 95:8, 674-679
CrossRef876
Pierre-A Clavien. (2007) Interferon. Annals of Surgery 245:6, 843-845
CrossRef877
R. A. Fisher, L. M. Kulik, C. E. Freise, A. S. F. Lok, T. H. Shearon, R. S. Brown, R. M. Ghobrial, J. H. Fair, K. M. Olthoff, I. Kam, C. L. Berg, . (2007) Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation. American Journal of Transplantation 7:6, 1601-1608
CrossRef878
Adel Bozorgzadeh, Mark Orloff, Peter Abt, Georgios Tsoulfas, Durald Younan, Randeep Kashyap, Ashok Jain, Parvez Mantry, Benedict Maliakkal, Alok Khorana, Seymour Schwartz. (2007) Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transplantation 13:6, 807-813
CrossRef879
Sven Jonas, Jens Mittler, Andreas Pascher, Guido Schumacher, Tom Theruvath, Christoph Benckert, Birgit Rudolph, Peter Neuhaus. (2007) Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transplantation 13:6, 896-903
CrossRef880
S. D. Chao, J. P. Roberts, M. Farr, F. Y. Yao. (2007) Short Waitlist Time Does Not Adversely Impact Outcome Following Liver Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 7:6, 1594-1600
CrossRef881
Fabio Piscaglia, Valeria Camaggi, Matteo Ravaioli, Gian Luca Grazi, Matteo Zanello, Simona Leoni, Giorgio Ballardini, Giulia Cavrini, Antonio Daniele Pinna, Luigi Bolondi. (2007) A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transplantation 13:6, 857-866
CrossRef882
Francis Y. Yao. (2007) Liver transplantation for hepatocellular carcinoma: The hepatitis C quandary. Liver Transplantation 13:6, 783-785
CrossRef883
N. Girard, F. Mornex, C. Trepo, P. Merle. (2007) Place de la radiothérapie dans la stratégie de traitement du carcinome hépatocellulaire. Oncologie 9:6, 482-486
CrossRef884
Yesim Erim, Mingo Beckmann, Sylvia Kroencke, Camino Valentin-Gamazo, Massimo Malago, Dieter Broering, Xavier Rogiers, Andrea Frilling, Christoph E. Broelsch, Karl-Heinz Schulz. (2007) Psychological strain in urgent indications for living donor liver transplantation. Liver Transplantation 13:6, 886-895
CrossRef885
Yagil Barazani, Jonathan R. Hiatt, Myron J. Tong, Ronald W. Busuttil. (2007) Chronic Viral Hepatitis and Hepatocellular Carcinoma. World Journal of Surgery 31:6, 1245-1250
CrossRef886
Florian Löhe, Martin K Angele, Markus Rentsch, Christian Graeb, Alexander Gerbes, Udo Löhrs, Ulrich Beuers, Karl-Walter Jauch. (2007) Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Clinical Transplantation 0:0, 070508211755005-???
CrossRef887
Sébastien Dharancy, Jeanne Boitard, Thomas Decaens, Géraldine Sergent, Emmanuel Boleslawski, Christophe Duvoux, Claire Vanlemmens, Carole Meyer, Jean Gugenheim, François Durand, Olivier Boillot, Nicole Declerck, Alexandre Louvet, Valérie Canva, Olivier Romano, Olivier Ernst, Philippe Mathurin, François René Pruvot. (2007) Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: A case-control study. Liver Transplantation 13:5, 665-671
CrossRef888
Thomas Soliman, Hubert Hetz, Christoph Burghuber, Georg Györi, Gerd Silberhumer, Rudolf Steininger, Ferdinand Mühlbacher, Gabriela A. Berlakovich. (2007) Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation. Transplant International 20:5, 447-452
CrossRef889
Adnan Said, Michael Einstein, Michael R Lucey. (2007) Liver transplantation: an update 2007. Current Opinion in Gastroenterology 23:3, 292-298
CrossRef890
Maximilian Schmeding, Ulf Peter Neumann, Gero Puhl, Marcus Bahra, Ruth Neuhaus, Peter Neuhaus. (2007) Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: A single-center study of 289 patients. Liver Transplantation 13:5, 687-692
CrossRef891
Franco Trevisani, Giulia Magini, Valentina Santi, Antonio Maria Morselli-Labate, Maria Chiara Cantarini, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gianludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Mauro Bernardi, . (2007) Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance. CME. The American Journal of Gastroenterology 102:5, 1022-1031
CrossRef892
Yuichiro Otsuka, John P. Duffy, Sammy Saab, Douglas G. Farmer, Rafik M. Ghobrial, Jonathan R. Hiatt, Ronald W. Busuttil. (2007) Postresection hepatic failure: Successful treatment with liver transplantation. Liver Transplantation 13:5, 672-679
CrossRef893
Claudia E. Falkensammer, Hugo Bonatti, Juergen Falkensammer, Jaime Aranda-Michel, Rolland C. Dickson, Kelly Norman, Ronald Hinder, Thomas Gonwa, Jeffrey Steers, Winston Hewitt, Justin H. Nguyen. (2007) Combined liver transplantation together with partial/total nephrectomy in patients with renal cell cancer and nonalcoholic steatohepatitis. Transplant International 20:5, 471-472
CrossRef894
Ye Htun Oo, James Neuberger. (2007) Recurrence of Nonviral Diseases. Clinics in Liver Disease 11:2, 377-395
CrossRef895
Aijaz Ahmed, Emmet B. Keeffe. (2007) Current Indications and Contraindications for Liver Transplantation. Clinics in Liver Disease 11:2, 227-247
CrossRef896
Sung Hoon Yang, Kyung-Suk Suh, Hae Won Lee, Eung-Ho Cho, Jai Young Cho, Yong Beom Cho, In Hwan Kim, Nam-Joon Yi, Kuhn Uk Lee. (2007) A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery 141:5, 598-609
CrossRef897
Richard B. Freeman. (2007) The Model for End-stage Liver Disease Comes of Age. Clinics in Liver Disease 11:2, 249-263
CrossRef898
Christian Toso, Glenda A. Meeberg, David L. Bigam, Jose Oberholzer, A M. James Shapiro, Klaus Gutfreund, Mang M. Ma, Andrew L. Mason, Winnie W. S. Wong, Vincent G. Bain, Norman M. Kneteman. (2007) De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects. Transplantation 83:9, 1162-1168
CrossRef899
Jacques Belghiti, François Durand. (2007) Hepatectomy vs. liver transplantation: A combination rather than an opposition. Liver Transplantation 13:5, 636-638
CrossRef900
Silvia Gómez Senent, César Gómez Raposo, José María Segura Cabral. (2007) Guía para el diagnóstico, estadificación y tratamiento del hepatocarcinoma. Medicina Clínica 128:19, 741-748
CrossRef901
Toshiyuki Itamoto, Hideki Nakahara, Hironobu Amano, Toshihiko Kohashi, Hideki Ohdan, Hirotaka Tashiro, Toshimasa Asahara. (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:5, 589-597
CrossRef902
Jean-Nicolas Vauthey, Dario Ribero, Eddie K. Abdalla, Sven Jonas, Ankit Bharat, Guido Schumacher, Jan Lerut, William C. Chapman, Alan W. Hemming, Peter Neuhaus. (2007) Outcomes of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment. Journal of the American College of Surgeons 204:5, 1016-1027
CrossRef903
S. R. Alberts, G. J. Gores, G. P. Kim, L. R. Roberts, M. L. Kendrick, C. B. Rosen, S. T. Chari, J. A. Martenson. (2007) Treatment Options for Hepatobiliary and Pancreatic Cancer. Mayo Clinic Proceedings 82:5, 628-637
CrossRef904
Teck Joo Kelvin Thia, Hock Foong Lui, Lucien London Ooi, Yaw Fui Chung, Pierce Kah-Hoe Chow, Peng Chung Cheow, Yu Meng Tan, Wan Cheng Chow. (2007) A Study Into the Risk of Exacerbation of Chronic Hepatitis B After Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 11:5, 612-618
CrossRef905
Shimul A. Shah, Alice C. Wei, Sean P. Cleary, Ilun Yang, Ian D. McGilvray, Steven Gallinger, David R. Grant, Paul D. Greig. (2007) Prognosis and Results After Resection of Very Large (≥10 cm) Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 11:5, 589-595
CrossRef906
Shimul A. Shah, Jensen C. C. Tan, Ian D. McGilvray, Mark S. Cattral, Gary A. Levy, Paul D. Greig, David R. Grant. (2007) Does Microvascular Invasion Affect Outcomes After Liver Transplantation for HCC? A Histopathological Analysis of 155 Consecutive Explants. Journal of Gastrointestinal Surgery 11:4, 464-471
CrossRef907
Yong Beom Cho, Kuhn Uk Lee, Hae Won Lee, Eung-Ho Cho, Sung-Hoon Yang, Jai Young Cho, Nam-Joon Yi, Kyung-Suk Suh. (2007) Outcomes of Hepatic Resection for a Single Large Hepatocellular Carcinoma. World Journal of Surgery 31:4, 795-801
CrossRef908
Xiaofeng Wu, Jia Fan, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Yao Yu, Yinkun Liu, Zhaoyou Tang. (2007) Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochemical and Biophysical Research Communications 355:4, 866-871
CrossRef909
U. Cillo, A. Vitale, F. Grigoletto, E. Gringeri, F. D'Amico, M. Valmasoni, A. Brolese, G. Zanus, N. Srsen, A. Carraro, P. Burra, F. Farinati, P. Angeli, D. F. D'Amico. (2007) Intention-to-Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria. American Journal of Transplantation 7:4, 972-981
CrossRef910
See Ching Chan, Sheung Tat Fan, Chi Leung Liu, Chung Mau Lo, Banny K. Lam, Evelyn W. Lee. (2007) Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation. Liver Transplantation 13:4, 509-515
CrossRef911
Philippe Rougier, Emmanuel Mitry, Jean-Claude Barbare, Julien Taieb. (2007) Hepatocellular Carcinoma (HCC): An Update. Seminars in Oncology 34, S12-S20
CrossRef912
Jeremy R. Parfitt, Paul Marotta, Mohammed AlGhamdi, William Wall, Anand Khakhar, Neville G. Suskin, Douglas Quan, Vivian McAllister, Cam Ghent, Mark Levstik, Carolyn McLean, Subrata Chakrabarti, Bertha Garcia, David K. Driman. (2007) Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence. Liver Transplantation 13:4, 543-551
CrossRef913
M KAIBORI, T SAITO, Y MATSUI, Y UCHIDA, M ISHIZAKI, Y KAMIYAMA. (2007) A review of the prognostic factors in patients with recurrence after liver resection for hepatocellular carcinoma. The American Journal of Surgery 193:4, 431-437
CrossRef914
Koichi Oishi, Toshiyuki Itamoto, Hironobu Amano, Saburo Fukuda, Hideki Ohdan, Hirotaka Tashiro, Fumio Shimamoto, Toshimasa Asahara. (2007) Clinicopathologic features of poorly differentiated hepatocellular carcinoma. Journal of Surgical Oncology 95:4, 311-316
CrossRef915
Umberto Cillo, Alessandro Vitale, Alberto Brolese, Giacomo Zanus, Daniele Neri, Michele Valmasoni, Pasquale Bonsignore, Francesco Grigoletto, Patrizia Burra, Fabio Farinati, Davide Francesco D'Amico. (2007) Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. Journal of Surgical Oncology 95:3, 213-220
CrossRef916
Yoshiki Asayama, Kengo Yoshimitsu, Hiroyuki Irie, Yunosuke Nishihara, Shinichi Aishima, Tsuyoshi Tajima, Masakazu Hirakawa, Kousei Ishigami, Daisuke Kakihara, Akinobu Taketomi, Hiroshi Honda. (2007) Poorly Versus Moderately Differentiated Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 31:2, 188-192
CrossRef917
C. Christophi. (2007) HEPATOCELLULAR CARCINOMA: IMPLICATIONS OF MICROVASCULAR INVASION AND TUMOUR THROMBI. ANZ Journal of Surgery 77:3, 99-100
CrossRef918
Roberts Brown, Jean C. Emond. (2007) Managing Access to Liver Transplantation: Implications for Gastroenterology Practice. Gastroenterology 132:3, 1152-1163
CrossRef919
Gerd Otto. (2007) Reply: Selection criteria for liver transplantation in patients with hepatocellular carcinoma: Beyond tumor size and number?. Liver Transplantation 13:3, 470-471
CrossRef920
Nicholas Onaca, Gary L. Davis, Robert M. Goldstein, Linda W. Jennings, Göran B. Klintmalm. (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transplantation 13:3, 391-399
CrossRef921
Stephen N. Wong, K. Rajender Reddy, Emmet B. Keeffe, Steven-Huy Han, Paul J. Gaglio, Robert P. Perrillo, Tram T. Tran, Timothy L. Pruett, Anna S.F. Lok, . (2007) Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transplantation 13:3, 334-342
CrossRef922
Ken Shirabe, Shinji Itoh, Tomoharu Yoshizumi, Yuji Soejima, Akinobu Taketomi, Shin-ichi Aishima, Yoshihiko Maehara. (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin. Journal of Surgical Oncology 95:3, 235-240
CrossRef923
Timothy M. Pawlik, Ana L. Gleisner, Robert A. Anders, Lia Assumpcao, Warren Maley, Michael A. Choti. (2007) Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy. Annals of Surgery 245:3, 435-442
CrossRef924
Salleh Ibrahim, Anupama Roychowdhury, Tay Khoon Hean. (2007) RISK FACTORS FOR MICROVASCULAR TUMOUR THROMBI IN HEPATOCELLULAR CARCINOMA: A UNIVARIATE AND MULTIVARIATE ANALYSIS. ANZ Journal of Surgery 77:3, 146-149
CrossRef925
Sameer Parikh, David Hyman. (2007) Hepatocellular Cancer: A Guide for the Internist. The American Journal of Medicine 120:3, 194-202
CrossRef926
M. Rossi, G. Mennini, Q. Lai, S. Ginanni Corradini, F.M. Drudi, F. Pugliese, P.B. Berloco. (2007) Liver transplantation. Journal of Ultrasound 10:1, 28-45
CrossRef927
Shimul A. Shah, Sean P. Cleary, Alice C. Wei, Ilun Yang, Bryce R. Taylor, Alan W. Hemming, Bernard Langer, David R. Grant, Paul D. Greig, Steven Gallinger. (2007) Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes. Surgery 141:3, 330-339
CrossRef928
Gunda Millonig, Ivo W. Graziadei, Martin C. Freund, Werner Jaschke, Sylvia Stadlmann, Ruth Ladurner, Raimund Margreiter, Wolfgang Vogel. (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation 13:2, 272-279
CrossRef929
Saburo Fukuda, Toshiyuki Itamoto, Hironobu Amano, Toshihiko Kohashi, Hideki Ohdan, Hirotaka Tashiro, Toshimasa Asahara. (2007) Clinicopathologic Features of Hepatocellular Carcinoma Patients with Compensated Cirrhosis Surviving More than 10 Years after Curative Hepatectomy. World Journal of Surgery 31:2, 345-352
CrossRef930
Jing Xu, Zhong-Yang Shen, Xin-Guo Chen, Qing Zhang, Hui-Jie Bian, Ping Zhu, Hui-Yun Xu, Fei Song, Xiang-Min Yang, Li Mi, Qing-Chuan Zhao, Rong Tian, Qiang Feng, Si-He Zhang, Yu Li, Jian-Li Jiang, Ling Li, Xiao-Ling Yu, Zheng Zhang, Zhi-Nan Chen. (2007) A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 45:2, 269-276
CrossRef931
Georgios C. Sotiropoulos, Massimo Malagó, Ernesto P. Molmenti, Christian Lösch, Hauke Lang, Andrea Frilling, Christoph E. Broelsch, Markus Neuhäuser. (2007) Hilar lymph nodes sampling at the time of liver transplantation for hepatocellular carcinoma: to do or not to do?.. Transplant International 20:2,
CrossRef932
Ronnie T. P. Poon. (2007) Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection?. Annals of Surgical Oncology 14:2, 541-547
CrossRef933
Oren K. Fix. (2007) SELECTION CRITERIA FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA: CAN WE IGNORE TUMOR STAGE?. Evidence-Based Gastroenterology 8:1, 23-24
CrossRef934
Daisuke Morioka, Hiroto Egawa, Mureo Kasahara, Takashi Ito, Hironori Haga, Yasutsugu Takada, Hiroshi Shimada, Koichi Tanaka. (2007) Outcomes of Adult-to-Adult Living Donor Liver Transplantation. Annals of Surgery 245:2, 315-325
CrossRef935
T. Ogawa, H. Tashiro, Y. Miyata, Y. Ushitora, Y. Fudaba, T. Kobayashi, K. Arihiro, M. Okajima, T. Asahara. (2007) Rho-Associated Kinase Inhibitor Reduces Tumor Recurrence After Liver Transplantation in a Rat Hepatoma Model. American Journal of Transplantation 7:2, 347-355
CrossRef936
M. Iavarone, P. Lampertico, F. Iannuzzi, E. Manenti, M. F. Donato, E. Arosio, F. Bertolini, M. Primignani, A. Sangiovanni, M. Colombo. (2007) Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. Journal of Viral Hepatitis 14:2, 133-139
CrossRef937
M. Tabone, L. Vigano', A. Ferrero, R. Pellerito, P. Carbonatto, L. Capussotti. (2007) Prevention of intrahepatic recurrence by adjuvant 131iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis. European Journal of Surgical Oncology (EJSO) 33:1, 61-66
CrossRef938
Jeffrey S. Crippin. (2007) Treatment of hepatocellular carcinoma after transplantation and human rights. Hepatology 45:2, 263-265
CrossRef939
Yueh-Wei Liu, Chao-Long Chen, Yaw-Sen Chen, Chih-Chi Wang, Shih-Ho Wang, Chih-Che Lin. (2007) Needle Tract Implantation of Hepatocellular Carcinoma After Fine Needle Biopsy. Digestive Diseases and Sciences 52:1, 228-231
CrossRef940
Norah A. Terrault, Mitchell L. Shiffman, Anna S.F. Lok, Sammy Saab, Lan Tong, Robert S. Brown, Gregory T. Everson, K. Rajender Reddy, Jeffrey H. Fair, Laura M. Kulik, Timothy L. Pruett, Leonard B. Seeff. (2007) Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation. Liver Transplantation 13:1, 122
CrossRef941
Martín Prieto, Victoria Aguilera, Marina Berenguer, Ramón Pina, Salvador Benlloch. (2007) Selección de candidatos para trasplante hepático. Gastroenterología y Hepatología 30:1, 42-53
CrossRef942
Ronnie T. P. Poon, Sheung Tat Fan, Chung Mau Lo, Chi Leung Liu, John Wong. (2007) Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation. Annals of Surgery 245:1, 51-58
CrossRef943
C. M. Lo, S. T. Fan, C. L. Liu, S. C. Chan, I. O.-L. Ng, J. Wong. (2007) Living donorversus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. British Journal of Surgery 94:1, 78-86
CrossRef944
Masafumi Ikeda, Takuji Okusaka, Hideki Ueno, Chigusa Morizane, Satoru Iwasa, Atsushi Hagihara, Yasushi Kojima. (2007) Hepatic Arterial Infusion Chemotherapy with Epirubicin in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis. Oncology 72:3-4, 188-193
CrossRef945
Claire Francoz, Jacques Belghiti, François Durand. (2007) Indications of liver transplantation in patients with complications of cirrhosis. Best Practice & Research Clinical Gastroenterology 21:1, 175-190
CrossRef946
Heung-Kyu Ko, Gi-Young Ko, Hyun Ki Yoon, Kyu-Bo Sung. (2007) Tumor Response to Transcatheter Arterial Chemoembolization in Recurrent Hepatocellular Carcinoma after Living Donor Liver Transplantation. Korean Journal of Radiology 8:4, 320
CrossRef947
H. Lang, C.E. Broelsch. (2007) Resektion und Transplantation bei Lebertumoren. Der Internist 48:1, 30-39
CrossRef948
Shigeki Arii. (2007) Tracing the history of hepatic surgery. Kanzo 48:10, 473-483
CrossRef949
Eveline Boucher, Etienne Garin, Anne Guylligomarc’h, Damien Olivié, Karim Boudjema, Jean-Luc Raoul. (2007) Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma. Radiotherapy and Oncology 82:1, 76-82
CrossRef950
Melanie Blum, Christian Mueller, Markus Peck‐Radosavljevic, Friedrich Wrba, Gabriela Berlakovich, Ferdinand Mühlbacher, Rudolf Steiniger, Maria Speiser, Mario Pones, Michael Hüpfl, Johannes Lammer, Joachim Kettenbach. (2007) MR‐guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation. Minimally Invasive Therapy & Allied Technologies 16:4, 230-240
CrossRef951
Shinji Tanaka, Norio Noguchi, Takanori Ochiai, Atsushi Kudo, Noriaki Nakamura, Koji Ito, Toru Kawamura, Kenichi Teramoto, Shigeki Arii. (2007) Outcomes and Recurrence of Initially Resectable Hepatocellular Carcinoma Meeting Milan Criteria: Rationale for Partial Hepatectomy as First Strategy. Journal of the American College of Surgeons 204:1, 1-6
CrossRef952
Alex Gutierrez-Dalmau, Josep M Campistol. (2007) Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients. Drugs 67:8, 1167-1198
CrossRef953
Vito R. Cicinnati, Xia Zhang, Zhengya Yu, Stanislav Ferencik, Klaus J. Schmitz, Grzegorz Dworacki, Elzbieta Kaczmarek, Karl Oldhafer, Andrea Frilling, Hideo A. Baba, Kurt W. Schmid, Hans Grosse-Wilde, Christoph E. Broelsch, Albert B. DeLeo, Guido Gerken, Susanne Beckebaum. (2006) Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma. International Journal of Cancer 119:12, 2851-2860
CrossRef954
Thomas Longerich, Peter Schirmacher. (2006) General aspects and pitfalls in liver transplant pathology. Clinical Transplantation 20:s17, 60-68
CrossRef955
Thomas Decaens, Françoise Roudot-Thoraval, Solange Hadni-Bresson, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre-Henri Bernard, Olivier Boillot, Laurent Sulpice, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges-Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Cherqui, Christophe Duvoux. (2006) Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transplantation 12:12, 1761-1769
CrossRef956
Patrick Pham, Raphaël Saffroy, Maámar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. (2006) Dépistage, diagnostic et suivi biologique du carcinome hépatocellulaire. Revue Francophone des Laboratoires 2006:387, 73-77
CrossRef957
Vincenzo Mazzaferro, Raffaele Romito, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sherrie Bhoori, Lorenzo Capussotti, Fulvio Calise, Riccardo Pellicci, Giulio Belli, Alessandro Tagger, Massimo Colombo, Ferruccio Bonino, Pietro Majno, Josep M. Llovet, . (2006) Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 44:6, 1543-1554
CrossRef958
Manuel de la Mata, Natividad Cuende, Jes??s Huet, Angel Bernardos, Jose Antonio Ferr??n, Julio Santoyo, Juan Manuel Pascasio, Juan Rodrigo, Guillermo Sol??rzano, Rafael Mart??n-Vivaldi, Manuel Alonso. (2006) Model for End-Stage Liver Disease Score-Based Allocation of Donors for Liver Transplantation: A Spanish Multicenter Experience. Transplantation 82:11, 1429-1435
CrossRef959
Ryosuke Tateishi, Shuichiro Shiina, Haruhiko Yoshida, Takuma Teratani, Shuntaro Obi, Noriyo Yamashiki, Hideo Yoshida, Masatoshi Akamatsu, Takao Kawabe, Masao Omata. (2006) Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 44:6, 1518-1527
CrossRef960
Christophe Duvoux. (2006) Transplantation hépatique pour carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 30:12, 1343-1345
CrossRef961
Laura M. Kulik, Bassel Atassi, Lodewijk van Holsbeeck, Tameem Souman, Robert J. Lewandowski, Mary F. Mulcahy, Russell D. Hunter, Albert A. Nemcek, Michael M. Abecassis, Kenneth G. Haines, Riad Salem. (2006) Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. Journal of Surgical Oncology 94:7, 572-586
CrossRef962
Josep M. Llovet. (2006) Expanding HCC criteria for liver transplant: The urgent need for prospective, robust data. Liver Transplantation 12:12, 1741-1743
CrossRef963
S.A. Muller, B.M. Schmied, T. Welsch, D.J. Martin, P. Schemmer, A. Mehrabi, J. Weitz, M.W. Buchler, J. Schmidt. (2006) How to increase inflow in liver transplantation. Clinical Transplantation 20:s17, 85-92
CrossRef964
Patricia M. Lopez, Augusto Villanueva, Sasan Roayaie, Josep M. Llovet. (2006) Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal. Liver Transplantation 12:12, 1747-1754
CrossRef965
Richard B. Freeman, Robert G. Gish, Ann Harper, Gary L. Davis, John Vierling, Leslie Lieblein, Goran Klintmalm, Jamie Blazek, Robert Hunter, Jeffrey Punch. (2006) Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transplantation 12:S3, S128-S136
CrossRef966
Laura Marelli, Rosa Stigliano, Christos Triantos, Marco Senzolo, Evangelos Cholongitas, Neil Davies, Dominic Yu, Tim Meyer, David W. Patch, A.K. Burroughs. (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treatment Reviews 32:8, 594-606
CrossRef967
Hui Xu, Xuan Li, Zheng-han Yang, Jing-xia Xie. (2006) In Vivo 1H MR Spectroscopy in the Evaluation of the Serial Development of Hepatocarcinogenesis in an Experimental Rat Model1. Academic Radiology 13:12, 1532-1537
CrossRef968
Russell Wiesner, John R. Lake, Richard B. Freeman, Robert G. Gish. (2006) Model for end-stage liver disease (MELD) exception guidelines. Liver Transplantation 12:S3, S85-S87
CrossRef969
Daisuke Morioka, Kuniya Tanaka, Ken-ichi Matsuo, Kazuhisa Takeda, Michio Ueda, Mitsutaka Sugita, Yasuhiko Nagano, Itaru Endo, Hitoshi Sekido, Shinji Togo, Hiroshi Shimada. (2006) Applicability of the Milan Criteria for Determining Liver Transplantation as a First-Line Treatment for Hepatocellular Carcinoma. Annals of Surgical Oncology 13:11, 1500-1510
CrossRef970
Richard B. Freeman. (2006) Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transplantation 12:S2, S8-S13
CrossRef971
Figen Özçay, Oğuz Canan, Banu Bilezikçi, Adnan Torgay, Hamdi Karakayali, Mehmet Haberal. (2006) Effect of living donor liver transplantation on outcome of children with inherited liver disease and hepatocellular carcinoma. Clinical Transplantation 20:6, 776-782
CrossRef972
Adrian P. Martin, Robert M. Goldstein, Jane Dempster, George J. Netto, Nora Katabi, Howard C. Derrick, Basel Altrabulsi, Linda W. Jennings, Takehisa Ueno, Srinath Chinnakotla, Sherfield Dawson, Henry B. Randall, Marlon F. Levy, Nicholas Onaca, Edmund Q. Sanchez, Douglas Orr, Goran B. Klintmalm. (2006) Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation ? a clinical and histological examination. Clinical Transplantation 20:6, 695-705
CrossRef973
Edoardo Giovanni Giannini, Domenico Risso, Roberto Testa, Franco Trevisani, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gian Ludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Eugenio Caturelli. (2006) Prevalence and Prognostic Significance of the Presence of Esophageal Varices in Patients With Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 4:11, 1378-1384
CrossRef974
Bachir Taouli, Glenn A. Krinsky. (2006) Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Liver Transplantation 12:S2, S1-S7
CrossRef975
Eiji Ando, Ryoko Kuromatsu, Masatoshi Tanaka, Akio Takada, Nobuyoshi Fukushima, Shuji Sumie, Sakae Nagaoka, Jyunji Akiyoshi, Kinya Inoue, Takuji Torimura, Ryukichi Kumashiro, Takato Ueno, Michio Sata. (2006) Surveillance Program for Early Detection of Hepatocellular Carcinoma in Japan. Journal of Clinical Gastroenterology 40:10, 942-948
CrossRef976
Michael L. Volk, Jorge A. Marrero, Anna S. Lok, Peter A. Ubel. (2006) Who Decides? Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma. Transplantation 82:9, 1136-1139
CrossRef977
M. Lesurtel, B. Müllhaupt, B. C. Pestalozzi, T. Pfammatter, P.-A. Clavien. (2006) Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis. American Journal of Transplantation 6:11, 2644-2650
CrossRef978
Debra L. Sudan. (2006) Transplantation for cholangiocarcinoma. Liver Transplantation 12:S2, S83-S84
CrossRef979
Alejandro Forner, Amelia J. Hessheimer, M. Isabel Real, Jordi Bruix. (2006) Treatment of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 60:2, 89-98
CrossRef980
Sung Hoon Yang, Kyung-Suk Suh, Hae Won Lee, Eung-Ho Cho, Jai Young Cho, Yong Beom Cho, Nam-Joon Yi, Kuhn Uk Lee. (2006) The role of18F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transplantation 12:11, 1655-1660
CrossRef981
Jean-Noël Talbot, Fabrice Gutman, Laetitia Fartoux, Jean-Didier Grange, Nathalie Ganne, Khaldoun Kerrou, Dany Grahek, Françoise Montravers, Raoul Poupon, Olivier Rosmorduc. (2006) PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 33:11, 1285-1289
CrossRef982
Tsutomu Masaki, Asahiro Morishita, Kazutaka Kurokohchi, Shigeki Kuriyama. (2006) Multidisciplinary treatment of patients with hepatocellular carcinoma. Expert Review of Anticancer Therapy 6:10, 1377-1384
CrossRef983
Richard B. Freeman, Abigail Mithoefer, Robin Ruthazer, Khanh Nguyen, Anthony Schore, Ann Harper, Erick Edwards. (2006) Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transplantation 12:10, 1504-1511
CrossRef984
L. Castells Fusté. (2006) Virus de la hepatitis B y carcinoma hepatocelular. Gastroenterología y Hepatología 29, 86-92
CrossRef985
Ankit Bharat, Daniel B. Brown, Jeffrey S. Crippin, Jennifer E. Gould, Jeffrey A. Lowell, Surendra Shenoy, Niraj M. Desai, William C. Chapman. (2006) Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival. Journal of the American College of Surgeons 203:4, 411-420
CrossRef986
Vincent Donckier, Roberto Troisi, Alain Le Moine, Michel Toungouz, Salvatore Ricciardi, Isabelle Colle, Hans Van Vlierberghe, Ligia Craciun, Myriam Libin, Marleen Praet, Lucien Noens, Patrick Stordeur, Marc Andrien, Micheline Lambermont, Michel Gelin, Nadine Bourgeois, Michael Adler, Bernard de Hemptinne, Michel Goldman. (2006) Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transplantation 12:10, 1523-1528
CrossRef987
Patrick J Healey, Jorge D Reyes. (2006) Liver transplantation for hepatocellular carcinoma in children. Current Opinion in Organ Transplantation 11:5, 528-531
CrossRef988
G Chen, J Zhou, Q Gao, X Huang, K Li, L Zhuang, M Huang, G Xu, S Wang, Y Lu, D Ma. (2006) Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo. Cancer Gene Therapy 13:10, 930-939
CrossRef989
A. Forner, M. Varela, J. Bruix. (2006) Hepatocarcinoma y VHC. Gastroenterología y Hepatología 29, 196-199
CrossRef990
Maria Varela, Alejandro Forner, Jordi Bruix. (2006) Diagnosis and staging of hepatocellular carcinoma prior to transplantation: Expertise or failure. Liver Transplantation 12:10, 1445-1447
CrossRef991
Hiroyuki Furukawa, Tsuyoshi Shimamura, Tomomi Suzuki, Masahiko Taniguchi, Kenichiro Yamashita, Toshiya Kamiyama, Michiaki Matsushita, Satoru Todo. (2006) Living-donor liver transplantation for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 13:5, 393-397
CrossRef992
M SUAREZMUNOZ. (2006) Detección de lesiones neoplásicas en pacientes cirróticos candidatos a trasplante hepático. Cirugía Española 80:3, 157-161
CrossRef993
Yoji Kishi, Yasuhiko Sugawara, Sumihito Tamura, Junichi Kaneko, Norihiro Kokudo, Masatoshi Makuuchi. (2006) Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation. Transplant International 19:9, 720-725
CrossRef994
Sakae Nagaoka, Satoshi Itano, Masatoshi Ishibashi, Takuji Torimura, Kenkichi Baba, Junji Akiyoshi, Junichi Kurogi, Satoru Matsugaki, Kinya Inoue, Nobuyoshi Tajiri, Akio Takada, Eiji Ando, Ryoko Kuromatsu, Hayato Kaida, Mina Kurogi, Hironori Koga, Ryukichi Kumashiro, Naofumi Hayabuchi, Masamichi Kojiro, Michio Sata. (2006) Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver International 26:7, 781-788
CrossRef995
Sonia Pascual, Pedro Zapater, Jose Such, Antonio Garcia-Herola, Laura Sempere, Javier Irurzun, Jose Maria Palazon, Fernando Carnicer, Miguel Perez-Mateo. (2006) Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver International 26:6, 673-679
CrossRef996
A Durnez, C Verslype, F Nevens, J Fevery, R Aerts, J Pirenne, E Lesaffre, L Libbrecht, V Desmet, T Roskams. (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49:2, 138-151
CrossRef997
P. Sharma, A. M. Harper, J. L. Hernandez, T. Heffron, D. C. Mulligan, R. H. Wiesner, V. Balan. (2006) Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation. American Journal of Transplantation 6:8, 1957-1962
CrossRef998
Francis Y. Yao. (2006) Selection criteria for liver transplantation in patients with hepatocellular carcinoma: Beyond tumor size and number?. Liver Transplantation 12:8, 1189-1191
CrossRef999
Georgios C. Sotiropoulos, Andreas Paul, Till Gerling, Ernesto P. Molmenti, Silvio Nadalin, Bogdan P. Napieralski, J??rgen Treckmann, Hauke Lang, Fuat Saner, Andrea Frilling, Christoph E. Broelsch, Massimo Malag??. (2006) Liver Transplantation with ???Rescue Organ Offers??? Within the Eurotransplant Area: A 2-year Report From the University Hospital Essen. Transplantation 82:3, 304-309
CrossRef1000
Erik J. Van Kleek, Jonathan M. Schwartz, Stephen C. Rayhill, Hugo R. Rosen, Scott J. Cotler. (2006) Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 40:7, 643-647
CrossRef1001
A. Martins, H. Cortez-Pinto, P. Marques-Vidal, N. Mendes, S. Silva, N. Fatela, H. Gloria, R. Marinho, I. Tavora, F. Ramalho, M. Carneiro de Moura. (2006) Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver International 26:6, 680-687
CrossRef1002
Gerd Otto, Sascha Herber, Michael Heise, Ansgar W. Lohse, Christian Mönch, Fernando Bittinger, Maria Hoppe-Lotichius, Marcus Schuchmann, Anja Victor, Michael Pitton. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transplantation 12:8, 1260-1267
CrossRef1003
G. J. Netto, B. Altrabulsi, N. Katabi, P. Martin, K. Burt, M. Levy, E. Sanchez, D. L. Watkins, L. Jennings, G. Klintmalm, R. Goldstein. (2006) Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and 'TUNEL' study. Liver International 26:6, 746-751
CrossRef1004
Lih-Hwa Hwang. (2006) Gene Therapy Strategies for Hepatocellular Carcinoma. Journal of Biomedical Science 13:4, 453-468
CrossRef1005
Xiao-Ping Chen, Fa-Zu Qiu, Zai-De Wu, Zhi-Wei Zhang, Zhi-Yong Huang, Yi-Fa Chen, Bi-Xiang Zhang, Song-Qing He, Wan-Guang Zhang. (2006) Effects of Location and Extension of Portal Vein Tumor Thrombus on Long-Term Outcomes of Surgical Treatment for Hepatocellular Carcinoma. Annals of Surgical Oncology 13:7, 940-946
CrossRef1006
Teh-Ia Huo, Han-Chieh Lin, Yi-Hsiang Huang, Jaw-Ching Wu, Jen-Huei Chiang, Pui-Ching Lee, Shou-Dong Lee. (2006) The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 107:1, 141-148
CrossRef1007
Jean-Claude Trinchet, Nathalie Ganne-Carrié. (2006) Faut-il dépister le carcinome hépatocellulaire ?. Gastroentérologie Clinique et Biologique 30:6-7, 880-886
CrossRef1008
Christian Müller. (2006) Hepatocellular carcinoma – Rising incidence, changing therapeutic strategies. Wiener Medizinische Wochenschrift 156:13-14, 404-409
CrossRef1009
Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Junichi Kaneko, Kayo Nojiri, Masao Omata, Masatoshi Makuuchi. (2006) Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transplantation 12:7, 1077-1083
CrossRef1010
Maria Varela, William Sanchez, Jordi Bruix, Gregory J. Gores. (2006) Hepatocellular carcinoma in the setting of liver transplantation. Liver Transplantation 12:7, 1028-1036
CrossRef1011
Ivo Graziadei. (2006) Liver transplantation organ allocation between Child and MELD. Wiener Medizinische Wochenschrift 156:13-14, 410-415
CrossRef1012
J Bruix, A J Hessheimer, A Forner, L Boix, R Vilana, J M Llovet. (2006) New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 25:27, 3848-3856
CrossRef1013
F. Chu, D.L. Morris. (2006) Single centre experience of liver resection for hepatocellular carcinoma in patients outside transplant criteria. European Journal of Surgical Oncology (EJSO) 32:5, 568-572
CrossRef1014
Andrew K Burroughs, Caroline Sabin, Keith Rolles. (2006) Analyse transplant outcomes in distinct epochs of follow-up – Authors' reply. The Lancet 367:9525, 1816-1817
CrossRef1015
R. B. Freeman, E. B. Edwards, A. M. Harper. (2006) Waiting List Removal Rates Among Patients with Chronic and Malignant Liver Diseases. American Journal of Transplantation 6:6, 1416-1421
CrossRef1016
Shimul A. Shah, Jensen C.C. Tan, Ian D. McGilvray, Mark S. Cattral, Sean P. Cleary, Gary A. Levy, Paul D. Greig, David R. Grant. (2006) Accuracy of Staging as a Predictor for Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 81:12, 1633-1639
CrossRef1017
Pietro Majno, Vincenzo Mazzaferro. (2006) Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: Questions, answers and demands for a common language. Liver Transplantation 12:6, 896-898
CrossRef1018
Eishiro Mizukoshi, Yasunari Nakamoto, Yohei Marukawa, Kuniaki Arai, Tatsuya Yamashita, Hirokazu Tsuji, Kiyotaka Kuzushima, Masafumi Takiguchi, Shuichi Kaneko. (2006) Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 43:6, 1284-1294
CrossRef1019
Yasutsugu Takada, Mikiko Ueda, Takashi Ito, Seisuke Sakamoto, Hironori Haga, Yoji Maetani, Kohei Ogawa, Mureo Kasahara, Fumitaka Oike, Hiroto Egawa, Koichi Tanaka. (2006) Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transplantation 12:6, 912-919
CrossRef1020
Angelo Sangiovanni, Gian Maria Prati, Pierangelo Fasani, Guido Ronchi, Raffaella Romeo, Matteo Manini, Ersilio Del Ninno, Alberto Morabito, Massimo Colombo. (2006) The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 43:6, 1303-1310
CrossRef1021
Massimo Malagó, Georgios C. Sotiropoulos, Silvio Nadalin, Camino Valentin-Gamazo, Andreas Paul, Hauke Lang, Arnold Radtke, Fuat Saner, Ernesto Molmenti, Susanne Beckebaum, Guido Gerken, Andrea Frilling, Christoph E. Broelsch. (2006) Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report. Liver Transplantation 12:6, 934-940
CrossRef1022
Alessandro Grasso, Rosa Stigliano, Filomena Morisco, Hugo Martines, Alberto Quaglia, Amar P. Dhillon, David Patch, Brian R. Davidson, Keith Rolles, Andrew K. Burroughs. (2006) Liver Transplantation and Recurrent Hepatocellular Carcinoma: Predictive Value of Nodule Size in a Retrospective and Explant Study. Transplantation 81:11, 1532-1541
CrossRef1023
Seth J Karp, Yonson Ku, Scott Johnson, Khalid Khwaja, Michael Curry, Douglas Hanto. (2006) Surgical and non-surgical approaches to hepatocellular cancer. Current Opinion in Organ Transplantation 11:3, 226-233
CrossRef1024
P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET. (2006) Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Alimentary Pharmacology and Therapeutics 23:11, 1535-1547
CrossRef1025
David S. Kotlyar, Mical S. Campbell, K. Rajender Reddy. (2006) Recurrence of Diseases Following Orthotopic Liver Transplantation. The American Journal of Gastroenterology 101:6, 1370-1378
CrossRef1026
Francesco Saverio Ferrari, Andrea Stella, Paolo Pasquinucci, Francesco Vigni, Letizia Civeli, Massimo Pieraccini, Fabrizio Magnolfi. (2006) Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results. European Journal of Gastroenterology & Hepatology 18:6, 659-672
CrossRef1027
Mankanwal Sachdev, Jose L. Hernandez, Pratima Sharma, David D. Douglas, Thomas Byrne, M. Edwyn Harrison, David Mulligan, Adyr Moss, Kunam Reddy, Hugo E. Vargas, Jorge Rakela, Vijayan Balan. (2006) Liver Transplantation in the MELD Era: A Single-Center Experience. Digestive Diseases and Sciences 51:6, 1070-1078
CrossRef1028
Udai S. Kammula. (2006) Predicting Outcomes After Percutaneous Ethanol Injection for Small Hepatocellular Cancer. The Cancer Journal 12:3, 175-177
CrossRef1029
A. ANDRIULLI, I. DE SIO, F. BRUNELLO, A. SALMI, L. SOLMI, D. FACCIORUSSO, E. CATURELLI, F. PERRI. (2006) Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection. Alimentary Pharmacology and Therapeutics 23:9, 1329-1335
CrossRef1030
X.-P. Chen, F.-Z. Qiu, Z.-D. Wu, Z.-W. Zhang, Z.-Y. Huang, Y.-F Chen. (2006) Long-term outcome of resection of large hepatocellular carcinoma. British Journal of Surgery 93:5, 600-606
CrossRef1031
Adnan Said, Michael R Lucey. (2006) Liver transplantation: an update. Current Opinion in Gastroenterology 22:3, 272-278
CrossRef1032
Teh-Ia Huo, Yi-Hsiang Huang, Han-Chieh Lin, Jaw-Ching Wu, Jen-Huei Chiang, Pui-Ching Lee, Full-Young Chang, Shou-Dong Lee. (2006) Proposal of a Modified Cancer of the Liver Italian Program Staging System Based on the Model for End-Stage Liver Disease for Patients with Hepatocellular Carcinoma Undergoing Loco-Regional Therapy. The American Journal of Gastroenterology 101:5, 975-982
CrossRef1033
Victor I. Machicao, Titte R. Srinivas, Alan W. Hemming, Consuelo Soldevila-Pico, Roberto J. Firpi, Alan I. Reed, Giuseppi J. Morelli, David R. Nelson, Manal F. Abdelmalek. (2006) Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transplantation 12:5, 754-761
CrossRef1034
Norah A. Terrault, Jonathan T. Carter, Laurie Carlson, Michelle E. Roland, Peter G. Stock. (2006) Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transplantation 12:5, 801-807
CrossRef1035
Maria A. Hawkins, Laura A. Dawson. (2006) Radiation therapy for hepatocellular carcinoma. Cancer 106:8, 1653-1663
CrossRef1036
Paul J. Gaglio. 2006. Liver Transplantation. .
CrossRef1037
Gunnar Soderdahl, Lars Backman, Helena Isoniemi, Christian Cahlin, Krister Hockerstedt, Ulrika Broome, Heikki Makisalo, Styrbjorn Friman, Bo-Goran Ericzon. (2006) A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transplant International 19:4, 288-294
CrossRef1038
Amit D. Tevar, Paul Succop, Chris R. Schneider, Thav Thambi-Pillai, Mark J. Thomas, Guy Neff, Fred Weber, Steven M. Rudich, E. Steve Woodle, Joseph F. Buell. (2006) Liver transplantation for primary and metastatic hepatic malignancy: a single center experience. Surgery 139:4, 535-541
CrossRef1039
Chi Leung Liu, Sheung Tat Fan. (2006) Adult-to-adult live-donor liver transplantation: the current status. Journal of Hepato-Biliary-Pancreatic Surgery 13:2, 110-116
CrossRef1040
Hajime Yokoi, Shuji Isaji, Kentaro Yamagiwa, Masami Tabata, Akiyoshi Nemoto, Hiroyuki Sakurai, Mosanobu Usui, Shinji Uemoto. (2006) The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 13:2, 123-130
CrossRef1041
Paul H. Hayashi, Adrian M. Di Bisceglie. (2006) The Progression of Hepatitis B– and C–Infections to Chronic Liver Disease and Hepatocellular Carcinoma: Presentation, Diagnosis, Screening, Prevention, and Treatment of Hepatocellular Carcinoma. Infectious Disease Clinics of North America 20:1, 1-25
CrossRef1042
Z.A. Zakaria ., A.M. Mat Jais ., M.R. Sulaiman ., S.S.P. Mohamed Isa ., S. Riffin .. (2006) The in vitro Antibacterial Activity of Methanol and Ethanol Extracts of Carica papaya Flowers and Mangifera indica Leaves. Journal of Pharmacology and Toxicology 1:3, 278-283
CrossRef1043
Eishiro Mizukoshi, Yasunari Nakamoto, Hirokazu Tsuji, Tatsuya Yamashita, Shuichi Kaneko. (2006) Identification of α-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. International Journal of Cancer 118:5, 1194-1204
CrossRef1044
Frederike G.I. van Vilsteren, Edwina S. Baskin-Bey, David M. Nagorney, Schuyler O. Sanderson, Walter K. Kremers, Charles B. Rosen, Gregory J. Gores, Timothy J. Hobday. (2006) Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transplantation 12:3, 448-456
CrossRef1045
Iwao Ikai, Etsuro Hatano, Suguru Hasegawa, Hideaki Fujii, Kojiro Taura, Naoki Uyama, Yasuyuki Shimahara. (2006) Prognostic Index for Patients with Hepatocellular Carcinoma Combined with Tumor Thrombosis in the Major Portal Vein. Journal of the American College of Surgeons 202:3, 431-438
CrossRef1046
Tilak U. Shah, Richard C. Semelka, Ertan Pamuklar, Zeynep Firat, Richard D. Gerber, Roshan Shrestha, Mark W. Russo. (2006) The Risk of Hepatocellular Carcinoma in Cirrhotic Patients with Small Liver Nodules on MRI. The American Journal of Gastroenterology 101:3, 533-540
CrossRef1047
Jeffrey S. Crippin. (2006) Biopsy of Suspicious Liver Nodules: Does it Change Management?. Clinical Gastroenterology and Hepatology 4:3, 296-298
CrossRef1048
Chi Leung Liu, Sheung Tat Fan, Chung Mau Lo, William Ignace Wei, See Ching Chan, Boon Hun Yong, John Wong. (2006) Operative Outcomes of Adult-to-Adult Right Lobe Live Donor Liver Transplantation. Annals of Surgery 243:3, 404-410
CrossRef1049
Marc G. Ghany, Edward C. Doo. (2006) Assessment and Management of Chronic Hepatitis B. Infectious Disease Clinics of North America 20:1, 63-79
CrossRef1050
William Sanchez, Jayant A. Talwalkar. (2006) Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation. Gastroenterology Clinics of North America 35:1, 201-219
CrossRef1051
Sung-Gyu Lee. (2006) Asian contribution to living donor liver transplantation. Journal of Gastroenterology and Hepatology 21:3, 572-574
CrossRef1052
Nikhil B. Amesur, Albert B. Zajko. (2006) Interventional radiology in liver transplantation. Liver Transplantation 12:3, 330-351
CrossRef1053
T. L. Husted, G. Neff, M. J. Thomas, T. G. Gross, E. S. Woodle, J. F. Buell. (2006) Liver Transplantation for Primary or Metastatic Sarcoma to the Liver. American Journal of Transplantation 6:2, 392-397
CrossRef1054
Matteo Ravaioli, Gian Luca Grazi, Giorgio Ercolani, Matteo Cescon, Massimo Del Gaudio, Matteo Zanello, Giorgio Ballardini, Giovanni Varotti, Gaetano Vetrone, Francesco Tuci, Augusto Lauro, Giovanni Ramacciato, Antonio Daniele Pinna. (2006) Liver Allocation for Hepatocellular Carcinoma: A European Center Policy in the Pre-MELD Era. Transplantation 81:4, 525-530
CrossRef1055
C. Arikan, M. Kilic, D. Nart, F. Ozgenc, T. Ozkan, Y. Tokat, R. V. Yagci, S. Aydogdu. (2006) Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Pediatric Transplantation 10:1, 42-47
CrossRef1056
Georgios C. Sotiropoulos, Massimo Malag??, Ernesto P. Molmenti, Silvio Nadalin, Arnold Radtke, Eirini I. Brokalaki, Hauke Lang, Andrea Frilling, Hideo A. Baba, Markus Neuh??user, Christoph E. Broelsch. (2006) Liver Transplantation and Incidentally Found Hepatocellular Carcinoma in Liver Explants: Need for a New Definition?. Transplantation 81:4, 531-535
CrossRef1057
François Durand, Jacques Belghiti, Roberto Troisi, Olivier Boillot, Adrian Gadano, Claire Francoz, Bernard de Hemptinne, Alain Mallet, Dominique Valla, Jean Louis Golmard. (2006) Living donor liver transplantation in high-risk vs. low-risk patients: Optimization using statistical models. Liver Transplantation 12:2, 231-239
CrossRef1058
S. Nadalin, M. Bockhorn, M. Malagó, C. Valentin-Gamazo, A. Frilling, C.E. Broelsch. (2006) Living donor liver transplantation. HPB: Official Journal of The International Hepato Pancreato Biliary Association 8:1, 10-21
CrossRef1059
L. Tarantino, G. Francica, F. Esposito, D. Pisaniello, D. Parmeggiani, G. Marzullo, I. M. F. Sordelli, P. Sperlongano. (2006) Seeding from hepatocellular carcinoma after percutaneous ablation: color Doppler ultrasound findings. Abdominal Imaging 31:1, 69-77
CrossRef1060
T. Soliman, G. A. Berlakovich, F. Mühlbacher, R. Steininger. (2006) Liver transplantation for hepatic malignancies. European Surgery 38:1, 63-68
CrossRef1061
Omar Almusa, Michael P. Federle. (2006) Abdominal imaging and intervention in liver transplantation. Liver Transplantation 12:2, 184-193
CrossRef1062
Shimul A. Shah, Paul D. Greig, Steven Gallinger, Mark S. Cattral, Elijah Dixon, Robin D. Kim, Bryce R. Taylor, David R. Grant, Charles M. Vollmer. (2006) Factors Associated with Early Recurrence after Resection for Hepatocellular Carcinoma and Outcomes. Journal of the American College of Surgeons 202:2, 275-283
CrossRef1063
D G Ward, Y Cheng, G N'kontchou, T T Thar, N Barget, W Wei, L J Billingham, A Martin, M Beaugrand, P J Johnson. (2006) Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. British Journal of Cancer 94:2, 287-292
CrossRef1064
R. Sutcliffe, D. Maguire, B. Portmann, M. Rela, N. Heaton. (2006) Selection of patients with hepatocellular carcinoma for liver transplantation. British Journal of Surgery 93:1, 11-18
CrossRef1065
Maria Chiara Cantarini, Franco Trevisani, Antonio Maria Morselli-Labate, Gianludovico Rapaccini, Fabio Farinati, Paolo Del Poggio, Maria Anna Di Nolfo, Luisa Benvegnu, Marco Zoli, Franco Borzio, Mauro Bernardi, . (2006) Effect of the Etiology of Viral Cirrhosis on the Survival of Patients with Hepatocellular Carcinoma. The American Journal of Gastroenterology 101:1, 91-98
CrossRef1066
Kenichi Takayasu, Yukio Muramatsu, Yasunori Mizuguchi, Noriyuki Moriyama, Takuji Okusaka. (2006) Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein. Journal of Gastroenterology and Hepatology 21:1, 288-294
CrossRef1067
W.Y. Lau, Simon C.H. Yu, Eric C.H. Lai, Thomas W.T. Leung. (2006) Transarterial Chemoembolization for Hepatocellular Carcinoma. Journal of the American College of Surgeons 202:1, 155-168
CrossRef1068
Rolland C. Dickson, Norah A. Terrault, Michael Ishitani, K. Rajender Reddy, Patricia Sheiner, Velimir Luketic, Consuelo Soldevila-Pico, Michael Fried, Donald Jensen, Robert S. Brown, Gary Horwith, Richard Brundage, Anna Lok. (2006) Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transplantation 12:1, 124-133
CrossRef1069
Hirokazu Komeichi, Yasumi Katsuta. (2006) Current Treatment of Hepatitis C and Hepatocellular Carcinoma. Nihon Ika Daigaku Igakkai Zasshi 2:2, 108-114
CrossRef1070
Aliya Qayyum, Ruedi F. Thoeni, Fergus V. Coakley, Ying Lu, Jeff P. Guay, Linda D. Ferrell. (2006) Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement. Journal of Magnetic Resonance Imaging 23:1, 17-22
CrossRef1071
Michele Bertolotto, Gabriele Pozzato, Lory Saveria Croc??, Fabiana Nascimben, Cristiana Gasparini, Maria Assunta Cova, Claudio Tiribelli. (2006) Blood Flow Changes in Hepatocellular Carcinoma After the Administration of Thalidomide Assessed by Reperfusion Kinetics During Microbubble Infusion. Investigative Radiology 41:1, 15-21
CrossRef1072
Abraham R. John, Saboor Khan, Darius F. Mirza, A. David Mayer, John A.C. Buckels, Simon R. Bramhall. (2006) Multivariate and Univariate Analysis of Prognostic Factors following Resection in HCC: The Birmingham Experience. Digestive Surgery 23:1-2, 103-109
CrossRef1073
Hideo Yoshida, Haruhiko Yoshida, Shuichiro Shiina, Masao Omata. (2005) Early liver cancer: concepts, diagnosis, and management. International Journal of Clinical Oncology 10:6, 384-390
CrossRef1074
Jacques Belghiti. (2005) Transplantation for Liver Tumors. Seminars in Oncology 32, 29-32
CrossRef1075
Francis Y. Yao, Ryutaro Hirose, Jeanne M. LaBerge, Timothy J. Davern, Nathan M. Bass, Robert K. Kerlan, Raphael Merriman, Sandy Feng, Chris E. Freise, Nancy L. Ascher, John P. Roberts. (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transplantation 11:12, 1505-1514
CrossRef1076
Shigeru Marubashi, Keizo Dono, Hiroaki Nagano, Kunihito Gotoh, Hidenori Takahashi, Kazuhiko Hashimoto, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Tomoaki Kato, Morito Monden. (2005) Living-Donor Liver Transplantation with Renoportal Anastomosis for Patients with Large Spontaneous Splenorenal Shunts. Transplantation 80:12, 1671-1675
CrossRef1077
Mauro Salizzoni, Elisabetta Cerutti, Renato Romagnoli, Francesco Lupo, Alessandro Franchello, Fausto Zamboni, Fabrizio Gennari, Paolo Strignano, Alessandro Ricchiuti, Andrea Brunati, Maria Maddalena Schellino, Antonio Ottobrelli, Alfredo Marzano, Bruna Lavezzo, Ezio David, Mario Rizzetto. (2005) The first one thousand liver transplants in Turin: a single-center experience in Italy. Transplant International 18:12, 1328-1335
CrossRef1078
Yoshitaka Takuma, Kazuhiro Nouso, Yasuhiro Makino, Syunsuke Saito, Yasushi Shiratori. (2005) Prophylactic Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Compensated Cirrhosis. Clinical Gastroenterology and Hepatology 3:12, 1245-1252
CrossRef1079
Hauke Lang, Georgios Sotiropoulos, Gernot Kaiser, Ernesto Molmenti, Massimo Malagó, Christoph Broelsch. (2005) The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB: Official Journal of The International Hepato Pancreato Biliary Association 7:4, 268-272
CrossRef1080
Pietro Lampertico, Mauro Viganò, Elena Manenti, Massimo Iavarone, Giovanna Lunghi, Massimo Colombo. (2005) Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 42:6, 1414-1419
CrossRef1081
Claudio Zavaglia, Luciano De Carlis, Alberto Battista Alberti, Ernesto Minola, Luca Saverio Belli, Abdallah Omar Slim, Aldo Airoldi, Alessandro Giacomoni, Gianfranco Rondinara, Carmine Tinelli, Domenico Forti, Giovambattista Pinzello. (2005) Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 100:12, 2708-2716
CrossRef1082
T. Clark Gamblin, David A. Geller. (2005) Downstaging hepatocellular carcinoma prior to liver transplantation. Liver Transplantation 11:12, 1466-1468
CrossRef1083
Aaron Shields, K. Rajender Reddy. (2005) Hepatocellular carcinoma: Current treatment strategies. Current Treatment Options in Gastroenterology 8:6, 457-466
CrossRef1084
Laetitia Fartoux, Lionel Arrive, Tony Andreani, Lawrence Serfaty, Olivier Chazouillères, Jean-Michel Tubiana, Raoul Poupon, Olivier Rosmorduc. (2005) Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroentérologie Clinique et Biologique 29:12, 1213-1219
CrossRef1085
S GARREAN, N JOSEPHESPAT. (2005) Yttrium-90 internal radiation therapy for hepatic malignancy. Surgical Oncology 14:4, 179-193
CrossRef1086
Jordi Bruix, Morris Sherman. (2005) Management of hepatocellular carcinoma. Hepatology 42:5, 1208-1236
CrossRef1087
Adrian M. Di Bisceglie. (2005) Pretransplant treatments for hepatocellular carcinoma: Do they improve outcomes?. Liver Transplantation 11:S2, S10-S13
CrossRef1088
John P. Roberts. (2005) Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation 11:S2, S45-S46
CrossRef1089
F. Löhe, M.K. Angele, A.L. Gerbes, U. Löhrs, K.-W. Jauch, R.J. Schauer. (2005) Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 31:9, 994-999
CrossRef1090
L. Capussotti, A. Muratore, M. Amisano, R. Polastri, H. Bouzari, P. Massucco. (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experience. European Journal of Surgical Oncology (EJSO) 31:9, 986-993
CrossRef1091
Jacques Belghiti. (2005) Systematic hepatectomy for liver cancer. Journal of Hepato-Biliary-Pancreatic Surgery 12:5, 362-364
CrossRef1092
Maurizio Pompili, Laura Riccardi, Marcello Covino, Brunella Barbaro, Carmine Di Stasi, Ruggero Orefice, Giovanni Gasbarrini, Gian Ludovico Rapaccini. (2005) Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver International 25:5, 954-961
CrossRef1093
Chan Kyo Kim, Dongil Choi, Hyo K. Lim, Seung Hoon Kim, Won Jae Lee, Min Ju Kim, Ji Yeon Lee, Yong Hwan Jeon, Jongmee Lee, Soon Jin Lee, Jae Hoon Lim. (2005) Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: Utility of contrast-enhanced agent detection imaging. European Journal of Radiology 56:1, 66-73
CrossRef1094
A AMADOR. (2005) Mil trasplantes hepáticos en el Hospital Clínic i Provincial de Barcelona. Cirugía Española 78:4, 231-237
CrossRef1095
Carlos Margarit, Alfredo Escartín, Lluis Castells, Víctor Vargas, Elena Allende, Itxarone Bilbao. (2005) Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transplantation 11:10, 1242-1251
CrossRef1096
Pietro Majno, Gilles Mentha, Vincenzo Mazzaferro. (2005) Resection, transplantation, either, or both? Other pieces of the puzzle. Liver Transplantation 11:10, 1177-1180
CrossRef1097
Georgios C. Sotiropoulos, Andreas Paul, Ernesto Molmenti, Hauke Lang, Andrea Frilling, Bogdan P. Napieralski, Silvio Nadalin, J??rgen Treckmann, Eirini I. Brokalaki, Till Gerling, Christoph E. Broelsch, Massimo Malag??. (2005) Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis within the Eurotransplant Area: An Additional Option with ???Livers that Nobody Wants???. Transplantation 80:7, 897-902
CrossRef1098
Shin Hwang, Sung-Gyu Lee, Jae-Won Joh, Kyung-Suk Suh, Dong-Goo Kim. (2005) Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations. Liver Transplantation 11:10, 1265-1272
CrossRef1099
Mary F. Mulcahy. (2005) Management of hepatocellular cancer. Current Treatment Options in Oncology 6:5, 423-435
CrossRef1100
F. Dazzani, M. Micati, P. Caraceni, G.M. Drago, M. Domenicali, P. Pacilli, V. Tomassetti, E. Gelonesi, F. Trevisani, M. Bernardi. (2005) Transthoracic electrical bioimpedance: A non-invasive technique for the evaluation of the haemodynamic alterations in patients with liver cirrhosis. Digestive and Liver Disease 37:10, 786-792
CrossRef1101
Alessandro Ferrero, Luca Viganò, Roberto Polastri, Dario Ribero, Roberto Lo Tesoriere, Andrea Muratore, Lorenzo Capussotti. (2005) Hepatectomy as Treatment of Choice for Hepatocellular Carcinoma in Elderly Cirrhotic Patients. World Journal of Surgery 29:9, 1101-1105
CrossRef1102
M. El-Meteini, A. Fayez, M. Fathy, A. Abdalaal, H. Safaan, I. Mostafa, M. Abdalaal, A. Mokhtar, M. Salah, A. El-Dorry, S. Abdalwahab, M. El-Monayeri, O. Boillot. (2005) Living Related Liver Transplantation for Hepatocellular Carcinoma in Egypt. Transplantation Proceedings 37:7, 3141-3143
CrossRef1103
Paolo De Simone, Paola Carrai, Lidiana Baldoni, Stefania Petruccelli, Laura Coletti, Luca Morelli, Franco Filipponi. (2005) Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation. Liver Transplantation 11:9, 1080-1085
CrossRef1104
A. Dalgic, H. Karakayali, G. Moray, R. Emiroglu, H. Sozen, A. Torgay, M. Haberal. (2005) Liver Transplantation and Tacrolimus Monotherapy for Hepatocellular Carcinoma With Expanded Criteria. Transplantation Proceedings 37:7, 3154-3156
CrossRef1105
Sven Jonas, Jens Mittler, Andreas Pascher, Tom Theruvath, Armin Thelen, Jochen Klupp, Jan M. Langrehr, Peter Neuhaus. (2005) Extended Indications in Living-Donor Liver Transplantation: Bile Duct Cancer. Transplantation 80:Supplement, S101-S104
CrossRef1106
Peter Sauer, Thomas W. Kraus, Peter Schemmer, Arianeb Mehrabi, Wolfgang Stremmel, Markus W. Buechler, Jens Encke. (2005) Liver Transplantation for Hepatocellular Carcinoma: Is there Evidence for Expanding the Selection Criteria?. Transplantation 80:Supplement, S105-S108
CrossRef1107
Laura M. Kulik, Mary F. Mulcahy, Russell D. Hunter, Albert A. Nemcek, Michael M. Abecassis, Riad Salem. (2005) Use of yttrium-90 microspheres (TheraSphere®) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report. Liver Transplantation 11:9, 1127-1131
CrossRef1108
Timothy M. Pawlik, Keith A. Delman, Jean-Nicolas Vauthey, David M. Nagorney, Irene Oi-Lin Ng, Iwao Ikai, Yoshio Yamaoka, Jacques Belghiti, Gregory Y. Lauwers, Ronnie T. Poon, Eddie K. Abdalla. (2005) Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation 11:9, 1086-1092
CrossRef1109
Maurizio Pompili, Vincenzo Giorgio Mirante, Gianfranco Rondinara, Luigi Rainero Fassati, Fabio Piscaglia, Salvatore Agnes, Marcello Covino, Matteo Ravaioli, Stefano Fagiuoli, Giovanni Gasbarrini, Gian Ludovico Rapaccini. (2005) Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplantation 11:9, 1117-1126
CrossRef1110
B PEREZSABORIDO, J MENEU, E MORENO, I GARCIA, A MORENO, Y FUNDORA. (2005) Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?. The American Journal of Surgery 190:3, 383-387
CrossRef1111
Andreas Lubienski. (2005) Hepatocellular Carcinoma: Interventional Bridging to Liver Transplantation. Transplantation 80:Supplement, S113-S119
CrossRef1112
Yuk Pang Yeung, Chung Mau Lo, Chi Leung Liu, Benjamin C. Wong, Sheung Tat Fan, John Wong. (2005) Natural History of Untreated Nonsurgical Hepatocellular Carcinoma. The American Journal of Gastroenterology 100:9, 1995-2004
CrossRef1113
Hector Rodriguez-Luna, Hugo E. Vargas, Adyr Moss, Kunam S. Reddy, Richard B. Freeman, David Mulligan. (2005) Regional Variations in Peer Reviewed Liver Allocation Under the MELD System. American Journal of Transplantation 5:9, 2244-2247
CrossRef1114
RUBEN R PLENTZ, HANS L TILLMANN, STEFAN KUBICKA, JORG S BLECK, MICHAEL GEBEL, MICHAEL P MANNS, KARL L RUDOLPH. (2005) Hepatocellular carcinoma and octreotide: Treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage. Journal of Gastroenterology and Hepatology 20:9, 1422-1428
CrossRef1115
Andreas Pascher, Jochen Klupp, Peter Neuhaus. (2005) Transplantation in the management of metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, 637-648
CrossRef1116
Chandrajit P. Raut, Francesco Izzo, Paolo Marra, Lee M. Ellis, Jean-Nicolas Vauthey, Francesco Cremona, Paolo Vallone, Angelo Mastro, Bruno D. Fornage, Steven A. Curley. (2005) Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis. Annals of Surgical Oncology 12:8, 616-628
CrossRef1117
Eddie K. Abdalla, Thomas A. Aloia, Jean-Nicolas Vauthey. (2005) Laparoscopy for diagnosis and staging of hepatobiliary malignancies. Surgical Practice 9:3, 78-89
CrossRef1118
Kiyoshi Hasegawa, Norihiro Kokudo, Hiroshi Imamura, Yutaka Matsuyama, Taku Aoki, Masami Minagawa, Keiji Sano, Yasuhiko Sugawara, Tadatoshi Takayama, Masatoshi Makuuchi. (2005) Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma. Annals of Surgery 242:2, 252-259
CrossRef1119
Jacques Belghiti, Valérie Vilgrain. (2005) Radiofrequency Ablation of Hepatocellular Carcinoma:Who Should Do It ?. Annals of Surgical Oncology 12:8, 579-580
CrossRef1120
R. Lencioni, C. Della Pina, C. Bartolozzi. (2005) Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdominal Imaging 30:4, 401-408
CrossRef1121
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Tanabe, Kenneth K., Blaszkowsky, Lawrence S., Chung, Raymond T., Blake, Michael A., Lauwers, Gregory Y., . (2005) Case 23-2005. New England Journal of Medicine 353:4, 401-410
Full Text1122
M. Angelico, B. Gridelli, M. Strazzabosco. (2005) Practice of adult liver transplantation in Italy. Digestive and Liver Disease 37:7, 461-467
CrossRef1123
Jean-Pierre E. N. Pierie, Alona Muzikansky, Kenneth K. Tanabe, Mark J. Ott. (2005) The Outcome of Surgical Resection Versus Assignment to the Liver Transplant Waiting List for Hepatocellular Carcinoma. Annals of Surgical Oncology 12:7, 552-560
CrossRef1124
Bachir Taouli, Jeffrey S. K Goh, Ying Lu, Aliya Qayyum, Benjamin M Yeh, Raphael B Merriman, Fergus V Coakley. (2005) Growth Rate of Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 29:4, 425-429
CrossRef1125
Robert Sutcliffe, Donal Maguire, Philip Murphy, Bernard Portmann, Mohamed Rela, Gerald O???Sullivan, Ghulam Mufti, Nigel Heaton. (2005) Detection and Clinical Significance of Bone Marrow Micrometastases in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Transplantation 80:1, 88-94
CrossRef1126
Thomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre-Henri Bernard, Olivier Boillot, Karim Boudjema, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Dhumeaux, Daniel Cherqui, Christophe Duvoux. (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transplantation 11:7, 767-775
CrossRef1127
Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Ryosuke Tateishi, Tomonori Fujishima, Takashi Ishikawa, Yukihiro Koike, Haruhiko Yoshida, Takao Kawabe, Masao Omata. (2005) A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma. Gastroenterology 129:1, 122-130
CrossRef1128
Takefumi Niguma, Tetusige Mimura, Nobumasa Tutui. (2005) Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. Journal of Hepato-Biliary-Pancreatic Surgery 12:3, 249-253
CrossRef1129
Stangou, Arie J., Heaton, Nigel D., , Hawkins, Philip N., . (2005) Transmission of Systemic Transthyretin Amyloidosis by Means of Domino Liver Transplantation. New England Journal of Medicine 352:22, 2356-2356
Full Text1130
Richard B Freeman, Ann Harper, Erick B Edwards. (2005) Liver transplantation outcomes under the model for end-stage liver disease and pediatric end-stage liver disease. Current Opinion in Organ Transplantation 10:2, 90-94
CrossRef1131
Taku Aoki, Hiroshi Imamura, Junichi Kaneko, Yoshihiro Sakamoto, Yutaka Matsuyama, Norihiro Kokudo, Yasuhiko Sugawara, Masatoshi Makuuchi. (2005) Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis. Liver Transplantation 11:6, 684-691
CrossRef1132
WILLIAM KEMP, STEPHEN PIANKO, SHARA NGUYEN, MICHAEL J BAILEY, STUART K ROBERTS. (2005) Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease. Journal of Gastroenterology and Hepatology 20:6, 873-881
CrossRef1133
Xiao-Ping Chen, Zhi-Yong Huang. (2005) Surgical treatment of hepatocellular carcinoma in China. Langenbeck's Archives of Surgery 390:3, 259-265
CrossRef1134
Hector Rodriguez-Luna, Hugo E. Vargas, Thomas Byrne, Jorge Rakela. (2005) Artificial Neural Network and Tissue Genotyping of Hepatocellular Carcinoma in Liver-Transplant Recipients: Prediction of Recurrence. Transplantation 79:12, 1737-1740
CrossRef1135
Karen F. Murray, Robert L. Carithers. (2005) AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 41:6, 1407-1432
CrossRef1136
Hideki Nakahara, Toshiyuki Itamoto, Koji Katayama, Hideki Ohdan, Hiroshi Hino, Makoto Ochi, Hirotaka Tashiro, Toshimasa Asahara. (2005) Indication of Hepatectomy for Cirrhotic Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B. World Journal of Surgery 29:6, 734-738
CrossRef1137
E. Berber, S. Rogers, A. Siperstein. (2005) Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer. Surgical Endoscopy 19:5, 710-714
CrossRef1138
Noriyo Yamashiki, Ryosuke Tateishi, Haruhiko Yoshida, Shuichiro Shiina, Takuma Teratani, Shinpei Sato, Norio Mine, Yuji Kondo, Takao Kawabe, Masao Omata. (2005) Ablation therapy in containing extension of hepatocellular carcinoma: A simulative analysis of dropout from the waiting list for liver transplantation. Liver Transplantation 11:5, 508-514
CrossRef1139
Myron Schwartz, Manoussos Konstadoulakis, Sasan Roayaie. (2005) Recurrence of hepatocellular carcinoma after liver transplantation: Is immunosuppression a factor?. Liver Transplantation 11:5, 494-496
CrossRef1140
Marco Vivarelli, Alessandro Cucchetti, Fabio Piscaglia, Giuliano La Barba, Luigi Bolondi, Antonino Cavallari, Antonio Daniele Pinna. (2005) Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression. Liver Transplantation 11:5, 497-503
CrossRef1141
Elisabetta Buscarini, Agostino Savoia, Gianfranco Brambilla, Fernanda Menozzi, Luigi Reduzzi, Deike Strobel, Johannes H
CrossRef1142
Eldad S. Bialecki, Adrian M. Di Bisceglie. (2005) Clinical presentation and natural course of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 17:5, 485-489
CrossRef1143
David S. K. Lu, Nam C. Yu, Steven S. Raman, Charles Lassman, Myron J. Tong, Carolyn Britten, Francisco Durazo, Sammy Saab, Steven Han, Richard Finn, Jonathan R. Hiatt, Ronald W. Busuttil. (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41:5, 1130-1137
CrossRef1144
Alex S. Befeler, Paul H. Hayashi, Adrian M. Di Bisceglie. (2005) Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology 128:6, 1752-1764
CrossRef1145
S. GIANNI, A. CECCHETTO, G. ALTAVILLA, R. RAGAZZI, M. BERTAZZO, M. DE GIORGIO, A. BALDAN, S. FAGIUOLI, F. FARINATI. (2005) Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma. Journal of Internal Medicine 257:4, 367-373
CrossRef1146
J. Wallis Marsh, Sydney D. Finkelstein, Myron E. Schwartz, M. Isabel Fiel, Igor Dvorchik. (2005) Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transplantation 11:4, 469-472
CrossRef1147
Esther Unitt, Simon M. Rushbrook, Aileen Marshall, Susan Davies, Paul Gibbs, Lesley S. Morris, Nicholas Coleman, Graeme J. M. Alexander. (2005) Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells. Hepatology 41:4, 722-730
CrossRef1148
CHYI-FENG JAN, CHIEN-JEN CHEN, HSIU-HSI CHEN. (2005) Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience. Journal of Gastroenterology and Hepatology 20:4, 521-526
CrossRef1149
Francis Y. Yao, Milan Kinkhabwala, Jeanne M. LaBerge, Nathan M. Bass, Robert Brown, Robert Kerlan, Alan Venook, Nancy L. Ascher, Jean C. Emond, John P. Roberts. (2005) The Impact of Pre-Operative Loco-Regional Therapy on Outcome After Liver Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 5:4, 795-804
CrossRef1150
Timothy M. Pawlik, Ronnie T. Poon, Eddie K. Abdalla, Iwao Ikai, David M. Nagorney, Jacques Belghiti, Reza Kianmanesh, Irene Oi-Lin Ng, Steven A. Curley, Yoshio Yamaoka, Gregory Y. Lauwers, Jean-Nicolas Vauthey. (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study. Surgery 137:4, 403-410
CrossRef1151
Daniel H. Palmer, Philip J. Johnson. (2005) Pre-operative Locoregional Therapy and Liver Transplantation for Hepatocellular Carcinoma: Time for a Randomized Controlled Trial. American Journal of Transplantation 5:4, 641-642
CrossRef1152
Dimitrios N. Samonakis, Christos K. Triantos, Ulrich Thalheimer, Alberto Quaglia, Gioacchino Leandro, Ros
CrossRef1153
Baburao Koneru, Lewis W. Teperman, Cosme Manzarbeitia, Marcelo Facciuto, Kyunghee Cho, David Reich, Patricia Sheiner, Adrian Fisher, Khristian Noto, Alec Goldenberg, Maria Korogodsky, Donna Campbell. (2005) A Multicenter Evaluation of Utility of Chest Computed Tomography and Bone Scans in Liver Transplant Candidates With Stages I and II Hepatoma. Annals of Surgery 241:4, 622-628
CrossRef1154
Herwig Pokorny, Michael Gnant, Susanne Rasoul-Rockenschaub, Bernd Gollackner, Birgit Steiner, Gunter Steger, Rudolf Steininger, Ferdinand Muhlbacher. (2005) Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?. American Journal of Transplantation 5:4, 788-794
CrossRef1155
Bieke Lambert, Marleen Praet, Peter Vanlangenhove, Roberto Troisi, Bernard de Hemptinne, Filip Gemmel, Hans Van Vlierberghe, Christophe Van de Wiele. (2005) Radiolabeled Lipiodol Therapy for Hepatocellular Carcinoma in Patients Awaiting Liver Transplantation: Pathology of the Explant Livers and Clinical Outcome. Cancer Biotherapy & Radiopharmaceuticals 20:2, 209-214
CrossRef1156
Chiaki Kawamoto, Kenichi Ido, Norio Isoda, Masanori Hozumi, Nobuhiko Nagamine, Kazunori Ono, Yoshiaki Sato, Yuko Kobayashi, Genta Nagae, Kentaro Sugano. (2005) Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. Cancer 103:5, 985-993
CrossRef1157
Paul H. Hayashi, Adrian M. Di Bisceglie. (2005) The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Medical Clinics of North America 89:2, 345-369
CrossRef1158
Riccardo Lencioni, Clotilde Della Pina, Jordi Bruix, Pietro Majno, Luigi Grazioli, Giovanni Morana, Antonella Filippone, Andrea Laghi, Carlo Bartolozzi. (2005) Clinical Management of Hepatic Malignancies: Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced Spiral Computed Tomography. Digestive Diseases and Sciences 50:3, 533-537
CrossRef1159
Josep Fuster, Ramon Charco, Josep M. Llovet, Jordi Bruix, Juan Carlos Garcia-Valdecasas. (2005) Liver transplantation in hepatocellular carcinoma. Transplant International 18:3, 278-282
CrossRef1160
M. Shimada, Y. Yonemura, H. Ijichi, N. Harada, S. Shiotani, M. Ninomiya, T. Terashi, T. Yoshizumi, Y. Soejima, Y. Maehara. (2005) Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Special Reference to a Preoperative Des-Gamma-Carboxy Prothrombin Value. Transplantation Proceedings 37:2, 1177-1179
CrossRef1161
Jacques Belghiti, Reza Kianmanesh. (2005) Surgical treatment of hepatocellular carcinoma. HPB: Official Journal of The International Hepato Pancreato Biliary Association 7:1, 42-49
CrossRef1162
C.-C. Wu, S.-B. Cheng, W.-M. Ho, the late J.-T. Chen, T.-J. Liu, F.-K. P'eng. (2005) Liver resection for hepatocellular carcinoma in patients with cirrhosis. British Journal of Surgery 92:3, 348-355
CrossRef1163
H.H. Lee, J.W. Joh, J.H. Park, K.W. Lee, J.S. Heo, S.H. Choi, S.J. Kim, S.K. Lee. (2005) Microvascular Tumor Embolism: Independent Prognostic Factor After Liver Transplantation in Hepatocellular Carcinoma. Transplantation Proceedings 37:2, 1251-1253
CrossRef1164
Philip Johnson. (2005) Non-surgical treatment of hepatocellular carcinoma. HPB: Official Journal of The International Hepato Pancreato Biliary Association 7:1, 50-55
CrossRef1165
H. Tanaka, S. Kubo, T. Tsukamoto, T. Shuto, S. Takemura, T. Yamamoto, T. Okuda, A. Kanazawa, K. Hirohashi. (2005) Recurrence Rate and Transplantability After Liver Resection in Patients With Hepatocellular Carcinoma Who Initially Met Transplantation Criteria. Transplantation Proceedings 37:2, 1254-1256
CrossRef1166
Annalisa Altimari, Elisa Gruppioni, Michelangelo Fiorentino, Rosella Petraroli, Antonio Daniele Pinna, Kyriakoula Petropulacos, Lorenza Ridolfi, Alessandro Nanni Costa, Walter Franco Grigioni, Antonia D??Errico Grigioni. (2005) Genomic Allelotyping for Distinction of Recurrent and De Novo Hepatocellular Carcinoma After Orthotopic Liver Transplantation. Diagnostic Molecular Pathology 14:1, 34-38
CrossRef1167
Jelica Kurtovic, Stephen M. Riordan, Roger Williams. (2005) Liver transplantation for hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 19:1, 147-160
CrossRef1168
David Axelrod, Alan Koffron, Laura Kulik, Patrice Al-Saden, Mary Mulcahy, Talia Baker, Jonathan Fryer, Michael Abecassis. (2005) Living Donor Liver Transplant for Malignancy. Transplantation 79:3, 363-366
CrossRef1169
Georgios C. Sotiropoulos, Massimo Malag??, Ernesto Molmenti, Andreas Paul, Silvio Nadalin, Eirini Brokalaki, Hilmar K??hl, Olaf Dirsch, Hauke Lang, Christoph E. Broelsch. (2005) Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis: Is Clinical Tumor Classification before Transplantation Realistic?. Transplantation 79:4, 483-487
CrossRef1170
Mindie H. Nguyen, Emmet B. Keeffe. (2005) General management. Best Practice & Research Clinical Gastroenterology 19:1, 161-174
CrossRef1171
Pratima Sharma, Jorge Rakela. (2005) Management of pre-liver transplantation patients?Part 1. Liver Transplantation 11:2, 124-133
CrossRef1172
T ITAMOTO, H NAKAHARA, H TASHIRO, H OHDAN, H HINO, M OCHI, T ASAHARA. (2005) Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis. The American Journal of Surgery 189:2, 167-172
CrossRef1173
Hubert E. Blum. (2005) Treatment of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 19:1, 129-145
CrossRef1174
Derek Patel, Norah A. Terrault, Francis Y. Yao, Nathan M. Bass, Uri Ladabaum. (2005) Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus–related cirrhosis. Clinical Gastroenterology and Hepatology 3:1, 75-84
CrossRef1175
M Taniguchi, H Furukawa, T Shimamura, T Suzuki, K Yamashita, S Todo. (2005) Present condition of liver transplantation and future problem. 1. Living liver transplantation and brain death liver transplantation. Trend in the world and present state in our country.. Kanzo 46:6, 299-305
CrossRef1176
F MUHLBACHER. 2005. Liver Transplantation for Metastases of the Liver. , 233-237.
CrossRef1177
Genta Nagae, Kenichi Ido, Norio Isoda, Shin Sato, Hiroto Kita, Kentaro Sugano. (2005) LAPAROSCOPIC ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA. Digestive Endoscopy 17:1, 1-8
CrossRef1178
John F. Renz, Cindy Kin, Milan Kinkhabwala, Dominique Jan, Rhaghu Varadarajan, Michael Goldstein, Robert Brown, Jean C. Emond. (2005) Utilization of Extended Donor Criteria Liver Allografts Maximizes Donor Use and Patient Access to Liver Transplantation. Transactions of the ... Meeting of the American Surgical Association 123:&NA;, 250-259
CrossRef1179
A GOMES. 2005. Radiologic Evaluation in the Liver Transplant Patient. , 447-471.
CrossRef1180
Lars Bäckman, John L.R. Forsythe, Bianca Miranda, Natividad Cuende, Jose Cañón, Carlos Margarit, Till Gerling, Guido G. Persijn. 2005. Liver Organ Allocation: The European Models. , 79-91.
CrossRef1181
Scott Wadler. (2005) Thalidomide for advanced hepatocellular carcinoma. Cancer 103:1, 1-4
CrossRef1182
Richard B. Freeman. 2005. Liver Allocation: The U.S. Model. , 63-77.
CrossRef1183
Ryosuke Tateishi, Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Yukihiro Koike, Tomonori Fujishima, Haruhiko Yoshida, Takao Kawabe, Masao Omata. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 103:6, 1201
CrossRef1184
T Yamada, K Tanaka, Y Takada, T Ito, Y Ogura, T Daimon. (2005) Present condition of liver transplantation and future problem. 6. Hepatocellular carcinoma and liver transplantation.. Kanzo 46:6, 327-335
CrossRef1185
Marvin J. Stone, J. Mark Fulmer, Goran B. Klintmalm. 2005. Transplantation for Primary Hepatic Malignancy. , 211-231.
CrossRef1186
Russell H Wiesner. (2005) Patient selection in an era of donor liver shortage: current US policy. Nature Clinical Practice Gastroenterology & Hepatology 2:1, 24-30
CrossRef1187
T.J.M. Ruers, K.P. de Jong, J.N.M. IJzermans. (2005) Radiofrequency for the Treatment of Liver Tumours. Digestive Surgery 22:4, 245-253
CrossRef1188
Michiyo KODAMA, Mikiya KITAMOTO, Hideki NAKAHARA, Yasuhiko FUKUDA, Waka OHISHI, Nami MORI, Akiko MATSUMOTO, Toshiko ONITAKE, Masaru IMAGAWA, Kazuaki CHAYAMA. (2005) A case of decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine and adefovir allowing repeated treatments for hepatocellular carcinomas. Kanzo 46:5, 262-269
CrossRef1189
Scott A. Fink, Robert S. Brown. 2005. Current Indications, Contraindications, Delisting Criteria, and Timing for Liver Transplantation. , 95-114.
CrossRef1190
Joseph F. Buell, Thomas M. Beebe, Michael J. Hanaway, Mark J. Thomas, Steven M. Rudich, E. Steve Woodle. 2005. Transplant-Related Malignancies. , 1149-1164.
CrossRef1191
Morris Sherman, Andrew Klein. (2004) AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. Hepatology 40:6, 1465-1473
CrossRef1192
Teh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, Fa-Yauh Lee, Ming-Chih Hou, Yi-Hsiang Huang, Pui-Ching Lee, Full-Young Chang, Shou-Dong Lee. (2004) Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transplantation 10:12, 1507-1513
CrossRef1193
Mitsugi Shimoda, Rafik M. Ghobrial, Ian C. Carmody, Dean M. Anselmo, Douglas G. Farmer, Hasan Yersiz, Pauline Chen, Sherfield Dawson, Francisco Durazo, Steve Han, Leonard I. Goldstein, Sammy Saab, Jonathan Hiatt, Ronald W. Busuttil. (2004) Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transplantation 10:12, 1478-1486
CrossRef1194
Eddie K. Abdalla, Jean-Nicolas Vauthey. (2004) Focus on Treatment of Large Hepatocellular Carcinoma. Annals of Surgical Oncology 11:12, 1035-1036
CrossRef1195
Matteo Ravaioli, Gian Luca Grazi, Giorgio Ercolani, Michelangelo Fiorentino, Matteo Cescon, Rita Golfieri, Franco Trevisani, Walter Franco Grigioni, Luigi Bolondi, Antonio Daniele Pinna. (2004) Partial Necrosis on Hepatocellular Carcinoma Nodules Facilitates Tumor Recurrence after Liver Transplantation. Transplantation 78:12, 1780-1786
CrossRef1196
Josep M. Llovet. (2004) Treatment of hepatocellular carcinoma. Current Treatment Options in Gastroenterology 7:6, 431-441
CrossRef1197
Jordi Bruix, Margarita Sala, Josep M. Llovet. (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127:5, S179-S188
CrossRef1198
Ronnie Tung-Ping Poon, Sheung-Tat Fan. (2004) Is Primary Resection and Salvage Transplantation for Hepatocellular Carcinoma a Reasonable Strategy?. Annals of Surgery 240:5, 925-928
CrossRef1199
Tae-Jin Song, Edmund Wai Kit Ip, Yuman Fong. (2004) Hepatocellular carcinoma: Current surgical management. Gastroenterology 127:5, S248-S260
CrossRef1200
Masao Omata, Ryosuke Tateishi, Haruhiko Yoshida, Shuichiro Shiina. (2004) Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 127:5, S159-S166
CrossRef1201
Timothy M. Pawlik, Eddie K. Abdalla, Jean-Nicolas Vauthey. (2004) Liver Transplantation for Hepatocellular Carcinoma: Need for a New Patient Selection Strategy. Annals of Surgery 240:5, 923-924
CrossRef1202
Jessica Y. Leung, Andrew X. Zhu, Fredric D. Gordon, Daniel S. Pratt, Abigail Mithoefer, Kathryn Garrigan, Adam Terella, Martin Hertl, A. Benedict Cosimi, Raymond T. Chung. (2004) Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study. Liver Transplantation 10:11, 1343-1354
CrossRef1203
Brian H. Lang, Ronnie T. Poon, Sheung T. Fan, John Wong. (2004) Outcomes of Patients with Hepatocellular Carcinoma Presenting with Variceal Bleeding. The American Journal of Gastroenterology 99:11, 2158-2165
CrossRef1204
KAZUFUMI DOHMEN. (2004) Many staging systems for hepatocellular carcinoma: Evolution from Child-Pugh, Okuda to SLiDe. Journal of Gastroenterology and Hepatology 19:11, 1227-1232
CrossRef1205
Jay H. Hoofnagle. (2004) Hepatocellular carcinoma: Summary and recommendations. Gastroenterology 127:5, S319-S323
CrossRef1206
Adrian M. di Bisceglie. (2004) Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 127:5, S104-S107
CrossRef1207
Vincenzo Mazzaferro, Carlo Battiston, Stefano Perrone, Andrea Pulvirenti, Enrico Regalia, Raffaele Romito, Dario Sarli, Marcello Schiavo, Francesco Garbagnati, Alfonso Marchian??, Carlo Spreafico, Tiziana Camerini, Luigi Mariani, Rosalba Miceli, Salvatore Andreola. (2004) Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation. Annals of Surgery 240:5, 900-909
CrossRef1208
Myron Schwartz. (2004) Liver transplantation for hepatocellular carcinoma. Gastroenterology 127:5, S268-S276
CrossRef1209
Bachir Taouli, Mariela Losada, Agnes Holland, Glenn Krinsky. (2004) Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 127:5, S144-S152
CrossRef1210
Russell H. Wiesner, Richard B. Freeman, David C. Mulligan. (2004) Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 127:5, S261-S267
CrossRef1211
Laura Kulik, Michael Abecassis. (2004) Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 127:5, S277-S282
CrossRef1212
Angelo Andriulli, Ilario de Sio, Luigi Solmi, Luciano De Carlis, Roberto Troisi, Alessandro Grasso, Virginia Festa, Eugenio Caturelli, Alessandro Giacomoni, Camillo Del Vecchio Blanco, Bernard De Hemptinne, Andrew Burroughs, Francesco Perri. (2004) Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transplantation 10:11, 1355-1363
CrossRef1213
Margarita Sala, Josep Fuster, Josep M. Llovet, Miquel Navasa, Manel Sol
CrossRef1214
William J. Wall. (2004) Hepatocellular cancer, transplantation, and sirolimus. Liver Transplantation 10:10, 1312-1314
CrossRef1215
Norman M. Kneteman, Jos
CrossRef1216
RA Fisher, D Maluf, AH Cotterell, T Stravitz, L Wolfe, V Luketic, R Sterling, M Shiffman, M Posner. (2004) Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clinical Transplantation 18:5, 502-512
CrossRef1217
Margarita Sala, Maria Varela, Jordi Bruix. (2004) Selection of candidates with HCC for transplantation in the MELD era. Liver Transplantation 10:S10, S4-S9
CrossRef1218
V DONCKIER. (2004) Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Transplant Immunology 13:2, 139-146
CrossRef1219
Umberto Cillo, Filippo Navaglia, Alessandro Vitale, Alfiero Molari, Daniela Basso, Marco Bassanello, Alberto Brolese, Giacomo Zanus, Umberto Montin, Francesco D'Amico, Francesco Antonio Ciarleglio, Amedeo Carraro, Alessio Bridda, Patrizia Burra, Paolo Carraro, Mario Plebani, Davide Francesco D'Amico. (2004) Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clinica Chimica Acta 347:1-2, 129-138
CrossRef1220
Matteo Ravaioli, Giorgio Ercolani, Matteo Cescon, Gaetano Vetrone, Claudio Voci, Walter Franco Grigioni, Antonia D'Errico, Giorgio Ballardini, Antonino Cavallari, Gian Luca Grazi. (2004) Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria. Liver Transplantation 10:9, 1195-1202
CrossRef1221
Satoru Todo, Hiroyuki Furukawa. (2004) Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma. Annals of Surgery 240:3, 451-461
CrossRef1222
Marc G. Ghany, Edward C. Doo. (2004) Management of chronic hepatitis B. Gastroenterology Clinics of North America 33:3, 563-579
CrossRef1223
P. Andreone, A. Gramenzi, C. Cursaro, M. Biselli, C. Camma, F. Trevisani, M. Bernardi. (2004) High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance. Journal of Viral Hepatitis 11:5, 439-442
CrossRef1224
Morris Sherman, Yuji Takayama. (2004) Screening and treatment for hepatocellular carcinoma. Gastroenterology Clinics of North America 33:3, 671-691
CrossRef1225
Kamran Ahrar, Robert A. Newman, Jihai Pang, Mary K. Vijjeswarapu, Michael J. Wallace, Kenneth C. Wright. (2004) 2004 Dr. Gary J. Becker Young Investigator Award: Relative Thermosensitivity of Cytotoxic Drugs Used in Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology 15:9, 901-905
CrossRef1226
Iwao Ikai, Shigeki Arii, Masamichi Kojiro, Takafumi Ichida, Masatoshi Makuuchi, Yutaka Matsuyama, Yasuni Nakanuma, Kiwamu Okita, Masao Omata, Kenichi Takayasu, Yoshio Yamaoka, . (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:4, 796-802
CrossRef1227
J Wallis Marsh, David A Geller, Sydney D Finkelstein, Joseph B Donaldson, Igor Dvorchik. (2004) Role of liver transplantation for hepatobiliary malignant disorders. The Lancet Oncology 5:8, 480-488
CrossRef1228
Franco Trevisani, Maria C. Cantarini, Antonello M. M. Labate, Stefania De Notariis, Gianludovico Rapaccini, Fabio Farinati, Paolo Del Poggio, Maria Anna Di Nolfo, Luisa Benvegnu, Marco Zoli, Franco Borzio, . (2004) Surveillance for Hepatocellular Carcinoma in Elderly Italian Patients With Cirrhosis: Effects on Cancer Staging and Patient Survival. The American Journal of Gastroenterology 99:8, 1470-1476
CrossRef1229
Hector Rodriguez-Luna, Vijayan Balan, Pratima Sharma, Thomas Byrne, David Mulligan, Jorge Rakela, Hugo E. Vargas. (2004) Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver Transplantation. Transplantation 78:4, 580-583
CrossRef1230
Francis Y. Yao, John P. Roberts. (2004) Applying expanded criteria to liver transplantation for hepatocellular carcinoma: Too much too soon, or is now the time?. Liver Transplantation 10:7, 919-921
CrossRef1231
Mark W. Russo, Joseph A. Galanko, Steven L. Zacks, Kimberly L. Beavers, Michael W. Fried and, Roshan Shrestha. (2004) Impact of Donor Age and Year of Transplant on Graft Survival in Liver Transplant Recipients with Chronic Hepatitis C. American Journal of Transplantation 4:7, 1133-1138
CrossRef1232
Kirti Shetty, Kate Timmins, Colleen Brensinger, Emma E. Furth, Sushil Rattan, Weijing Sun, Mark Rosen, Michael Soulen, Abraham Shaked, K. Rajender Reddy, Kim M. Olthoff. (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transplantation 10:7, 911-918
CrossRef1233
Pascal Artru, Gérard Lledo. (2004) Transplantation hépatique pour CHC une indication de choix chez des patients sélectionnés!. Acta Endoscopica 34:3, 361-361
CrossRef1234
Linda L Wong, Kathryn Tanaka, Lansdale Lau, Steven Komura. (2004) Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clinical Transplantation 18:3, 227-234
CrossRef1235
Darrell H.G. Crawford, Linda M. Fletcher, Stefan G. Hubscher, Katherine A. Stuart, Edward Gane, Peter W. Angus, Gary P. Jeffrey, Geoffrey W. McCaughan, Paul Kerlin, Lawrie W. Powell, Elwyn E. Elias. (2004) Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology 39:6, 1655-1662
CrossRef1236
Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama, Yasuhiro Sone, Makoto Tanikawa, Yasuhiro Hisanaga, Kazuhiko Hayashi, Takashi Honda, Shusuke Kitabatake, Teiji Kuzuya, Koji Nonogaki, Toshifumi Kasugai, Junichi Shimizu. (2004) Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000. Cancer 100:11, 2415-2421
CrossRef1237
Ronnie T. Poon, Sheung Tat Fan. (2004) Resection prior to liver transplantation for hepatocellular carcinoma: A strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transplantation 10:6, 813-815
CrossRef1238
O. S. Lin, E. B. Keeffe, G. D. Sanders, D. K. Owens. (2004) Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Alimentary Pharmacology and Therapeutics 19:11, 1159-1172
CrossRef1239
Henry Lik-Yuen Chan, Albert Ka-Keung Chui, Wan-Yee Lau, Francis Ka-Leung Chan, Alex Yui Hui, Araga Ramesha Nitin Rao, John Wong, Eric Chun-Hung Lai, Joseph Jao-Yiu Sung. (2004) Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis. Clinical Transplantation 18:3, 295-300
CrossRef1240
Jill Allen, Alan Venook. (2004) Hepatocellular carcinoma: Epidemic and treatment. Current Oncology Reports 6:3, 177-183
CrossRef1241
Noriyo Yamashiki, Jeffrey J. Gaynor, Tomoaki Kato, K. Rajender Reddy, Abhasnee Sobhonslidsuk, David Levi, Seigo Nishida, Juan Madariaga, Jose Nery, Eugene R. Schiff, Andreas G. Tzakis. (2004) Competing Risks Analysis of Predictors of Delisting Owing to Tumor Progression in Liver Transplant Candidates with Hepatocellular Carcinoma. American Journal of Transplantation 4:5, 774-781
CrossRef1242
Francis Y. Yao, Nathan M. Bass, Nancy L. Ascher, John P. Roberts. (2004) Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transplantation 10:5, 621-630
CrossRef1243
David H. Van Thiel, Sherri Yong, S. David Li, Marc Kennedy, John Brems. (2004) The development ofde novo hepatocellular carcinoma in patients on a liver transplant list: Frequency, size, and assessment of current screening methods. Liver Transplantation 10:5, 631-637
CrossRef1244
Gidon Almogy, Sivan Lieberman, Maya Gips, Orit Pappo, Yair Edden, Oded Jurim, B. Simon Slasky, B. Uzieli, Ahmed Eid. (2004) Clinical outcomes of surgical resections for primary liver sarcoma in adults: results from a single centre. European Journal of Surgical Oncology (EJSO) 30:4, 421-427
CrossRef1245
J.I. Herrero Santos, J. Quiroga Vila. (2004) Trasplante hepático. Medicine - Programa de Formación Médica Continuada Acreditado 9:9, 569-577
CrossRef1246
Giovan Giuseppe Di Costanzo, Francesco Paolo Picciotto, Giuseppina Marino Marsilia, Antonio Ascione. (2004) Hepatic splenosis misinterpreted as hepatocellular carcinoma in cirrhotic patients referred for liver transplantation: Report of two cases. Liver Transplantation 10:5, 706-709
CrossRef1247
Christoph E Broelsch, Andrea Frilling, Massimo Malago. (2004) Hepatoma—resection or transplantation. Surgical Clinics of North America 84:2, 495-511
CrossRef1248
Sasan Roayaie, Jonathan D. Schwartz, Max W. Sung, Sukru H. Emre, Charles M. Miller, Gabriel E. Gondolesi, Nancy R. Krieger, Myron E. Schwartz. (2004) Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Liver Transplantation 10:4, 534-540
CrossRef1249
Linda L Wong, Naoky Tsai, Whitney Limm, Livingston Wong. (2004) Liver transplant for hepatocellular cancer: a treatment for the select few. Clinical Transplantation 18:2, 205-210
CrossRef1250
Richard B. Freeman, Russell H. Wiesner, John P. Roberts, Suzanne McDiarmid, Dawn M. Dykstra, Robert M. Merion. (2004) Improving liver allocation: MELD and PELD. American Journal of Transplantation 4:s9, 114-131
CrossRef1251
Kuo-Feng Tai, Ding-Shinn Chen, Lih-Hwa Hwang. (2004) Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: Mechanisms for the superior antitumor activity of live tumor cell vaccines. Journal of Biomedical Science 11:2, 228-238
CrossRef1252
Chung-Mau Lo, Sheung-Tat Fan, Chi-Leung Liu, See-Ching Chan, John Wong. (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 10:3, 440-447
CrossRef1253
A. Ferlitsch, A. Kreil, E. Bauer, H. Schmidinger, M. Schillinger, A. Gangl, M. Peck-Radosavljevic. (2004) Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma. European Journal of Clinical Investigation 34:3, 218-223
CrossRef1254
Robert A. Fisher. (2004) Living donor liver transplantation for hepatocellular carcinoma: Altruism to the rescue. Liver Transplantation 10:3, 448-448
CrossRef1255
Yamini K. Maddala, Linda Stadheim, James C. Andrews, Lawrence J. Burgart, Charles B. Rosen, Walter K. Kremers, Gregory Gores. (2004) Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transplantation 10:3, 449-455
CrossRef1256
Timothy M. Pawlik, Charles R. Scoggins, Melanie B. Thomas, Jean-Nicolas Vauthey. (2004) Advances in the Surgical Management of Liver Malignancies. The Cancer Journal 10:2, 74-87
CrossRef1257
Nobuhiko Shimozawa, Kazuhiro Hanazaki. (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma1 1No competing interests declared.. Journal of the American College of Surgeons 198:3, 356-365
CrossRef1258
Nicholas N. Nissen, Emanuel Cavazzoni, Tram T. Tran, Fred P. Poordad. (2004) Emerging Role of Transplantation for Primary Liver Cancers. The Cancer Journal 10:2, 88-96
CrossRef1259
Ronnie Tung-Ping Poon, Sheung-Tat Fan. (2004) Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome. Liver Transplantation 10:S2, S39-S45
CrossRef1260
Masatoshi Makuuchi, Keiji Sano. (2004) The surgical approach to HCC: Our progress and results in Japan. Liver Transplantation 10:S2, S46-S52
CrossRef1261
Aur
CrossRef1262
Josep M. Llovet, Josep Fuster, Jordi Bruix, . (2004) The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transplantation 10:S2, S115-S120
CrossRef1263
Guido Torzilli, Jacques Belghiti, Masatoshi Makuuchi. (2004) Differences and similarities in the approach to hepatocellular carcinoma between Eastern and Western institutions. Liver Transplantation 10:S2, S1-S2
CrossRef1264
Umberto Cillo, Alessandro Vitale, Marco Bassanello, Patrizia Boccagni, Alberto Brolese, Giacomo Zanus, Patrizia Burra, Stefano Fagiuoli, Fabio Farinati, Massimo Rugge, Davide Francesco DʼAmico. (2004) Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma. Annals of Surgery 239:2, 150-159
CrossRef1265
Myron Schwartz. (2004) Liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation 10:S2, S81-S85
CrossRef1266
Stuart J. Knechtle. (2004) Challenging Choices. Annals of Surgery 239:2, 160-161
CrossRef1267
Pratima Sharma, Vijayan Balan, Jose L. Hernandez, Ann M. Harper, Erick B. Edwards, Hector Rodriguez-Luna, Thomas Byrne, Hugo E. Vargas, David Mulligan, Jorge Rakela, Russell H. Wiesner. (2004) Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transplantation 10:1, 36-41
CrossRef1268
Jean Marc Regimbeau, Eddie K. Abdalla, Jean Nicolas Vauthey, Gregory Y. Lauwers, Fran
CrossRef1269
Richard B. Freeman. (2004) Liver allocation for HCC: A moving target. Liver Transplantation 10:1, 49-51
CrossRef1270
Jong-Hyun Kim, Kyung-Ran You, In Hee Kim, Baik-Hwan Cho, Chan-Young Kim, Dae-Ghon Kim. (2004) Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology 39:1, 129-138
CrossRef1271
Paul H. Hayashi, James F. Trotter, Lisa Forman, Marcelo Kugelmas, Tracy Steinberg, Paul Russ, Michael Wachs, Thomas Bak, Igal Kam, Gregory T. Everson. (2004) Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transplantation 10:1, 42-48
CrossRef1272
Laurie Blendis, Morris Sherman. (2004) Hepatocellular Carcinoma. American Journal of Cancer 3:6, 349-368
CrossRef1273
Sakae Nagaoka, Hiroshi Yatsuhashi, Hisayuki Hamada, Koji Yano, Takehiro Matsumoto, Manabu Daikoku, Kokichi Arisawa, Hiromi Ishibashi, Michiaki Koga, Michio Sata, Michitami Yano. (2003) The des-?-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer 98:12, 2671-2677
CrossRef1274
Jacques Belghiti, Alexandre Cortes, Eddie K. Abdalla, Jean-Marc Régimbeau, Kurumboor Prakash, François Durand, Daniele Sommacale, Federica Dondero, Mickael Lesurtel, Alain Sauvanet, Olivier Farges, Reza Kianmanesh. (2003) Resection Prior to Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 238:6, 885-893
CrossRef1275
Jonathan M. Schwartz, John M. Ham. (2003) Treatment of hepatocellular carcinoma. Current Treatment Options in Gastroenterology 6:6, 465-472
CrossRef1276
Josep M Llovet, Andrew Burroughs, Jordi Bruix. (2003) Hepatocellular carcinoma. The Lancet 362:9399, 1907-1917
CrossRef1277
Sandy Feng, Joseph F. Buell, Ravi S. Chari, J. Michael DiMaio, Douglas W. Hanto. (2003) Tumors and Transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. American Journal of Transplantation 3:12, 1481-1487
CrossRef1278
Massimo Colombo. (2003) Hepatitis C infection and hepatocellular carcinoma. Current Hepatitis Reports 2:4, 166-172
CrossRef1279
John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan. (2003) Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 4:12, 2175-2185
CrossRef1280
J.-L. Raoul, M. Messner, E. Boucher, J.-F. Bretagne, J.-P. Campion, K. Boudjema. (2003) Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of131I-labelled lipiodol. British Journal of Surgery 90:11, 1379-1383
CrossRef1281
Masami Minagawa, Masatoshi Makuuchi, Tadatoshi Takayama, Norihiro Kokudo. (2003) Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma. Annals of Surgery 238:5, 703-710
CrossRef1282
Marta Burrel, Josep M. Llovet, Carmen Ayuso, Carmela Iglesias, Margarita Sala, Rosa Miquel, Teresa Caralt, Juan Ramon Ayuso, Manel Solé, Marcelo Sanchez, Concepció Brú, Jordi Bruix. (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation. Hepatology 38:4, 1034-1042
CrossRef1283
Mauro Salizzoni, Renato Romagnoli, Francesco Lupo, Ezio David, Stefano Mirabella, Elisabetta Cerutti, Antonio Ottobrelli. (2003) Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation 76:5, 844-848
CrossRef1284
Vincent Donckier, Jean Luc Van Laethem, Daniel Van Gansbeke, Brigitte Ickx, Pierre Lingier, Jean Closset, Issam El Nakadi, Pascale Feron, Nathalie Boon, Nadine Bourgeois, Michael Adler, Michel Gelin. (2003) New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. Journal of Surgical Oncology 84:1, 36-44
CrossRef1285
A Shaw. (2003) Ultrasound of Non-vascular Complications in the Post Liver Transplant Patient. Clinical Radiology 58:9, 672-680
CrossRef1286
Guillermo Marı́n-Hargreaves, Daniel Azoulay, Henri Bismuth. (2003) Hepatocellular carcinoma: surgical indications and results. Critical Reviews in Oncology/Hematology 47:1, 13-27
CrossRef1287
L. Bolondi, F. Piscaglia, V. Camaggi, G. L. Grazi, A. Cavallari. (2003) Liver transplantation for HCC. Treatment options on the waiting list. Alimentary Pharmacology and Therapeutics 17:s2, 145-150
CrossRef1288
S. Gaiani, N. Celli, L. Cecilioni, F. Piscaglia, L. Bolondi. (2003) Percutaneous treatment of hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 17:s2, 103-110
CrossRef1289
J. C. Trinchet, N. Ganne-Carrie, M. Beaugrand. (2003) Intra-arterial treatments in patients with hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 17:s2, 111-118
CrossRef1290
M. Mela, A. Mancuso, A. K. Burroughs. (2003) Hepatocellular carcinoma: indications for liver transplantation. Alimentary Pharmacology and Therapeutics 17:s2, 130-137
CrossRef1291
T. Steinmuller, S. Jonas, P. Neuhaus. (2003) Liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 17:s2, 138-144
CrossRef1292
Luciano De Carlis, Alessandro Giacomoni, Vincenzo Pirotta, Andrea Lauterio, Abdhallah O Slim, Cinzia Sammartino, Massimo Cardillo, Domenico Forti. (2003) Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. Journal of the American College of Surgeons 196:6, 887-897
CrossRef1293
M. Varela, M. Sala, J. M. Llovet, J. Bruix. (2003) Natural history and prognostic prediction of patients with hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 17:s2, 98-102
CrossRef1294
Marine Gross-Goupil, Philippe Riou, Jean-Fran
CrossRef1295
P. Mathurin, B. Raynard, S. Dharancy, S. Kirzin, D. Fallik, F.-R. Pruvot, D. Roumilhac, V. Canva, J.-C. Paris, J.-C. Chaput, S. Naveau. (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 17:10, 1247-1261
CrossRef1296
Giorgio Ercolani, Gian Luca Grazi, Matteo Ravaioli, Massimo Del Gaudio, Andrea Gardini, Matteo Cescon, Giovanni Varotti, Francesco Cetta, Antonino Cavallari. (2003) Liver Resection for Hepatocellular Carcinoma on Cirrhosis. Annals of Surgery 237:4, 536-543
CrossRef1297
D. Maluf, R. A. Fisher, T. Maroney, A. Cotterell, A. Fulcher, J. Tisnado, M. Contos, V. Luketic, R. Stravitz, M. Shiffman, R. Sterling, M. Posner. (2003) Non-Resective Ablation and Liver Transplantation in Patients with Cirrhosis and Hepatocellular Carcinoma (HCC): Safety and Efficacy. American Journal of Transplantation 3:3, 312-317
CrossRef1298
Chao-Long Chen, Sheung-Tat Fan, Sung-Gyu Lee, Masatoshi Makuuchi, Koichi Tanaka. (2003) Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 75:Supplement, S6-S11
CrossRef1299
Luciano Carlis, Alessandro Giacomoni, Andrea Lauterio, Abdallah Slim, Cinzia Sammartino, Vincenzo Pirotta, Giovanni Colella, Domenico Forti. (2003) Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?. Transplant International 16:2, 115-122
CrossRef1300
Satoshi Kaihara, Tetsuya Kiuchi, Mikiko Ueda, Fumitaka Oike, Yasuhiro Fujimoto, Kohei Ogawa, Koichi Kozaki, Koichi Tanaka. (2003) Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75:Supplement, S37-S40
CrossRef1301
Michael C. Soulen. (2003) Multimodality Image-Guided Therapy for Liver Tumors. Journal of Vascular and Interventional Radiology 14:2, P211-P217
CrossRef1302
R. H. Wiesner, J. Rakela, M. B. Ishitani, D. C. Mulligan, J. R. Spivey, J. L. Steers, R. A. F. Krom. (2003) Recent Advances in Liver Transplantation. Mayo Clinic Proceedings 78:2, 197-210
CrossRef1303
N. W. W. Choong, S. Asfandiyar, L. R. Roberts. (2003) 67-Year-Old Man With Hepatitis C Infection and Abdominal Distention. Mayo Clinic Proceedings 78:2, 217-220
CrossRef1304
E Dick. (2003) MR-guided Laser Thermal Ablation of Primary and Secondary Liver Tumours. Clinical Radiology 58:2, 112-120
CrossRef1305
Bruno Daniele, Ilario De Sio, Francesco Izzo, Gaetano Capuano, Augusto Andreana, Roberto Mazzanti, Antonino Aiello, Paolo Vallone, Francesco Fiore, Giovan Battista Gaeta, Francesco Perrone, Sandro Pignata, Ciro Gallo. (2003) Hepatic Resection and Percutaneous Ethanol Injection as Treatments of Small Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 36:1, 63-67
CrossRef1306
Chun-Nan Yeh, Wei-Chen Lee, Miin-Fu Chen. (2003) Hepatic Resection and Prognosis for Patients With Hepatocellular Carcinoma Larger Than 10 cm: Two Decades of Experience at Chang Gung Memorial Hospital. Annals of Surgical Oncology 10:9, 1070-1076
CrossRef1307
Sven Jonas, Thomas Steinmuller, Stefan G. Tullius, Armin Thelen, Utz Settmacher, Thomas Berg, Cornelia Radtke, Peter Neuhaus. (2003) Increased mortality after liver transplantation for hepatocellular carcinoma in hepatitis B-associated cirrhosis. Transplant International 16:1, 33-36
CrossRef1308
René Adam, Daniel Azoulay, Denis Castaing, Rony Eshkenazy, Gérard Pascal, Kentaro Hashizume, Didier Samuel, Henri Bismuth. (2003) Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis. Transactions of the ... Meeting of the American Surgical Association 121, 201-212
CrossRef1309
Charles H. Cha, Leyo Ruo, Yuman Fong, William R. Jarnagin, Jinru Shia, Leslie H. Blumgart, Ronald P. DeMatteo. (2003) Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation. Transactions of the ... Meeting of the American Surgical Association 121, 9-17
CrossRef1310
Jorge A. Marrero, Robert J. Fontana, Grace L. Su, Hari S. Conjeevaram, Dawn M. Emick, Anna S. Lok. (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States. Hepatology 36:6, 1349-1354
CrossRef1311
Yujin Hoshida, Yasushi Shiratori, Masao Omata. (2002) Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma. Liver International 22:6, 479-485
CrossRef1312
MOHAMED RELA, ANIL AGARWAL. (2002) Liver transplantation. Journal of Gastroenterology and Hepatology 17:s3, S294-S297
CrossRef1313
JOSEP M LLOVET. (2002) Evidence-based medicine in the treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 17:s3, S428-S433
CrossRef1314
KC TAN. (2002) Surgery for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 17:s3, S421-S423
CrossRef1315
William B. Eubank, Kimberly L. Wherry, Jeff H. Maki, Hakan Sahin, Charles P. Funkhouser, Udo P. Schmiedl. (2002) Preoperative evaluation of patients awaiting liver transplantation: Comparison of multiphasic contrast-enhanced 3D magnetic resonance to helical computed tomography examinations. Journal of Magnetic Resonance Imaging 16:5, 565-575
CrossRef1316
Charles Cha, Ronald P. DeMatteo, Leslie H. Blumgart. (2002) Surgery and Ablative Therapy for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 35, S130-S137
CrossRef1317
Kunio Okuda, Yasuni Nakanuma, Masaru Miyazaki. (2002) Cholangiocarcinoma: Recent progress. Part 2: Molecular pathology and treatment. Journal of Gastroenterology and Hepatology 17:10, 1056-1063
CrossRef1318
David P Vogt, J.Michael Henderson, William D Carey, David Barnes. (2002) The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 132:4, 775-781
CrossRef1319
Robert A Fisher, Timothy P Maroney, Ann S Fulcher, Daniel Maluf, John A Clay, Luke G Wolfe, Sherfield Dawson, Adrian Cotterell, R Todd Stravitz, Velimir A Luketic, Mitchell Shiffman, Richard K Sterling, Marc P Posner. (2002) Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation. Clinical Transplantation 16:s7, 52-58
CrossRef1320
S SACCHERI, A LOVARIA, A SANGIOVANNI, A NICOLINI, C DEFAZIO, G RONCHI, P FASANI, E DELNINNO, M COLOMBO. (2002) Segmental Transcatheter Arterial Chemoembolization Treatment in Patients with Cirrhosis and Inoperable Hepatocellular Carcinomas. Journal of Vascular and Interventional Radiology 13:10, 995-999
CrossRef1321
K. Okuda. (2002) Hepatocellular carcinoma — History, current status and perspectives. Digestive and Liver Disease 34:9, 613-616
CrossRef1322
K Kamada. (2002) Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. The American Journal of Surgery 184:3, 284-290
CrossRef1323
FIDEL A. VALEA. (2002) Liver and Hepatic Duct Cancer. Clinical Obstetrics and Gynecology 45:3, 939-951
CrossRef1324
D. Samuel. (2002) Liver transplantation in Italy. Letter to Italian friends. Digestive and Liver Disease 34:9, 619-620
CrossRef1325
Mukesh G Harisinghani, Peter F Hahn. (2002) Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterology Clinics of North America 31:3, 759-776
CrossRef1326
S. Fagiuoli, V.G. Mirante, M. Pompili, S. Gianni, G. Leandro, G.L. Rapaccini, A. Gasbarrini, R. Naccarato, L. Pagliaro, M. Rizzetto, G. Gasbarrini. (2002) Liver transplantation: the Italian experience. Digestive and Liver Disease 34:9, 640-648
CrossRef1327
M CHOTI. (2002) Surgical Management of Hepatocellular Carcinoma: Resection and Ablation. Journal of Vascular and Interventional Radiology 13:9, S197-S203
CrossRef1328
C PATT, P THULUVATH. (2002) Role of Liver Transplantation in the Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S205-S210
CrossRef1329
D RAMSEY, L KERNAGIS, M SOULEN, J GESCHWIND. (2002) Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 13:9, S211-S221
CrossRef1330
R SALEM, K THURSTON, B CARR, J GOIN, J GESCHWIND. (2002) Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer. Journal of Vascular and Interventional Radiology 13:9, S223-S229
CrossRef1331
Takuma Teratani, Takashi Ishikawa, Yasushi Shiratori, Shuichiro Shiina, Haruhiko Yoshida, Masatoshi Imamura, Shuntaro Obi, Shinpei Sato, Keisuke Hamamura, Masao Omata. (2002) Hepatocellular carcinoma in elderly patients. Cancer 95:4, 816-823
CrossRef1332
G. W. McCaughan, D. J. Koorey, S. I. Strasser. (2002) Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal 32:8, 394-400
CrossRef1333
J. Gournay, J. Tchuenbou, C. Richou, C. Masliah, F. Lerat, B. Dupas, T. Martin, J. F. Nouel, M. Schnee, P. Montigny, A. D'Alincourt, A. Hamy, J. Paineau, J. -C. Le Neel, J. Le Borgne, J. P. Galmiche. (2002) Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis. Alimentary Pharmacology and Therapeutics 16:8, 1529-1538
CrossRef1334
PAUL J GOW, PETER W ANGUS. (2002) Disease recurrence after liver transplantation: Need we worry?. Journal of Gastroenterology and Hepatology 17:7, 733-736
CrossRef1335
Alex S. Befeler, Adrian M. Di Bisceglie. (2002) Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 122:6, 1609-1619
CrossRef1336
Jeffrey D. Wayne, Gregory Y. Lauwers, Iwao Ikai, Dorota A. Doherty, Jacques Belghiti, Yoshio Yamaoka, Jean-Marc Regimbeau, David M. Nagorney, Kim-Anh Do, Lee M. Ellis, Steven A. Curley, Raphael E. Pollock, Jean-Nicolas Vauthey. (2002) Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas. Annals of Surgery 235:5, 722-731
CrossRef1337
Sasan Roayaie, Jason S. Frischer, Sukru H. Emre, Thomas M. Fishbein, Patricia A. Sheiner, Max Sung, Charles M. Miller, Myron E. Schwartz. (2002) Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters. Annals of Surgery 235:4, 533-539
CrossRef1338
Linda L Wong. (2002) Current status of liver transplantation for hepatocellular cancer. The American Journal of Surgery 183:3, 309-316
CrossRef1339
Jean-Marc Regimbeau, Reza Kianmanesh, Olivier Farges, Federica Dondero, Alain Sauvanet, Jacques Belghiti. (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131:3, 311-317
CrossRef1340
Ronnie Tung-Ping Poon, Sheung Tat Fan, Chung Mau Lo, Chi Leung Liu, John Wong. (2002) Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function. Annals of Surgery 235:3, 373-382
CrossRef1341
Burckhardt Ringe. (2002) Transplantation for liver tumors: current status. Liver International 22:1, 1-7
CrossRef1342
Paul R. Engstrom. 2002. Hepatocellular Carcinoma (HCC). , 363-371.
CrossRef1343
Markus Sagmeister, Eberhard L. Renner, Beat Mullhaupt, John B. Wong. (2002) Simulation of hepatitis C based on a mandatory reporting system. European Journal of Gastroenterology & Hepatology 14:1, 25-34
CrossRef1344
M. Harris, P. Gibbs, J. Cebon, R. Jones, R. Sewell, T. Schelleman, P. Angus. (2001) Hepatocellular carcinoma and chemoembolization. Internal Medicine Journal 31:9, 517-522
CrossRef1345
Massimo Colombo. (2001) Treatment of hepatocellular carcinoma. Antiviral Research 52:2, 209-215
CrossRef1346
Francis Yao, Norah Terrault. (2001) Hepatitis C and hepatocellular carcinoma. Current Treatment Options in Oncology 2:6, 473-483
CrossRef1347
F. Farinati, S. Gianni, G. Marin, S. Fagiuoli, M. Rinaldi, R. Naccarato. (2001) Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?. European Journal of Gastroenterology & Hepatology 13:10, 1217-1224
CrossRef1348
(2001) Transplantation of Liver Grafts from Living Donors into Adults. New England Journal of Medicine 345:12, 923-924
Full Text1349
Adam E. Levy, Kris V. Kowdley. (2001) Unresectable Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 33:3, 180-182
CrossRef1350
Masakazu Yamamoto, Ken Takasaki, Takehito Ohtsubo, Hideo Katsuragawa, Chifumi Fukuda, Satoshi Katagiri. (2001) Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: Retrospective analysis. Surgery 130:3, 443-448
CrossRef1351
Steve J. Cheng, Daniel S. Pratt, Richard B. Freeman, Marshall M. Kaplan, John B. Wong. (2001) LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1. Transplantation 72:5, 861-868
CrossRef1352
Yasushi Shiratori, Haruhiko Yoshida, Masao Omata. (2001) Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Review of Anticancer Therapy 1:2, 277-290
CrossRef1353
B. Brans, F. De Winter, L. Defreyne, R. Troisi, P. Vanlangenhove, H. Van Vlierberghe, B. Lambert, M. Praet, B. de Hemptinne, R. A. Dierckx. (2001) The Anti-Tumoral Activity of Neoadjuvant Intra-Arterial 131 I-Lipiodol Treatment for Hepatocellular Carcinoma: A Pilot Study. Cancer Biotherapy & Radiopharmaceuticals 16:4, 333-338
CrossRef1354
Gian Luca Grazi, Giorgio Ercolani, Filippo Pierangeli, Massimo Del Gaudio, Matteo Cescon, Antonino Cavallari, Alighieri Mazziotti. (2001) Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added Value. Annals of Surgery 234:1, 71-78
CrossRef1355
F. Farinati, S. Gianni, M. Franco. (2001) Le carcinome hépato-cellulaire, prévention et diagnostic précoce: où en sommes-nous?. Acta Endoscopica 31:4, 515-520
CrossRef1356
T Livraghi. (2001) Guidelines for treatment of liver cancer. European Journal of Ultrasound 13:2, 167-176
CrossRef1357
Anna S. Lok, E. Jenny Heathcote, Jay H. Hoofnagle. (2001) Management of hepatitis B: 2000—Summary of a workshop. Gastroenterology 120:7, 1828-1853
CrossRef1358
Alan W. Hemming, Mark S. Cattral, Alan I. Reed, Willem J. Van der Werf, Paul D. Greig, Richard J. Howard. (2001) Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 233:5, 652-659
CrossRef1359
Myron J Tong, Lawrence M Blatt, Vincent WC Kao. (2001) Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. Journal of Gastroenterology and Hepatology 16:5, 553-559
CrossRef1360
Hidenori Toyoda, Takashi Kumada, Satoshi Nakano, Isao Takeda, Keiichi Sugiyama, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Sone, Yasuhiro Hisanaga. (2001) Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 91:5, 957-963
CrossRef1361
F Farinati, S Gianni. (2001) Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?. European Journal of Cancer Prevention 10:1, 111-115
CrossRef1362
Sasan Roayaie, Menahem Ben Haim, Sukru Emre, Thomas M. Fishbein, Patricia A. Sheiner, Charles M. Miller, Myron E. Schwartz. (2000) Comparison of Surgical Outcomes for Hepatocellular Carcinoma in Patients With Hepatitis B Versus Hepatitis C: A Western Experience. Annals of Surgical Oncology 7:10, 764-770
CrossRef1363
Josep M Llovet, Jordi Bruix. (2000) Early diagnosis and treatment of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 14:6, 991-1008
CrossRef1364
J-F Emile, R Adam, M Sebagh, E Marchadier, B Falissard, E Dussaix, H Bismuth, M Reynes. (2000) Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology 37:6, 523-529
CrossRef1365
Fabio Farinati, Michela Rinaldi, Simona Gianni, Remo Naccarato. (2000) How should patients with hepatocellular carcinoma be staged?. Cancer 89:11, 2266-2273
CrossRef1366
D. Rohan Jeyarajah. (2000) Localized hepatocellular carcinoma. Current Treatment Options in Gastroenterology 3:6, 463-472
CrossRef1367
William J. Wall, Paul J. Marotta. (2000) Surgery and transplantation for hepatocellular cancer. Liver Transplantation 6:6B, s16-s22
CrossRef1368
Gregory T. Everson. (2000) Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transplantation 6:6B, s2-s10
CrossRef1369
Alan P. Venook. (2000) Hepatocellular carcinoma. Current Treatment Options in Oncology 1:5, 407-414
CrossRef1370
Takashi Nishizaki, Keishi Kishikawa, Tomoharu Yoshizumi, Hideaki Uchiyama, Shinji Okano, Toru Ikegami, Koji Hashimoto, Kenichi Nomoto, Mitsuo Shimada, Katsuhiko Yanaga, Kenji Takenaka, Keizo Sugimachi, Yukio Ando, Masayuki Ando. (2000) DOMINO LIVER TRANSPLANTATION FROM A LIVING RELATED DONOR. Transplantation 70:8, 1236-1239
CrossRef1371
Hugo R. Rosen, Paul Martin. (2000) VIRAL HEPATITIS IN THE LIVER TRANSPLANT RECIPIENT. Infectious Disease Clinics of North America 14:3, 761-784
CrossRef1372
Russell W. Strong. (2000) Transplantation for liver and biliary cancer. Seminars in Surgical Oncology 19:2, 189-199
CrossRef1373
René Adam, Valérie Cailliez, Pietro Majno, Vincent Karam, Paul McMaster, Roy Y Calne, John O'Grady, Rudolf Pichlmayr, Peter Neuhaus, Jean-Bernard Otte, Krister Hoeckerstedt, Henri Bismuth. (2000) Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. The Lancet 356:9230, 621-627
CrossRef1374
Usha Dutta. (2000) Treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 15:8, 822-824
CrossRef1375
Emily K. Bergsland, Alan P. Venook. (2000) Hepatocellular carcinoma. Current Opinion in Oncology 12:4, 357-361
CrossRef1376
Maya Gambarin-Gelwan, David C. Wolf, Robert Shapiro, Myron E. Schwartz, Albert D. Min. (2000) Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. The American Journal of Gastroenterology 95:6, 1535-1538
CrossRef1377
Juan Figueras, Eduardo Jaurrieta, Carlos Valls, Emilio Ramos, Teresa Serrano, Antonio Rafecas, Juan Fabregat, Jaime Torras. (2000) Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy11No competing interests declared.. Journal of the American College of Surgeons 190:5, 580-587
CrossRef1378
Olle Ringd??n, Gunnar S??derdahl, Jonas Mattsson, Mehmet Uzunel, Mats Remberger, Patrik Hentschke, Hans H??gglund, Elda Sparrelid, Annika Elmhorn-Rosenborg, Frans Duraj, Henrik Zetterquist, Bo-G??ran Ericzon. (2000) TRANSPLANTATION OF AUTOLOGOUS AND ALLOGENEIC BONE MARROW WITH LIVER FROM A CADAVERIC DONOR FOR PRIMARY LIVER CANCER1. Transplantation 69:10, 2043-2048
CrossRef1379
St Fan, St Cheung, Cm Lo. (2000) Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 15:5 (Suppl.), E181-E186
CrossRef1380
Massimo Colombo. (2000) Hepatocellular carcinoma in patients with HCV. Best Practice & Research Clinical Gastroenterology 14:2, 327-339
CrossRef1381
Motoyasu Ishii, Hiroko Gama, Nobuyuki Chida, Yoshiyuki Ueno, Haruhide Shinzawa, Tooru Takagi, Takayoshi Toyota, Tsuneo Takahashi, Reiji Kasukawa, . (2000) Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. The American Journal of Gastroenterology 95:4, 1036-1040
CrossRef1382
Leonhard Mohr, Srinivas Shankara, Seung-Kew Yoon, Tim U. Krohne, Michael Geissler, Bruce Roberts, Hubert E. Blum, Jack R. Wands. (2000) Gene therapy of hepatocellular carcinomain vitro andin vivo in nude mice by adenoviral transfer of theescherichia coli purine nucleoside phosphorylase gene. Hepatology 31:3, 606-614
CrossRef1383
Gianluca Perseghin, Vincenzo Mazzaferro, Lucia Piceni Sereni, Enrico Regalia, Stefano Benedini, Elena Bazzigaluppi, Andrea Pulvirenti, Adriana Antonio Silva Le
CrossRef1384
Thomas Zimmermann, Matthias Holtappels, Jörg Buhr, Karl-Heinz Berghäuser, Winfried M. Padberg. (2000) The efficacy of adjuvant cytostatic therapy after organ transplantation for malignancy: an experimental study with a combined transplantation/tumor model. Transplant International 13:2, 136-141
CrossRef1385
Nancy A. Dower, Lesley J. Smith. (2000) Liver transplantation for malignant liver tumors in children. Medical and Pediatric Oncology 34:2, 136-140
CrossRef1386
Robert L. Carithers. (2000) Liver transplantation. Liver Transplantation 6:1, 122-135
CrossRef1387
Afonso Ribeiro, David M. Nagorney, Gregory J. Gores. (2000) Localized hepatocellular carcinoma: Therapeutic options. Current Gastroenterology Reports 2:1, 72-81
CrossRef1388
Enrico Souto, Gregory J. Gores. (2000) When should a liver mass suspected of being a hepatocellular carcinoma be biopsied?. Liver Transplantation 6:1, 73-75
CrossRef1389
Jordi Bruix, Josep M. Llovet. (1999) Locoregional treatments for hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 13:4, 611-622
CrossRef1390
Morris Sherman. (1999) Screening for hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 13:4, 623-635
CrossRef1391
Ronald P. DeMatteo, Yuman Fong, Leslie H. Blumgart. (1999) Surgical treatment of malignant liver tumours. Best Practice & Research Clinical Gastroenterology 13:4, 557-574
CrossRef1392
Josep M. Llovet, Josep Fuster, Jordi Bruix, . (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 30:6, 1434-1440
CrossRef1393
Akk Chui, Arn Rao, Gw McCaughan, R Waugh, Dj Verran, D Koorey, D Painter, Agr Sheil. (1999) An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?. Clinical Transplantation 13:6, 531-535
CrossRef1394
Thomas R. Riley, Jill P. Smith. (1999) Preventive Care in Chronic Liver Disease. Journal of General Internal Medicine 14:11, 699-704
CrossRef1395
Susumu Hasegawa, Naruhiro Yamasaki, Takuya Hiwaki, Katsumi Sako, Yasuji Komorizono, Yoshirou Baba, Yasushi Imamura, Osamu Kubozono, Aichi Yoshida, Terukatsu Arima. (1999) Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 86:9, 1682-1690
CrossRef1396
A. K. K. Chui, A. R. N. Rao, G. W. Mccaughan, R. Waugh, D. J. Verran, D. Koorey, A. G. R. Sheil. (1999) LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS. ANZ Journal of Surgery 69:11, 798-801
CrossRef1397
Junji Yamamoto, Shunzaburo Iwatsuki, Tomoo Kosuge, Igor Dvorchik, Kazuaki Shimada, J. Wallis Marsh, Susumu Yamasaki, Thomas E. Starzl. (1999) Should hepatomas be treated with hepatic resection or transplantation?. Cancer 86:7, 1151-1158
CrossRef1398
Naga Chalasani, John C. Horlander, Areen Said, Helena Hoen, Kenyon K. Kopecky, Stephan M. Stockberger, Rajesh Manam, Paul Y. Kwo, Lawrence Lumeng. (1999) Screening for hepatocellular carcinoma in patients with advanced cirrhosis. The American Journal of Gastroenterology 94:10, 2988-2993
CrossRef1399
Christian Gouillat, Dimitri Manganas, Guillermo Saguier, René Duque-Campos, Philippe Berard. (1999) Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study11No competing interests declared.. Journal of the American College of Surgeons 189:3, 282-290
CrossRef1400
Naga Chalasani, Areen Said, Reid Ness, Helena Hoen, Lawrence Lumeng. (1999) Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. The American Journal of Gastroenterology 94:8, 2224-2229
CrossRef1401
Leona Kim Schluger, Franklin M Klion. (1999) The Indications for and Timing of Liver Transplantation. Journal of Intensive Care Medicine 14:3, 109-117
CrossRef1402
Yuman Fong, Ruth L. Sun, William Jarnagin, Leslie H. Blumgart. (1999) An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center. Annals of Surgery 229:6, 790
CrossRef1403
U. Dutta, K. Byth, J. Kench, M. H. Khan, S. A. Coverdale, M. Weltman, R. Lin, C. Liddle, G. C. Farrell. (1999) Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study. Australian and New Zealand Journal of Medicine 29:3, 300-307
CrossRef1404
G Francica. (1999) Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. European Journal of Ultrasound 9:2, 145-153
CrossRef1405
Denise M. Harnois, Jeffery Steers, James C. Andrews, Joseph C. Rubin, Henry C. Pitot, Lawrence Burgart, Russell H. Wiesner, Gregory J. Gores. (1999) Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transplantation and Surgery 5:3, 192-199
CrossRef1406
Carlos Esquivel, Emmet Keeffe, Gabriel Garcia, Joanne Imperial, Maria Millan, Humberto Monge, Samuel So. (1999) Resection versus transplantation for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 14:5s, S37-S41
CrossRef1407
Karin W. Houben, John L. McCall. (1999) Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: A systematic review. Liver Transplantation and Surgery 5:2, 91-95
CrossRef1408
Lawrie Powell, Warwick Selby, Geoffrey Mccaughan, Michael Grimm. (1999) Fifty years of gastroenterology in Australia. Journal of Gastroenterology and Hepatology 14:2, 179-193
CrossRef1409
Chris E. Freise, Linda Ferrell, Tao Liu, Nancy L. Ascher, John P. Roberts. (1999) EFFECT OF SYSTEMIC CYCLOSPORINE ON TUMOR RECURRENCE AFTER LIVER TRANSPLANTATION IN A MODEL OF HEPATOCELLULAR CARCINOMA1. Transplantation 67:4, 510-513
CrossRef1410
Ronnie Tung-Ping Poon, Sheung-Tat Fan, Chung-Mau Lo, Chi-Leung Liu, John Wong. (1999) Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma. Annals of Surgery 229:2, 216-222
CrossRef1411
Naofumi Nagasue, Hitoshi Kohno, Mitsuo Tachibana, Akira Yamanoi, Haruki Ohmori, Osama Nazmy El-Assal. (1999) Prognostic Factors After Hepatic Resection for Hepatocellular Carcinoma Associated With Child-Turcotte Class B and C Cirrhosis. Annals of Surgery 229:1, 84-90
CrossRef1412
Josep M. Llovet, Javier Bustamante, Antoni Castells, Ramon Vilana, Maria Del Carmen Ayuso, Margarita Sala, Concepci
CrossRef1413
H.-Peter Allgaier, Peter Deibert, Manfred Olschewski, Cornelia Spamer, Ulrich Blum, Wolfgang Gerok, Hubert E. Blum. (1998) Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection—a single-center analysis including 132 patients. International Journal of Cancer 79:6, 601-605
CrossRef1414
Jean-Paul Achkar, Victor Araya, Richard L. Baron, J. Wallis Marsh, Igor Dvorchik, Jorge Rakela. (1998) Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation. Liver Transplantation and Surgery 4:6, 477-482
CrossRef1415
Masatoshi Hori, Takamichi Murakami, Tonsok Kim, Satoru Takahashi, Hiromichi Oi, Kaname Tomoda, Yoshifumi Narumi, Hironobu Nakamura. (1998) Sensitivity of Double-Phase Helical CT During Arterial Portography for Detection of Hypervascular Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 22:6, 861-867
CrossRef1416
Hie-Won L. Hann. (1998) Hepatocellular carcinoma in Asian Americans. Cancer 83:S8, 1723-1729
CrossRef1417
Michael R. Lucey, Kimberly A. Brown, Gregory T. Everson, John J. Fung, Robert Gish, Emmet B. Keefe, Norman M. Kneteman, John R. Lake, Paul Martin, Jorge Rakela, Mitchell L. Shiffman, Samuel So, Russell H. Wiesner. (1998) MINIMAL CRITERIA FOR PLACEMENT OF ADULTS ON THE LIVER TRANSPLANT WAITING LIST. Transplantation 66:7, 956-962
CrossRef1418
R BOTTELLI, J TIBBALLS, D HOCHHAUSER, A WATKINSON, R DICK, A BURROUGHS. (1998) Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clinical Radiology 53:10, 713-716
CrossRef1419
Andrea Veltri, Maurizio Grosso, Maria C. Martina, Alessia Ciancio, Ezio David, Mauro Salizzoni, Umberto Soldano, Joseph Galli, Cesare Fava. (1998) Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: A retrospective study. CardioVascular and Interventional Radiology 21:5, 393-398
CrossRef1420
Bruno Sangro, Maite Herráiz, Miguel A. Martínez-González, Ignacio Bilbao, Ignacio Herrero, Oscar Beloqui, Maite Betés, Andrés de-la-Peña, Javier A. Cienfuegos, Jorge Quiroga, Jesús Prieto. (1998) Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institution. Surgery 124:3, 575-583
CrossRef1421
Fran
CrossRef1422
A. Königsrainer, B. W. Hochleitner. (1998) Multimodal anticancer therapy and liver transplantation for hepatocellular carcinoma. European Surgery 30:4, 225-226
CrossRef1423
Josep M. Llovet, Jordi Bruix, Josep Fuster, Antoni Castells, Juan Carlos Garcia-Valdecasas, Llu
CrossRef1424
S. N. Schotman, E. O. Schraa, R. L. Marquet, P. E. Zondervan, J. N. M. Ijzermans. (1998) Hepatocellular carcinoma and liver transplantation: an animal model. Transplant International 11:s1, S201-S205
CrossRef1425
W. O. Bechstein, O. Guckelberger, N. Kling, N. Rayes, S. G. Tullius, H. Lobeck, T. Vogl, S. Jonas, P. Neuhaus. (1998) Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transplant International 11:s1, S189-S192
CrossRef1426
M. Adham, E. Oussoultzoglou, C. Ducerf, B. Bancel, T. Bizollon, A. Rode, N. Berthoux, E. De La Roche, J. Baulieux. (1998) Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics. Transplant International 11:s1, S197-S200
CrossRef1427
Mario Lise, Stefano Bacchetti, Pierpaolo Da Pian, Donato Nitti, Pier Luigi Pilati, Paolo Pigato. (1998) Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma. Cancer 82:6, 1028-1036
CrossRef1428
Wolfgang Fischbach, Volker Groß, Jürgen Schölmerich, Christian Ell, Peter Layer, Wolfgang E. Fleig. (1998) Update Gastroenterologie 1997—Teil II. Medizinische Klinik 93:3, 146-164
CrossRef1429
Iwao Ikai, Yoshio Yamaoka, Yuzo Yamamoto, Nobuhiro Ozaki, Yoshiharu Sakai, Seiji Satoh, Niobuhiko Shinkura, Masayuki Yamamoto. (1998) Surgical Intervention for Patients With Stage IV-A Hepatocellular Carcinoma Without Lymph Node Metastasis. Annals of Surgery 227:3, 433-439
CrossRef1430
Gerd Otto, Udo Heuschen, Walter J. Hofmann, Georg Krumm, Ulf Hinz, Christian Herfarth. (1998) Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma. Annals of Surgery 227:3, 424-432
CrossRef1431
Souhei Ohguchi, Harushige Nakatsukasa, Toshihiro Higashi, Kozo Ashida, Kazuhiro Nouso, Masahiko Ishizaki, Naoki Hino, Yoshiyuki Kobayashi, Shuji Uematsu, Takao Tsuji. (1998) Expression of ?-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology 27:2, 599-607
CrossRef1432
Rudolf Pichlmayr, Arved Weimann, Karl J. Oldhafer, Hans J. Schlitt, Günter Tusch, Rudolf Raab. (1998) Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 24:1, 60-67
CrossRef1433
Mathurin, Rixe, Carbonell, Bernard, Cluzel, Bellin, Khayat, Opolon, Poynard. (1998) Review article: overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis?. Alimentary Pharmacology and Therapeutics 12:2, 111-126
CrossRef1434
David L. Paterson, Nina Singh, Timothy Gayowski, Ignazio R. Marino. (1998) Pulmonary Nodules in Liver Transplant Recipients. Medicine 77:1, 50-58
CrossRef1435
Kunihiko Ohnishi, Hisashi Yoshioka, Susumu Ito, Kenji Fujiwara. (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:1, 67-72
CrossRef1436
Jane Collier, Morris Sherman. (1998) Screening for hepatocellular carcinoma. Hepatology 27:1, 273-278
CrossRef1437
Christoph Bremer, Thomas Allkemper, Josef Menzel, Udo Sulkowski, Ernst Rummeny, Peter Reimer. (1998) Preliminary clinical experience with laser-induced interstitial thermotherapy in patients with hepatocellular carcinoma. Journal of Magnetic Resonance Imaging 8:1, 235-239
CrossRef1438
Pietro E. Majno, René Adam, Henri Bismuth, Denis Castaing, Arie Ariche, Jinane Krissat, Hubert Perrin, Daniel Azoulay. (1997) Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis. Annals of Surgery 226:6, 688-703
CrossRef1439
G. W. McCaughan, D. J. Koorey. (1997) Liver transplantation. Australian and New Zealand Journal of Medicine 27:4, 371-378
CrossRef1440
Eiji Ando, Fumihiko Yamashita, Masatoshi Tanaka, Kyuichi Tanikawa. (1997) A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79:10, 1890-1896
CrossRef1441
Stuart J. Knechtle, Munci Kalayoglu, Anthony M. D'Alessandro, Layton F. Rikkers. (1997) Proceed with Caution: Liver Transplantation for Metastatic Neuroendocrine Tumors. Annals of Surgery 225:4, 345-346
CrossRef1442
Frank Hartmann, Michael Pfreundschuh. (1997) Onkologie ’96. Medizinische Klinik 92:2, 83-100
CrossRef1443
Williams, Roger, Rizzi, Paolo, . (1996) Treating Small Hepatocellular Carcinomas. New England Journal of Medicine 334:11, 728-729
Full Text
